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When cardiac 
complaints occur 
in the absence 
of organic findings, 
underlying 
anxiety may be 
one factor 
The influence of anxiety on heart function 
Excessive anxiety is one of a combina, 
tion of factors that may trigger a series of 
maladaptive functional reactions which can 
generate further anxiety. Often involved in 
this vicious circle are some cardiac arrhyth, 
mias, paroxysmal supraventricular tachycar, 
dia and premature systoles. When these 
symptoms resemble those associated with 
actual organic disease, the overanxious 
patient needs reassurance that they have no 
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organic basis and that reduction of exces, 
sive anxiety and emotional overreaction 
would be medically beneficial. 
The benefits of antianxiety therapy 
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INTRODUCTION 
Recently, important strides have been made 
in clinical neurology and clinical neurosurgery, cul-
minating in improved patient care. The last ten 
years have witnessed a new sophistication in neuro-
radiology, and the clear development of neuro-
ophthalmology as a subspecialty. The addition of 
the operating microscope to neurosurgery has im-
proved the quaiity of the operation which we can 
provide for our patients. A renewed interest in and 
study of cerebral vascular disease has aided our 
understanding of the pathophysiology of this dis-
order. Of the various clinical neuroscience frontiers 
that have been forged, an improved understanding 
of the pathophysiology of brain injury is one of 
major significance. Much has been learned, both in 
laboratory and in clinical investigation, concerning 
the brain's response to insults such as anoxia-ische-
mia, elevated intracranial pressure, trauma, and 
neoplasm. Aiterations in cerebral blood flow and 
infracranial pressure in these conditions have been 
studied, and more recently studies of the brain's 
metabolic response to insults have been conducted. 
The clinical goal of improving our treatment of the 
insulted brain is becoming more of a reality. 
It is to these areas that the speakers at the 
27th Stoneburner Lecture Series addressed them-
selves. The Stoneburner Lecturer was Dr. Thomas 
W. Langfitt, Charles H. Frazier Professor and 
Chairman of the Division of Neurosurgery at the 
University of Pennsylvania. Leading us are Dr. 
Langfitt's pioneering efforts and continuing studies 
investigating the brain's pathophysiological response 
to injury. His first lecture, "The Interrelationship 
of Intracranial Pressure, Cerebral Blood Flow, and 
Brain Metabolism in Experimental Brain Injury," 
summarized much of his own work and provided 
a basic introduction to the program. His second 
lecture, "Clinical Advances in the Management of 
Patients with Severe Head Injury," demoristrated 
how an improved understanding of the brain's re-
sponse to an insult can improve patient care. 
The first part of the program emphasized cere-
bral vascular disease, and is presented in this issue. 
The second part of the program related primarily 
to the clinical care of patients with mechanical 
brain injury, brain tumors, and seizures, and will 
be presented in the following issue of the MCV 
Quarterly. 
DONALD P. BECKER, M.D. 
Professor and Chairman 
Division of Neurosurgery 
Medical College of Virginia 
Virginja Commonwealth University 
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The Interrelationship of lntracranial Pressure, Cerebral 
Blood Flow, and Brain Metabolism in Experimental 
Brain lniury* 
THOMAS W. LANGFITT, M.D. 
Charles H. Frazier Professor and Chairman, Division of Neurosurgery, 
University of Pennsylvania, Philadelphia 
This presentation will be concerned with some 
of the relationships between intracranial pressure, 
cerebral blood flow, and brain metabolism as defined 
in animal models (Fig. 1). We will also be concerned 
with the pathophysiological changes that occur among 
these numerous variables. 
We begin with the idea that our greatest concern 
is . with normal brain function. The brain, as we 
know, functions through the electrical activity of 
its neurons, but another way of measuring or de-
fining brain function is in terms of metabolism. For 
our purposes, the brain metabolizes only two sub-
stances-oxygen and glucose. Apparently, the brain 
does not have a store of oxygen nor does it have 
a significant store of glucose. It is, therefore, de-
pendent upon a constant supply of these metabolites. 
It is also known that the brain is selectively vulner-
able to ischemia, that the brain will not tolerate more 
than five minutes of cerebral circulatory arrest with-
out irreversible brain damage-a unique feature of 
the brain. One can put a tourniquet around the arm, 
totally occlude the circulation to the arm for a period 
of an hour or two for purposes of doing surgery, 
and following the removal of the tourniquet, the 
arm functions perfectly normally. The arm contains 
bone and muscle, but it also contains nerve and the 
neuromuscular junction. What is so unique about 
the brain that permits it to tolerate only five minutes 
* This is an edited transcription of a lecture presented 
by Dr. Langfitt at the 27th Annual Stoneburner Lecture 
Series, February 7, 1974, at the Medical College of Vir-
ginia, Richmond. 
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of ischemia, whereas peripheral nerve and neuro-
muscular junction can tolerate up to two hours of 
ischemia? This is one of the major dilemmas in our 
search for the pathophysiological and metabolic basis 
of brain injury; as of the moment, we do not really 
have a decent answer. 
The cerebral metabolic rate of oxygen utilization 
and the cerebral metabolic rate of glucose utilization 
are dependent upon an adequate delivery of oxygen 
and glucose. The amount of oxygen that is available 
to the brain is determined by two major factors: the 
oxygen content of the blood and the cerebral blood 
flow. The amount of oxygen in the blood is, in turn, 
determined by the pulmonary function and by the 
blood oxygen-carrying capacity. Figure 2 shows the 
familiar oxygen-hemoglobin dissociation curve. As 
the three curves at pH 7.6, 7.4, and 7.2 reach 
asymptote, they do so at a partial pressure of oxygen 
(Pa0 ,) in the blood of about 80-100 mm Hg. When 
the Pa0 , drops below this value, the degree of hemo-
globin saturation is significantly influenced by the 
pH. The normal patient may show a Pa0 , value from 
80 up to 140 or 200 mm Hg and the saturation of 
hemoglobin does not increase significantly, and there-
fore, in terms of treatment, it does not make much 
difference whether the Pa0 , is 80 or 200. We must 
remember, however, that the amount of oxygen avail-
able to the brain is a function not only of this value 
but also of cerebral blood flow. For example, if the 
cerebral blood flow is at a critical level, and the Pao, 
drops by only a small amount (from 100 to 80), this 
may be quite sufficient to plunge the brain into 
hypoxia. It follows, therefore, that in our acutely 
l 01 
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brain-injured patients, it is necessary to keep the Pa0 , 
at 100 mm Hg or above. When the Pa0 , is markedly 
decreased (to a value of 40 or 50 mm Hg), the pH 
value is of definite significance. At an alkalotic pH 
of 7.6 and about 40-50 mm Hg, one can see that 
hemoglobin is 853 saturated; whereas in acidosis, 
it is about 60% saturated. The important factor here 
is that in alkalosis, the hemoglobin hangs onto the 
oxygen; it will not release the oxygen as effectively as 
in acidosis. Therefore, in a situation where there is 
systemic hypoxia, a low Pa0 ,, and a reduction of 
cerebral blood flow approaching a critical value, the 
pH of the systemic blood becomes a tremendously 
important factor. It is quite possible, as the patient 
passes from an acidotic to an alkalotic pH, for the 
brain to be again plunged into hypoxia because at 
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that alkalotic pH, the hemoglobin will not give up 
the oxygen as well as it did when the pH was acidotic. 
What are the factors which govern the flow 
of blood through the brain? The two major ones 
include the cerebral perfusion pressure~ordinarily 
defined as the inflow pressure (the carotid artery 
pressure) minus the outflow pressure (the jugular 
vein pressure )-and the cerebral vascular resistance 
(Fig. 1 ) . The cerebral perfusion pressure, in turn, 
is influenced by the systemic arterial pressure (SAP) 
and the intracranial pressure (ICP). The cerebral 
vascular resistance, under normal circumstances, is 
primarily a function of arterial resistance; they are 
therefore called the resistance vessels, the arteries, 
and the arterioles. Also, under pathological condi-
tions, cerebral vascular resistance is tremendously 
influenced by events that occur within the microcir-
culation in the capillary bed, in the form of such 
things as edema of the wall of the capillaries and 
sludging of the intravascular blood. 
Figure 3 shows Poiseuille's equation for the flow 
of Newtonian fluids through a system of rigid tubes. 
This is only roughly applicable to a vascular bed but 
is helpful to us as we proceed through this discussion. 
Flow "Q" is directly proportional to the perfusion 
pressure and to the fourth power of the radius, dem-
onstrating that the diameter or the radius of the 
cerebrovascular bed is extremely important in govern-
ing the flow through it. If we substitute "R" resistance 
for "R" radius, we come up with a rather simple 
Ohm's law for the cerebral circulation, which says 
that the blood flow is equal to the inflow pressure 
minus the outflow pressure divided by the resistance (I = i) · Under normal circumstances, the perfusion 
pressure is defined as the carotid artery pressure minus 
the jugular vein pressure. It is very important, how-
Q 
Fig. 3. 
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ever, that in the presence of increased intracranial 
pressure, this relationship no longer holds. This is 
because it has been well demonstrated that as the 
intracranial pressure rises, the cerebral venous pres-
sure rises in concert, and the two pressures are es-
sentially equal to all levels of elevated intracranial 
pressure. It has become the convention to say, there-
fore, that the perfusion pressure across the brain, in 
the presence of increased intracranial pressure, is 
equal to the carotid artery pressure minus the intra-
cranial pressure again divided by the resistance. 
If the vascular resistance, the denominator R, 
remained the same during a change in perfusion 
pressure, cerebral blood flow would passively follow 
changes in perfusion pressure, whether the perfusion 
pressure was decreased by decreasing blood pressure 
or decreased by increasing the intracranial pressure. 
We know that this is not true because of the phe-
nomenon of autoregulation. Autoregulation is a 
ubiquitous physiological phenomenon which occurs 
in the brain, in the pulmonary circulation, the heart, 
gastrointestinal tract, and in the kidney. The one con-
spicuous organ which does not autoregulate is the 
skin. We define "pressure" autoregulation as a change 
in the diameter of the resistance vessels where blood 
flow remains constant in the presence of a change in 
perfusion pressure. According to Ohm's law of the 
cerebral circulation, if one reduces the perfusion 
pressure, the cerebral vessels dilate, thereby main-
taining blood flow and if one increases the perfusion 
pressure, the cerebral vessels constrict, thereby main-
taining the same blood flow. The origin of this par-
ticular type of autoregulation is somewhat uncertain, 
but our own data, as well as those of many others, 
would suggest that it is probably myogenic in origin 
and that it is probably a vascular reflex of the small 
arteries and the arterioles of the organ. 
In man, normal cerebral blood flow is between 
50~55 mlf 100 gm/ min. What one sees in man is a 
constant blood flow, even as the mean arterial blood 
pressure is slowly decreased, until the mean arterial 
pressure reaches a value of approximately 50-55 mm 
Hg at which point cerebral blood flow falls off 
abruptly; the reason it does so at this level is that 
the blood vessels are now maximally dilated, and 
they cannot dilate any further in response to the 
continued decrease in perfusion pressure. It is only 
at this point that blood flow bears a passive relation-
ship to perfusion pressure. 
One of the questions which we asked ourselves 
103 
sometime ago was whether or not the cerebral ves-
sels autoregulate in the same manner to increased 
intracranial pressure, decreasing perfusion pressure, 
as they autoregulate to decreased arterial pressure, 
decreasing perfusion pressure. This seemed extremely 
important because so many of our patients with a 
wide variety of brain insults develop intracranial 
hypertension. In fact, one could probably say that 
increased intracranial pressure, as a cause of de-
creased perfusion pressure, is more common in our 
patients than decreased blood pressure, or at least 
we can say that the blood pressure is more readily 
correctable. 
Douglas Miller conducted a series of experiments 
with dogs in our laboratory, in an attempt to dem-
onstrate the relationship between autoregulation and 
increased ICP. In these experiments, a hollow screw 
was put into the torcular Herophili of the dog and 
an extracorporeal shunt run from the torcular Hero-
phili to the jugular vein; the remaining venous out-
flow from the dog's head was occluded. Either an 
electromagnetic flow meter or a bubble flow meter 
can be used to measure blood flow through the shunt. 
This gives one a continuous measurement of cerebral 
blood flow (CBF). Further studies have shown that 
we are measuring total or nearly total CBF from the 
hemispheres and the diencephalon in this preparation. 
Some of Miller's data are seen in Figure 4. First, he 
decreased the arterial pressure by bleeding the animal 
and measured the CBF over a wide range of perfusion 
pressures. He was then able to develop an autoregula-
tory curve, reflected by the open circles. This is a 
typical curve of autoregulation showing that there 
is no significant change in CBF until the mean arterial 
pressure is reduced to about 50 mm Hg. In the same 
preparation, he then raised the arterial pressure back 
to normal by reinfusing blood. While the arterial 
pressure was constant, he raised the intracranial pres-
CBF o=aMAP•SE 
ml/min •=4 ICP 
•=P<0.01 
• • i~ ii ~ 
3o~n=9 
~:~" '~''' 
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CPPmm Hg 
Fig. 4. 
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sure, thereby reducing the perfusion pressure. That, 
then, is represented by the upper curve, the autoregula-
tory curve for increased intracranial pressure. One 
can see that the cerebral vessels do, in fact, autoregu-
late just as well to increased ICP as they do to de-
creased SAP and, for unexplained reasons, they 
autoregulate somewhat better to increased ICP. These 
animals were then subjected to a period of brain 
hypoxia by reducing the Pa 0 , to values of about 15- 20 
mm Hg for a period of ten minutes. In other words, 
the animals were subjected to brain insult. The exact 
procedure was repeated. Figure 5 shows a pressure 
passive system. Following the cerebral insult, auto-
regulation was destroyed and the blood flow followed 
the perfusion pressure passively whether the pressure 
was decreased again by either decreasing blood pres-
sure or by increasing intracranial pressure. 
The importance of these kinds of data is that 
they demonstrate that when autoregulation is intact 
in a patient, he will tolerate large decreases in blood 
pressure, shock, or large increases in intracranial 
pressure without significant cerebral ischemia. If, 
however, the patient has had a brain injury of some 
kind and autoregulation is defective, the brain be-
comes much more vulnerable to either decreased 
blood pressure or to increased intracranial pressure. 
Trauma to the brain in animals abolishes auto-
regulation just as hypoxia does. In a study at the 
University of Pennsylvania, regional cerebral blood 
flow was recorded from the surface of the cat's brain 
using the 85Kr clearance technique, which is very 
similar to the 133Xe clearance technique. During the 
control period, the blood flow from the cortex was 
normal during a drop in mean arterial pressure, show-
ing values as high as 170 down to about 60 mm Hg. 
The trauma in this case was minimal, consisting 
of directing a 500 millisecond impact of nitrogen 
gas through a nozzle at the surface of the brain. 
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It was minimal in the sense that there was no 
histological damage of the brain; the blood brain 
barrier was intact, and the EEG alteration was 
slight and immediately reversible. Autoregulation, 
however, was impaired, as demonstrated ]Jy the fact 
that following the trauma, when arterial pressure 
was again varied over a wide range, the characteris-
tic picture of abolished autoregulation, was seen. 
There is a second and equally important type 
of autoregulation which we term "metabolic" auto-
regulation, to be distinguished from pressure auto-
regulation. We can define metabolic autoregulation 
as a change in the diameter of the resistance vessels 
in order to meet the metabolic demands of the 
tissue. A good example of this is a change in cere-
bral blood flow in the region of the brain during an 
epileptic attack. Before the seizure occurs, blood 
flow is set for a given metabolic rate of oxygen. 
During the seizure, the tremendous increase in 
neuronal activity is accompanied by intense vaso-
dilation, markedly increasing the blood flow to that 
region of the brain appropriate to the increased 
metabolic demands of the epileptic tissue. Whereas 
pressure autoregulation is a physiologic phenome-
non, most likely a physiologic vascular reflex, meta-
bolic autoregulation, by contrast, is presumably a 
chemical phenomenon, probably due to a change 
in extracellular pH at the level of the resistance 
vessels, the small arteries and the arterioks. As the 
neuron increases its activity, it produces more lac-
tate and hydrogen ions. The hydrogen ions rapidly 
diffuse out of the neuron, through the extracellular 
space, and into the vasoactive vessel; the focal 
acidosis causes the vessel to dilate. The linkage 
in autoregulation, then, is apparently a hydrogen 
ion linkage. This means that if metabolism changes, 
a change in blood flow will follow which will be 
proportional to the change in metabolism as long 
as metabolic autoregulation is intact. 
An excellent example of this rule can be demon-
strated by what happens in hypothermia (Fig. 6). 
Hypothermia 
CBF (ml/lOOgm/min) CMR 0 
37'C 50 
30'C 25 
Fig. 6. 
2 
(ml/lOOgm / min) 
3.50 
1. 75 
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In hypothermia, the primary change is decrease in 
brain metabolism. Under normothermic conditions 
of 37°C, CBF is 50 and the cerebral metabolic rate of 
oxygen utilization (CMR0 , ) is 3.5 ml/100 gm/ min. 
When one qecreases the CMR0 , to half that value, 
1.75, by decreasing the temperature to 30°C, CBF falls 
at the exact same rate-from 50 to 25. If one did not 
know about the fall in CMR0 ,, seeing only that the 
blood flow had decreased by one-half, he would say 
that the brain was about to become ischemic because 
the CBF was at a critical level. This is not true because 
CMR0 , has decreased the same amount. Even though 
CBF is markedly reduced, it is perfectly adequate for 
the needs of the hypothermic brain. · 
We have stated that pressure autoregulation is 
sensitive ta various types of brain injury. The same 
statement can be made about metabolic autoregula-
tion; thus, with certain kinds of insults, an unlinkage 
occurs between metabolism and blood flow and they 
go their separate ways. Figure 7 shows some setective 
data from · our patients to demonstrate this fact. All 
of these patients were unconscious; most of them had 
severe head injuries. In all of these patients the CMRo, 
is reduced. The normal value of 3.5 is reduced to as 
low as one-third of that value and even lower in two 
of the patients. The first patient (BJS) shows a me-
tabolism that is one-third of normal but the mean 
CBF is 114 ml/100 gm/ min, the highest mean hemi-
sphere blood flow we have seert in our series. In this 
circumstance, the patient has a condition which we 
defined a number of years ago as "vasomotor paraly-
sis"- in which there is no metabolic or pressure 
control of the cerebral vessels; the tone of the cerebral 
vessels has been destroyed. They passively dilate, 
thereby increasing cerebral blood flow. It is impossible 
to influence this process because both the pressure 
and the metabolic control of the blood vessels has been 
Patient CBF CMR 02 Outcome 
BJS 114 1. 05 Dead 
ED 77 1. 42 Dead 
JL 52 1. 76 Alive, well 
EF 34 0.76 Alive, demented 
MF 32 0.87 Alive, well 
Fig. 7. 
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destroyed. We see the same thing in the second patient 
(ED) with a CBF about 503 above normal, the 
CMR0 , again about one-third . normal. The third 
patient (JL) has a normal CBF, but it would not be 
normal if metabolic aµtoregulation were intact 
because the CMR0 , is only one-half normal. 
Some of the factors we are most interested in are: 
What constitutes a critical l~vel of Pa0 ,, a critical 
level of mean arterial pressure, and a critical level of 
CBF for brain function? How much can we reduce 
the oxygen content of the blood or the cerebral blood 
flow before hypo)l.ic tissue damage occurs? There is 
currently an argument as to what criteria should be 
used in determining hypoxic tissue damage. Two of 
these criteria are a decrease in high-energy phos-
phates (ATP and phosphocteatine) and an increase 
in anaerobic glycolysis. Normally, most of the glucose 
that is metabolized by the brain is done so aerobically. 
When the amount of oxygen is insufficient to maintain 
aerobic metabolism, anaerobic metabolism through 
the Embden-Meyerhof pathway increases, and there 
is a marked increase in the utilization of glucose. 
Generically, hypoxia means insufficient oxygen to 
the brain. But hypoxia may be divided into two cate-
gories: hypoxic hypoxia, generally due to inadequate 
pulmonary function, and ischemic hypoxia, due to 
inadequate blood flow. It is possible experimentally, 
in .the rat, to reduce the arterial Pa0 , to a value of 
about 25-30 mm Hg at which point a decrease i~ 
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phosphocreatine occurs. ATP does not change be-
cause the phosphocreatine is converted to ATP 
temporarily. This process, which is a derangement 
in oxidative phosphorylation in the mitochondria, 
is one criterion of hypoxic damage. Again, in rats, 
if the arterial Pa0 , is kept constant but the blood 
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pressure is dropped, in order to find out what the 
critical mean arterial blood pressure is for the main-
tenance of adequate oxidative phosphorylation, the 
valiie is about 30 mm Hg, at which point we see a 
drop in phosphocteatine and ATP and art increase 
in AMP and ADP. 
There have been a number of studies in recent 
years, both in nian and in experimental animals, 
which show that the critical value for cerebral blood 
flow is approximately 45 % of normal. According 
to Dr. Sundt's studies on patients undergoing endar-
terectomy, when the CBF dreipped to a value of 
18 or 19, about 45% of normal, there were EEG 
changes characteristic of brain ischemia. 
There is another new concept regarding the 
linkage between metabolism and cerebral blood flow . 
We have said that in metabolic autoregulation, the 
primary change occurs in metabolism and blood 
flow follows due to hydrogen ion linkage. Iri some 
of our patient studies, we found evidence to suggest 
a reverse mechanism-when blood flow decreased 
due to increased intracranial pressure, metabolism 
seemed to decrease with the decrease in blood flow. 
Teleologically this is extremely important because it 
means that if one decreases the CBF slowly enough 
over a perieid of time, the metabolism wili decrease 
by some unknown mechanism. 
Studying the autoregulation curve in the dog with 
the experimental design described pteviousiy, where 
cerebral blood is measured continuously by the torcu-
lar outflow technique, we found that when the mean 
cerebral perfusion pressure was decreased to about 
50 mm Hg by elevating the ICP, blood flow remained 
constant, but below a perfusion pressure of 50, blood 
:flow began to fall. We had been concerned mostly 
with the horizontal portion of the curve and had 
not paid much attention to the falling portiOn. What 
we did, therefore, was to increase the intracranial 
pressure very carefully in small increments in order to 
produce 103 decreases in CBF. At each one of these 
levels, we measured the cerebral metabolic rate of 
oxygen and glucose. Figure 8 shows the data regarding 
the CMR0,. On the abscissa, we have CBF beginning 
with the normal value of close to 50; CMR 0 , is on 
the ordinate. We see that when CBF has been de-
creased to about 703 of control, CMR0 , begins to 
fall and follows CBF down to approximately one-fifth 
of control. This decrease in CMR0 , occurs at values of 
CBF 703 of normal, far above those 'values required 
to provide the brain with art adequate amount of 
oxygen. At this point, therefore, it seems clear to us 
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that the decrease in cerebral metabolism is not a 
manifestation of brain damage; rather it appears to be 
due to some kind of metabolic control mechanism 
which tends to turn off the brain as the oxygen supply 
is reduced, a protective mechanism intrinsic to the 
brain. 
Figure 9 shows some of the dl:lta fqr the glucose 
-not quite so impressive, but again we see a decline 
in the cerebral metabolic rate of glucose with de-
creasing CBF. When we look at the area of the 
curve where CBF is 15 ml/ 100 gm/ min, we see 
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that this is the point where there is an increase 
in glucose metabblism. This is a manifestation of 
the onset of th~ 1 hypoxic tissue damage-anaerobic 
glycolysis-which occurs at about 45 % of control 
CBF. Figure 10 shows this more clearly in the form 
of the so-called glucose index. Normally the brain 
metabolizes about 90-95% of its glucose aero-
bically. One can see that at a value of 20~22, about 
45 % of control CBF, there is a marked change in 
the oxygen glucose index-a marked increase in 
anaerobic glycolysis. 
Arteriography of Cerebrovascular Disease* 
FREDERICK S. VINES, M.D. 
Associate Professor of Radiology and Neurology; Chief, Section of Neuroradiology, Medi-
cal College of Virginia, Health Sciences Division of Virginia Commonwealth University, 
Richmond 
Advances in reconstructive va~cular surgery 
have increased the importance of accurate angio-
graphic demonstration of the extracranial vascular 
tree. The limitations of the clinical examination 
are well recognized and make it essential that com-
plete angiography be obtained prior to contemplated 
surgery. The locus of cerebral involvement may be 
determined clinically, but the site and extent of 
vascular disease in a surgically accessible location 
must be confirmed. The role of the angiographer 
is, therefore, twofold: Firstly, he must be able to 
safely perform complete angiography with adequate 
evaluation of the multiple sites of possible involve-
ment; secondly, he must be aware of the j::>atho-
physiological changes which may occur and recognize 
·the techniques and pitfalls he may encounter in 
delineating these changes. The present communica-
tion will describe the more common findings ob-
served during angiography, along with some pitfalls 
the angiographer and clinician may encounter. 
The example of carotid stenosis in Figure lA 
certainly would be considered by most to be a 
surgical candidate with a remaining internal carotid 
lumen of less than 1 mm; however, the patient shown 
in Figure lB, with smooth carotid artery stenosis 
narrowing the lumen by approximately 60%, may 
not be a candidate for operative intervention. Extra-
cranial surgery was originally performed based on 
a theory of decreased cerebral blood flow, relative 
to an arbitrary degree of narrowing of the proximal 
arterial lumen. Thus, factors such as hypotension 
or cardiac arrhythmias which would result in de-
creased flow were considered to produce cerebral 
* Presented by Dr. Vines at the 27th Annual Stone-
burner Lecture Series, February 7, 1974, at the Medical 
College of Virginia, Richmond. 
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symptoms in the territory supplied by the stenotic 
vessel. This "stenotic theory" is now considered 
to play a minor role irt the production of symptoms 
of cerebral ischemia ( 1). A significant change has oc-
curred in recent years, so that now the patient with 
an "ulcerated plaqµe" and recurrent symptoms distal 
to this lesion is considered to be the prime candi-
date for extracranial carotid artery surgery. These 
ulcerated plaques are considered to be a source of 
cerebral emboli from clumps of blood elements or 
atheromatous materials which have developed from 
an area of irregularity and ulceration in a preexisting 
plaque. This explains the recurrent episodes of 
cerebral ischemia and the symptoms that may be 
present with a minor plaque or stenosis. Several 
· examples of ulcerated plaques are seen in Figure 2. 
It is imperative that the carotid artery be evaluated 
carefully in multiple angulations, since these ulcers 
may at times be quite small and seen in only one 
projection. It is true, however, that most of the 
atherosclerotic disease and subsequent ulcer forma-
tion is on the posterior wall and the critical view 
is a lateral projection. 
Another common problem in evaluating the 
extracranial carotid artery is the presence of an 
"irregular" plaque. This is a somewhat arbitrary 
designation and indicates only that there is no 
single focal area of ulceration (Fig. 3). The angiog-
rapher must be completely aware that the ulceration 
itself, however, may be filled with debris at the time 
of the contrast injection and should not be surprised 
if the pathological sample shows a much more 
irregular and ulcerated lesion. Additionally, a per-
fectly smooth carotid stenosis angiographically may 
at the time of surgery have a focal area of ulceration. 
Some authors consider that an irregular plaque 
cannot be differentiated from an ulcerated plaque 
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Fig. IA- Severe internal carotid artery stenosis. 
and that both should be treated as possible sources 
for cerebral emboli. This finding has been estimated 
to occur in 10-30% of the cases, but one might 
consider that this incidence could be reduced by 
utilizing multiple projections of the carotid bifurca-
tion (2). Thus, one should examine the carotid bifur-
' 
Fig. IE-Moderate internal carotid artery stenosis with 
smooth borders. 
Fig. 2A, B-"Ulcerated" internal carotid artery plaques. The atherosclerotic plaque projects into the arterial lumen with 
the collection of contrast in the "ulcer" crater (arrow). 
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Fig. 3- Irregular internal carotid artery plaque. There 
is mild stenosis with irregular borders of the contrast 
posteriorly. 
cation in at least three views-the frontal, lateral, 
and oblique. The angiographer should also have a 
low threshold for performing additional views if 
necessary for adequate evaluation. 
Unfortunately, the presence of an ulcerated 
plaque does not indicate that this is the cause for 
the patient's symptoms. We are certainly observing 
"asymptomatic" ulcerated plaques in a large num-
ber of cases studied for other clinical problems. 
Conversely, there may be distal vascular lesions 
that are equal in importance to the bifurcation 
lesion. The second most common site of carotid 
atherosclerotic disease is its cavernous portion. Se-
vere stenosis and ulcerations at this site may pre-
clude surgical repair of the cervical carotid artery. 
One may also see stenosis of the middle cerebral 
artery or proximal anterior cerebral artery that 
would limit surgical therapy. Careful subtraction 
may be necessary when the vessel is not well de-
lineated and free from the dense bony structures 
at the base of the skull. The small size of these 
ulcers and overlapping of vessels, which occurs with 
arch aortography, also severely limit its use alone 
to evaluate patients suspected of having vascular 
lesions. 
Others have commented on the frequency of 
other pathological findings in the intracranial cir-
culation of a patient studied for clinically suspected 
extracranial vascular disease. With more sophisti-
cated brain scanning techniques and ancillary tools 
of clinical examination in recent years, however, 
the incidence of this observation is certainly lower 
than the previous reports of 5 % . We do suggest 
routine angiography of the intracranial as well as 
the extracranial circulation, therefore, but for evalu-
ating the distal vascular bed rather than for primary 
evaluation of an unsuspected subdural hematoma 
or neoplasm. 
Complete occlusion of the internal carotid 
artery is now considered by most surgeons to be 
a nonoperable condition ( 3) . The incidence of intra-
cranial hemorrhage following reestablishment of cir-
culation after an acute occlusion has made this 
procedure hazardous, and the poor success rate in 
reestablishing circulation in a chronically occluded 
lesion has made most surgeons unwilling to attack 
this lesion. There are, however, cautions of which 
Fig. 4-Distal internal carotid embolus (white arrow). 
An area of infarction with arteriovenous shunting is present 
(black arrow). Avascular areas of branch occlusions are 
present in front of and behind the area of luxury perfusion. 
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Fig. SA, B-Frontal and lateral views of major branch occlusion of the middle cerebral artery (arrow). 
one must be aware when evaluating what appears 
to be complete occlusion of the cervical portion of 
the internal carotid artery. The typical occluded 
internal carotid artery will obtain its intracranial 
filling via the opposite anterior cerebral artery or 
by the supraorbital branches of the ipsilateral ex-
ternal carotid, filling the ophthalmic artery and 
cavernous carotid in a retrograde manner. "Pseudo-
occlusion" of the internal carotid artery may occur, 
however, when the stenosis is so severe that only 
a trickle of contrast extends beyond the obstruction, 
even though the internal carotid lumen. immediately 
distal to the stenosis is normal. This faint linear 
accumulation of contrast may be obscured by over-
lying external carotid branches and may not reach 
the supraclinoid carotid for several seconds. There-
fore, every apparent internal carotid "occlusion" 
should have a series prolonged for 10'-15 seconds 
with a careful search for any patency into the skull. 
The significance of cerebral emboli from other 
sources is also assuming increased clinical impor-
tance. Certainly most of the emboli will arise from 
a cardiac valve or an endocardial surface but in-
creasing interest is developing regarding the possi-
bility of emboli from the pulmonary veins. Large 
emboli may obstruct the carotid artery itself and 
this possibility must be carefully evaluated whenever 
there is obstruction other than at the bifurcation 
Fig. SC, D-Frontal and lateral view of recanalization of this occlusion. Minor narrowing of the lumen is still present 
(arrow). An avascular area of a peripheral branch occlusion persists in frontal operculum. 
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Fig. 6A-Basilar artery occlusion (black arrow). Col-
lateral filling of superior cerebellar arteries has occurred 
via cortical anastomosis with the posterior inferior cere-
bellar arteries. 
or in the cavernous carotid, for example, the com-
mon carotid or the midcervical carotid. These 
emboli may also lodge in the intracranial vascular 
tree, creating a flow deformity (Fig. 4) with re-
Fig. 68-Embolic basilar artery occlusion (arrow). 
current symptomatology as fragments of the em-
bolus migrate distally. An area of "luxury perfusion" 
is seen peripheral to the obstructed frontal opercular 
branch with a poorly defined stain and early venous 
filling. This patient developed further left hemi-
sphere symptoms, and pathological confirmation was 
obtained of large hemorrhagic infarction involving 
most of the left hemisphere. Not all emboli result 
in this course, however. The patient in Figure 5 
developed acute occlusion of the middle cerebral 
artery, two of the redundant trifurcation branches be-
ing occluded. Subsequent repeat angiography in sev-
eral days, however, shows that this middle cerebral 
artery has recanalized and only a single frontal 
branch is now occluded. This illustrates a major rea-
son for the frequent normal angiographic findings in 
the stroke syndrome. Emboli may be rapidly lysed 
and may migrate distally, allowing a positive angio-
graphic diagnosis to be obtained only in the first few 
hours after the onset of clinical symptoms. 
Basilar artery occlusive disease is a more serious 
problem, usually with a fatal outcome. Recent clini-
cal data indicate, however, that some of these people 
survive with a reasonably minor neurological deficit. 
The patient in Figure 6A developed signs of severe 
upper midbrain dysfunction, with angiographic find-
ings of complete occlusion of the basilar artery 
just below the origin of the superior cerebellar 
arteries and retrograde filling via the posterior in-
ferior cerebellar arteries . A recent case illustrates 
a surgically altered course with a large basilar artery 
embolus (Fig. 6B). There is a filling defect ob-
Fig. 6C-Postoperative patency of the basilar artery and its 
branches. 
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structing the distal basilar artery with markedly 
delayed flow. This view was obtained nine seconds 
following the injection of contrast. Collateral filling 
of the superior cerebellar arteries occurred via the 
posterior inferior cerebellar arteries. There was no 
filling of the posterior cerebral arteries or the dome 
of the basilar artery from either carotid injection 
or from collateral vessels. The patient underwent 
surgical removal of a large basilar artery embolus 
that was extending into both posterior cerebral ar-
teries. The postoperative arteriogram (Fig. 6C) 
shows restoration of patency of the basilar artery 
and posterior cerebral arteries. This procedure did 
not alter the ultimate outcome of the patient but 
does indicate the development of surgical techniques 
and procedures which allow the performance of this 
em bolectomy. 
Summary. The importance of complete an-
giographic studies in patients suspected of extra-
cranial vascular disease has beep. emphasized. 
Examples of a variety of lesions of the intracranial 
and extracranial circulation have been shown. It is 
important that the angiographer obtaip. adequate 
visualization of the circulation cephalad to the 
aortic arch with awareness of the type of lesion and 
technical problems that may be encountered. It 
is only in this way that further understanding of the 
"stroke syndrome" can be ~ttained with appropriate 
therapy. 
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The Neuro-Ophthalmology of Cerebrovascular 
Disease* 
JOHN W. HARBISON, M.D. 
Associate Professor, Department of Neurology, Medical College of 
Virginia, Health Sciences Division of Virginia Commonwealth 
University, Richmond 
The neuro-ophthalmology of cerebrovascular 
disease is a vast plain of neuro-o'phthalmic vistas, 
encompassing virtually all areas of disturbances of 
the eye-brain mechanism. This paper will be re-
stricted to those areas of the neuro-ophthalmology 
of cerebrovascular disease which one might con-
sider advances in its clinical diagnosis and treatment. 
Most practitioners of medical and surgical neu-
rology give little thought to that aspect of medicine 
generally accepted as the ideal approach to any 
disease-prevention. Usually when one is presented 
with an illness of the central nervous sys~em, it 
seems to be a fait accompli. Although prevention 
is by no means new, certain aspects of it qualify 
as advances. There is one advance in cerebrovascu-
lar disease in which prevention plays a significant 
role. This is the recognition and surgical correction 
of atherosclerotic lesions of the extracranial carotid 
system which threaten the patient with that bane 
of antiquity-the "stroke." 
Neuro-ophthalmology, largely by virtue of the 
carotid origin of the ophthalmic artery, plays a 
valuable role in the ~ecognition, evaluation, therapy, 
and prognosis of disease of the extracranial internal 
carotid artery. Even this markedly restricted aspect 
of the neuro-ophthalmology of cerebrovascular dis-
ease is far too extensive to review adequately in 
this paper. I have therefore selected for discussion 
certain aspects of our nei.iro-ophthalmic approach 
to extracranial carotid disease. Some of these are 
well known; others are less obvious and frequently 
overlooked in our evaluation of patients. Tpey all, 
* Presented by Dr. Harbison at the 27th Annual 
Stoneburner Lecture Series, February 7, 1974, at the Medi-
cal College of Virginia, Richmond. 
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however, are important pieces to the puzzle the 
patient may present. A wide variety of afflictions 
of the eye occur by virtue of its arterial dependence 
on the internal carotid artery. It is also logical to 
assume that changes in the distribution of the 
ophthalmic artery may reflect changes taking place 
in other chanqels of the internal carotid artery-
the middle cerebral, the anterior cerebral, and de-
pending upon anatomic variations, the posterior 
cerebral artery. This paper will discuss these afflic-
tions, those common as well as rare, those well 
recognized, and those frequently overlooked. 
Historically, the recognition of the eye as an 
index of cerebrovascular disease presents an inter-
rupted course. Virchow is credited with the first 
autopsy correlation of ipsilateral blindness with 
carotid thrombosis; Gowers in 1875 demonstrated 
embolization as a source of central retinal artery 
and middle cerebral artery occlusion, resulting in 
monocular blindness and contralateral hemiplegia; 
Chiari followed in 1905 with his identification of 
the carotid bifurcation as a common source of 
atheromatous emboli to the cerebral circulation; in 
1914 Ramsey Hunt emphasized the significance of 
transient symptoms involving the ipsilateral eye and 
contralateral extremities as strong evidence of 
ischemia. Thus by the turn of the century, the 
stage was set for incrimination of the extracranial 
internal carotid artery as a major source of "strokes." 
Embolization was known as a basis for ipsilateral 
eye and contralateral extremity symptoms and 
signs; the carotid bifurcation was known as a source 
of emboli; and transient symptoms were recognized 
as reflections of ischemia-a stroke prodrome or 
warning was discovered. Yet it was for Fisher in 
1951 to rekindle interest in extracranial carotid 
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disease with his emphasis on transient ipsilateral 
visual and contralateral extremity symptoms as pre-
cursors of future strokes. It is this reawakening 
which has led directly to the current advances in 
the medical and surgical neurologic care of extra-
cranial internal carotid disease. 
Amaurosis fugax, "fleeting blindness," has be-
come a household phrase of those involved in the 
diagnosis and care of patients with carotid disease. 
The clinical picture of amaurosis fugax is reasonably 
straightforward. It consists of transient monocular 
painless visual loss. Much has been made of the 
character, duration, mode of onset, and resolution 
of the visual loss. Perhaps too much emphasis has 
been placed on such characteristic patterris as the 
window shade or picket fence effect. As a result, 
we find that many patients we see have already been 
"well educated" by housestaff. The potential patterns 
of visual loss are many. They include 1) · an upper 
altitudinal loss o( vision, "the window shade"; 2) a 
lower altitudinal loss of vision, "the picket fence"; 
3) a generalized peripheral loss of vision; 4) a total 
blackout of vision; and 5) a central blurring of 
vision. The onset is most frequently abrupt; the 
curtain seldom drops or rises slowly. Occasionally, 
the event is associated with photopsia-crude visual 
hallucinations, usually 1n the form of showers ,or 
flecks of light but suggestions of geometric character 
will sometimes be seen. The key factors differentiat-
ing this photopsia from occipital disease and mi-
graine are its clear unilaterality, the patient's age, 
and a detailed analysis of the history, which excludes 
migraine as a consideration and supports amaurosis 
fugax. The event need not be simply a blackout; 
dimming with a sensation of color may occur with 
green and yellow having popularity. In my experi-
ences, color sensation has been uncommon. 
The duration is generally brief, lasting two 
or three minutes, or rarely, five-to-ten minutes. We 
have found a common tendency for patients to 
misjudge the time sequence with frequent exaggera-
tion of the period of visual loss. As this tendency 
to misjudge the duration of visual handicap may 
be bothersome diagnostically, we have adopted a 
simple time confirmation method. It consists of 
instructing the patient that you are going to begin to 
count and he is to assume that this is the onset 
of his visual symptomatology. We encourage the 
patient to "relive" the experience and With the use 
of our verbal clock, determine the average duration 
of visual loss. The rule is to find a duration of from 
one and one-half to two or three minutes despite 
the patient's initial claim of five, ten minutes, or 
longer of impairment. A watch second hand or stop 
watch could also be used; however, the vocal metro-
nome seems helpfuL 
Although empP.asis has been placed on the 
association of ipsilateral eye and contralateral ex-
tremity signs and symptoms, it should be recognized 
that their actual temporal association is unnecessary 
diagnostically and infrequent clinically. The eye 
symptoms and signs in isolation as evidence of 
cervical internal carotid disease are, in ali likelihood, 
far more common than many practitioners realize. 
The work of Lubow and associates at Ohio State 
regarding "retinal strokes" underlines this concept. 
On rare occasions, transient homonymous visual 
impairment may be a reflection of internal carotid 
disease by virtue of a carotid origin of the posterior 
cerebral artery. Correct diagnosis will depend upon 
associated symptoms and signs. 
The precise pathophysiology of these brief 
alterations of visual ftinction continues to excite 
some debate. It seems certain that most are based 
upon emboli of either platelet aggregates or athero-
sclerotic debris. The exact point at which the em-
bolus works its evil is less certain. As will be 
discussed, visible emboli in central retinal arterioles 
must play a role; whether they are the sole inciting 
force is less certain. Emboli to the choroid, not 
apparent clinicaily, may be. important. The role of 
dynamic reduction of blood flow in the production 
of visual symptoms of carotid disease is probably 
small. It does, however, in selected but infrequent 
instances, probably play a significant role. Total 
carotid occlusions obviously cause some transient 
visual symptoms; generally, the symptoms cease 
following the stabilization occurring postocclusiori. 
Our diagnostic evaluation of patients with 
symptoms of transient visual loss consists of the 
careful analysis and integration of the specific physi-
cal signs with the presenting and elicited symptoms. 
Although we have defined amaurosis fugax as 
transient painless monocular visual loss, occasionally, 
residual deficits of vision remain. In addition, a 
number of patients with cervical internal carotid 
disease present not with transient ipsilateral eye 
symptoms but with fixed deficits. 
Needless to say, the diagnostic evaluation of 
all patients with eye symptoms and signs suggesting 
ipsilateral carotid disease must begin with docu-
mentation of visual function-this includes best 
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corrected visual acuity, pupillary reactivity, and 
quantitative visual field evaluation. Although we 
palpate neck vessels, much less than total absence 
of vessel pulsation is lightly regarded. Auscultation 
is considered an important adjunct, with realiza-
tion that bruits at sites other than the suspected 
symptomatic area may be significant. A bruit in 
isolation, however, is of dubious benefit. 
The final , but perhaps most valuable, aspect 
of the neuro-ophthalmic diagrtostic evaluation of 
patients suspected of harboring atherosclerotic dis-
ease is the dilated funduscopic examination with the 
recording of retinal artery pressures. If one is for-
tunate enough to be present during an amaurotic 
event, funduscopy may reveal white platelet emboli or 
bright cholesterol plaques passing through the central 
retinal arterioles. As this is a distinctly uncommon 
opportunity, one must usually be satisfied with resi-
due which remains behind-most commonly, bright 
cholesterol material lodged at . arteriole bifurcations. 
Hollenhorst, who first recognized the significance of 
retinal emboli in 1961 , recorded a 33% incidence of 
these "Hollenhorst plaques" in patients with sympto-
matic cerebrovascular insufficiency. 
Ophtha]modynamometry (ODM) should be 
routinely performed . following a thorough fundu-
scopic survey. The technique of ODM was first 
devised by Baillart in 1917 to measure central 
artery pressure. Svien and Hollenhorst popularized 
its use in 1956. One must keep in mind that ODM's 
are not a measuremertt of absolute pressures. This 
is, by and large, not a disadvantage as their primary 
benefit is a relative comparison of one eye with 
the other. We, as do many others, commonly record 
only the diastolic reading and routinely perform 
the OI)M's in the sitting position. Before we con-
sider the asymmetry significant, we require a 15 % 
difference when the readings are below 40 units and 
a 20% difference when the readings are above 40 
units. Any readings below 20 units are considered 
abnormal. The basic mechanism of ODM is the 
simple increase of intraocular pressure to levels 
above the central artery pressure. Needless to say, 
either increased or decreased intraocular tension 
will falsely alter the reading obtained. For this 
reason, tonometry-the recording of intraocular 
pressure-is essential in conjunction with ophthal-
modynamometty. Despite great care in technique, 
false negative readings abound. Our experience has 
suggested that significant ophthalmodynamometric 
asymmetry indicates extreme stenosis, if not actual 
occlusion, of the symptomatic internal carotid ar-
tery. Ophthalmodynamometry plays a definite, 
though limited, role in the diagnosis of atheroscle-
rotic cervical internal carotid disease. With the value 
of ODM's in perspective, we continue to use them 
routinely. 
A discussion of amaurosis fugax is not com-
plete without a brief review of the differential diag-
nosis . Although almost all transient monocular visual 
loss is due to internal carotid arterial disease, there 
are other considerations which include temporal 
arteritis , migraine and migraine equivalents, glau-
coma, papilledema, Raynaud's disease, and other 
emboli. It is seldom difficult to identify these addi-
tional sources of transient monocular visual loss 
if they are appropriately sought. 
Amaurosis fugax , although the hallmark of 
occlusive internal carotid disease and certainly its 
most common symptomatic neuro-ophthalmic pre-
sentation, is by no means the only eye manifesta-
tion encountered in internal carotid vascular disease. 
The following discussion will describe a number of 
less commonly recognized clinical syndromes caused 
by occlusive internal carotid disease. 
Retinal stroke, although commonly an integral 
aspect of the syndrome of amaurosis fugax, cer-
tainly occurs in the absence of prior symptomatic 
transient monocular visual loss; there can be little 
doubt that the occurrence strongly suggests athero-
sclerotic disease of the cervical internal carotid 
artery. The work of Lubow and associates at Ohio 
State in 1972 has shown, angiographicaily, a 95% 
incidence of carotid bifurcation disease in patients 
having retinal strokes as compared to asymptomatic 
age-matched controls in which angiography demon-
strated a 25 % incidence of bifurcation abnormal-
ities. What do re.tinal strokes consist of? They 
consist of occlusive disease of the retina, previously 
relegated to ophthalmic practice. It has become ap-
parent, however, that many "retinal strokes" are 
of embolic origin and manifest cholesterol plaques 
exactly like those seen in amaurosis fugax. 
Central retinal artery and artery branch oc-
clusions, as well as more distal cholesterol emboli, 
producing peripheral defects frequently unappreci-
ated by the patient, constitute the retinal stroke. 
Their clinical manifestation is abrupt, usually pain-
less, persistent monocular visual loss. Blindness and 
optic atrophy frequently follow retinal strokes. In 
our brief historical review, one may recall Gowers' 
allusion to ipsilateral optic atrophy and blindness as-
sociated with contralateral hemiplegia. Carotid dis-
ease is obviously likely with this association . What 
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must not be forgotten is that isolated blindness and 
optic atrophy may also reflect cervical internal ca-
rotid disease. Other funduscopic alterations causally 
related to cervical or extracranial internal carotid 
disease occur. It is not commonly recognized that 
ipsilateral carotid occlusive disease may serve to pre-
vent the expression of both hypertensive and diabetic 
retinopathy. When a patient is seen with remarkably 
asymmetric hypertensive or diabetic retinopathy, con-
sideration of the possible presence of occlusive in-
ternal carotid disease should follow. 
Ischemic retinopathy, recognized as evidence 
of chronic retinal ischemia by Kearns and Hollen-
horst in 1963, is a syndrome consisting of a retinal 
picture similar to diabetic retinopathy with dilated 
veins, some resultant blot hemorrhages and micro-
aneurysms, low ophthalmodynamometric values, and 
at times, severe orbital pain. Ischemic retinopathy 
can be differentiated from diabetic retinopathy by the 
fact that it is unilateral and that there is no biochemi-
cal evidence of diabetes mellitus. Obviously, diabetes 
and the Kearns ischemic retinopathy may coexist. 
The significance of ischemic retinopathy is its re-
flection of severe impairment of internal carotid 
as well as collateral circulation to the eye and 
orbit. Not uncommonly, the major trunks from the 
aortic arch are the site of the vascular occlusion. 
There are three additional presentations of 
eye signs reflecting occlusive vascular disease which 
generally indicate, as does ischemic retinopathy, a 
more severe and diffuse vascular embarrassment of 
orbital as well as central retinal circulation. These 
are ischemic inflammation, "pseudouveitis"; ocular 
hypotony; and neovascular glaucoma. 
Ocular inflammation resembling uveitis may 
result from chronic ocular ischemia secondary to 
diffuse occlusive vascular disease, involving not only 
the internal carotid but the collateral channels as 
well. This syndrome is characterized by dilatation 
of episcleral veins, a turbid anterior chamber, iris 
synechiae, corneal precipitates, and edema. On 
occasion, vitreous hemorrhage may occur and 
cataracts may rapidly develop. 
In circumstances where acute reduction of 
orbital blood flow affects more specifically the 
ciliary body, reduced production of aqueous humor 
results leading to ocular hypotony and potentially 
phthisis bulbi. 
Chronic ischemia in the eye is also a stimulus 
to new vessel production. Prolonged reduction of 
orbital blood flow may result in proliferation of 
neovascular tissue on the surface and angle of the 
iris . This will often culminate in occlusion of the 
anterior chamber angle and a malignant form of 
secondary glaucoma referred to as neovascular or 
hemorrhagic glaucoma. 
It is obvious that the last three syndromes 
reflecting eye involvement, secondary not simply 
to carotid stenosis but most certainly to more severe 
carotid occlusive disease, as well as occlusive disease 
of the usual orbital collateral channels, may occur 
either in sequence or in combination. Their inci-
dence in reality is quite low. Ischemic retinopathy, 
a less severe manifestation of the same process, is 
reported in only 5 % of unilateral carotid occlusions. 
It is wise, however, to realize that eye signs other 
than simple transient or permanent monocular visual 
loss may point to disease of the cervical carotid 
vessels. 
In conclusion, one should mention the occur-
rence of unilateral Homer's syndrome in a not 
insignificant number of unilateral internal carotid 
occlusions. This quite likely represents involvement 
by edema and ischemia of the carotid sympathetic 
plexus in the adventitia. 
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Medical Management of Cerebral Vascular Disease* 
WILLIAM K. HASS, M.D. 
Professor of Neurology, New York University, New York, New York 
I shall begin with two axioms and a few defini-
tions and, subsequently, offer conclusions and a few 
words to the medical lexicon. Axiom # 1-there 
is no such thing as a CV A. In the year 197 4, 
with cerebral angiography widely available and with 
computerized axial transverse tomography coming 
into its own, CV A can only stand for "confused 
vascular analysis." Axiom #2-the best time to 
treat a stroke is before it happens or at the very 
least, before it significantly disables the patient. 
Ultimately, there are two fundamental kinds 
of stroke: cerebral infarction or ischemia and cere-
bral hemorrhage. The first relates to a focal cerebral 
dysfunction due to transient or persistent insuffi-
ciency of blood in a given cerebral vascular territory. 
The second relates to the often massive escape of 
blood into the brain parenchyma, the subarachnoid 
space, or both locations. From a practical stand-
point, a lumbar puncture which fails to reveal blood, 
and particularly xanthochromia, effectively rules out 
almost all cerebral hemorrhages and suggests the 
process of cerebral ischemia or infarction. The two 
major kinds of stroke can be differentiated clinically 
without too much difficulty. On the other hand, 
the problems of etiology, pathogenesis, and manage-
ment continue to challenge the clinician. Since 
strokes due to cerebral ischemia and/ or infarction 
account for 75% or more of all observed strokes, 
and because of the preponderance of strokes of this 
variety and the limits of space, we will confine our 
attention here entirely to the problem of cerebral 
ischemia and infarction. 
If one is to classify strokes due to cerebral 
ischemia, one may do so in terms of the nature 
and duration of the episode, on the one hand, and 
the vascular territory of involvement, on the other 
* Presented by Dr. Hass at the 27th Annual Stone-
burner Lecture Series, February 7, 1974, at the Medical 
College of Virginia, Richmond. 
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hand. When an episode of focal cerebral dysfunction 
occurs which is related to a given vascular territory, 
persists for minutes to at most 12-24 hours, and 
then vanishes completely, we say that the patient 
has had a transient ischemic cerebral attack. If the 
episode involves the vision of one or the other eye 
(patients often state that it seemed as though a shade 
was drawn across the vision of the eye), we state 
that the patient has had a transient retinal ischemic 
attack or amaurosis fugax. Onset over a period of 
a few seconds to a few minutes characterizes these 
episodes. If an episode develops either quickly or 
over a period of minutes to hours and if the focal 
deficit persists for many days and then largely but 
not completely clears, we say that the patient has 
had a transient ischemic episode with incomplete 
recovery. From a pathogenic and treatment stand-
point, the transient ischemic episodes and transient 
ischemic episodes with incomplete recovery are 
considered to be a single entity. If the focal deficit 
appears over minutes to hours or sometimes even 
days and persists, severely disabling the patient, we 
say that the patient has suffered from a completed 
stroke. In this situation, cerebral infarction, charac-
teristically, is the underlying cerebral pathology. 
Quite frankly, most neurologists in the field 
at this time can point to no satisfactory treatment 
for the completed stroke, except for good medical 
care with attention to cardiopulmonary function, 
management of blood pressure, withholding of oral 
intake, and treatment entirely by intravenous fluids 
during the acute period, particularly when the pa-
tient is mildly obtunded. These efforts have stood 
the test of time. More specific therapy, such as 
stellate ganglion block and C02 inhalation, as well 
as streptokinase and urokinase, have fallen by the 
wayside, some buried by their own initial advocates. 
Nevertheless, the search must go on. In only one 
area, that of stroke in evolution involving the brain 
stem, has a specific form of therapy, anticoagulation, 
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reduced mortality and morbidity to a degree-ten-
fold-which causes the Mayo group to advocate 
its use with vigor in this specific instance. 
Ischemic strokes are also defined in terms of 
territory of presumed blood vessel involvement. The 
two major territories are those of the carotid middle 
cerebral-anterior cerebral system and the vertebro-
basilar system. Carotid territory dysfunction is char-
acterized by one or more of the following: ipsi-
lateral, transient or rarely persistent visual loss due 
to the fact that the ophthalmic artery is the first 
branch of the carotid artery, contralateral weakness, 
contralateral cortical sensory dysfunction, contra-
lateral hemianopia, and in almost all of the right-
handed individuals and in some 60% of left-handed 
individuals, aphasia or dysphasia-the impairment 
of the faculty of language when the left internal 
carotid artery territory and left cerebral hemisphere 
are involved. The words of the psalmist, "If I forget 
thee, O' Jerusalem, let my right band forget its 
cunning and let my tongue cleave to the roof of my 
mouth," characterize the classic dominant carotid 
territory lesion. 
Strokes due to vertebrobasilar involvement 
rarely give rise to the classic crossed syndromes so 
familiar in neuroanatomy texts, such as Weber's 
syndrome, characterized by an ipsilateral third nerve 
palsy and a contralateral bemiplegia. More often, one 
or more of the following characterize ischemia in 
the vertebrobasilar territory: alternating bemiparesis, 
ataxia, diplopia, dysarthria, hiccup, alterations in 
respiratory pattern, nausea and vomiting, and pupil-
lary changes. 
Many things can cause transient or persistent 
focal cerebral or retinal ischemia. Particularly when 
ischemia is encountered in younger individuals, one 
may suspect a primary cardiac source involving 
the valves as in rheumatic endocarditis or verrucous 
endocarditis, left atrial thrombosis in rheumatic 
heart disease with mitral stenosis and atrial myxoma. 
Changing pulses and/ or chest pain should suggest a 
dissecting aneurysm. Atrial fibrillation should always 
suggest a primary cardiac source. A variety of sys-
temic diseases including polycythemia, thrombotic 
thrombocytopenic purpura, idiopathic thrombocyto-
sis, and granulomatous angiitis, as well as dissemi-
nated intravascular coagulation should be thought of 
in all cases; but the garden variety of transient or 
persistent stroke due to focal cerebral ischemia, as 
seen in the hospital, usually appears in a seemingly 
healthy male at an average age of 62. The incidence 
of what is still fashionably called "cerebral throm-
bosis" in this patient population approaches 1 % per 
year in the age group 65-74. Almost 40% of these 
patients have a history of increased blood pressure, 
20% a history of diabetes, and at least 50% will give 
a history of a previous transient cerebral iscbemic 
episode. Hypertension, diabetes, and previous TIA's 
constitute the triad of the stroke-prone profile; 
indeed, 30-37% of patients with transient ischemic 
episodes will exhibit a full-blown completed stroke 
within five years if untreated. 
Our New York University (NYU) study of 
the surgical treatment of transient and persistent 
focal cerebral ischemia revealed approximately one-
third of the patients with transient ischemic attacks, 
one-third with transient ischemic attacks and incom-
plete recovery, and one-third with completed strokes . 
Arteriograpbic studies had borne out the fact, first 
extensively studied by Hutchinson and Yates, that 
the garden variety of transient or persistent focal 
cerebral iscbemia is related more to observable 
extracranial atberomatous arterial disease, particu-
larly in the carotid arteries than to primary intra-
cranial occlusive disease and indeed, more to steno-
sis than to occlusion. 
Various studies have defined the preferred sites 
of atheromatous disease in the surgically approach-
able areas of the brachiocephalic system. Predomi-
nance of the carotid bifurcation involvement is ap-
parent with stenosis of greater than 30% being 
present in more than one-third of all right and 
one-third of all left carotid arteries. Frank occlusion 
is much less common. In the intracranial circulation, 
observable stenotic lesions in the carotid territory 
fall tenfold. The values for occlusion in the distal 
carotid artery are inflated because in many cases 
occlusion is taken to represent propagation of clot 
from the origin of the internal carotid artery. Proxi-
mal vertebral artery involvement bas been seen in 
approximately 20% of all vertebral origins on the 
right and left. Considerably less often, but probably 
symptomatically much more important, is stenosis 
which is seen distally in the vertebrobasilar system. 
There is no clear-cut relationship between 
frank carotid occlusion and the degree of neuro-
logical deficit. Another problem encountered is that 
patients often do not present with a single high 
grade stenotic lesion in the artery appropriate to 
their cerebral symptoms; rather they present with a 
complex mixture of arterial lesions which may give 
rise to the exact same symptomatology. 
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In our NYU experience with 400 patients, we 
tried to group all of the cases into a meaningful 
framework. It is understood that every patient's 
vascular fingerprint is individual and that there are 
almost as many patterns of lesions as there are 
symptomatic patients. It was interesting that when 
we classified a lesion as a lesion, if the stenosis oc-
cupied more than 30% of the vascular lumen in 
any x-ray plane, 17 % of the patients showed no 
lesions which occupied 30% or more of a vessel 
lumen after four-vessel angiQgraphy. The existence 
of this pleomorphic pattern of vascular lesions, 
paired with the fact that 50% of all individuals 
over the age of 50 have a major stenosis of at least 
one of the four major vessels (two carotid and two 
vertebrals, all leading to the brain), and that only 
10% ultimately become symptomatic, offered nu-
merous roadblocks to our eventual understanding 
of the pathogenesis of at least most of the carotid 
territory transient and persistent strokes. 
Until the 1960's, it had been customary to 
attribute the patient's symptoms to the degree of 
stenosis or occlusion of the vessel developing by 
one or more pathogenic processes, which led to 
marked luminal compromise and then, presumably, 
to symptoms which developed in proportion to the 
degree of collateral circulation possessed by the 
patient. Surgical studies compared with angiographic 
observations, however, began to question this 
stenotic theory of pathogenesis of strokes. A new 
concept of pathogenesis, best characterized as the 
embolic theory, arose. 
The sources of arterial emboli from lesions, 
which may occupy less than 30% of the vascular 
lumen formerly considered to be insignificant, were 
as follows: necrotic plaque, clot from ulcer, and 
platelet emboli from ulcer. Ulcerations can easily 
be seen on angiography, in the initial phases asso-
ciated often with high grade stenosis, and the dye 
can also be seen hung up in the ulcer crater. Distal 
propagation of thrombus, significantly compromising 
the internal carotid lumen, can be seen. Radiologic 
evidence from NYU disclosed 24 ulcerative and 22 
irregular lesions at the origin of the internal carotid 
arteries of the neck in the cerebral angiograms of 
71 patients with history of cerebral vascular oc-
clusive disease. Further, the incidence of middle 
cerebral branch occlusion associated with either 
irregular or ulcerative lesions of the extracranial 
carotid arteries was 3 3 % , compared to 16% of 
patients with angiographically "normal" or smoothly 
stenosed extracranial carotid arteries. More and 
more evidence, therefore, implicates the process of 
arterial-arterial embolization as a major one, par-
ticularly in transient and often in persistent focal 
cerebral ischemia. 
Thus we have a process of arterial-arterial 
embolization as distinct from cardiac-cerebral artery 
embolization, which apears to be a major patho-
genic factor in ischemic strokes toward which treat-
ment should be aimed before the stroke occurs, 
when we are warned by the presence of a transient 
episode. Since the term embolus is overextended 
and usually implies cardiac source, muddying our 
thinking about cerebral ischemia, I have long felt 
that to require the term "cerebral embolus" to in-
clude in its embrace the widespread process of ar-
terial embolization would be like asking a mouse 
to extend its amorous interests to an elephant; it 
would confound confusion where too much con-
fusion already exists. I have proposed, therefore, 
the acronym, "artarem,'' to describe an embolus 
which arises in an artery (art-) and lodges in a 
distal artery ( -ar-) by a process of embolization 
(-em). The process can be described as being 
artaremic. On the other hand, if the embolus, from 
clinical evidence, appears to arise from the heart, 
the term "cardiarem" will serve, and the process of 
heart-to-artery embolization might be described as 
"cardiaremic." Adjectival modifiers such as cerebral 
fibrinoplatelet artarem or myxomatous cerebral car-
diarem could give rise to further diagnostic precision. 
Having noted angiographic and operative evi-
dence of the artaremic process, research began for 
a safe medication which could delay or inhibit the 
first step in fibrinoplatelet emboli. Surgical studies had 
already clearly revealed that the neck lesion often 
was related to visual and cerebral symptoms since 
these symptoms disappeared after surgery, whereas 
control patients who were not surgically treated with 
known similar lesions often developed stroke or 
permanent visual defect. The experience of the 
Cooperative Study of Extracranial Arterial Occlu-
sion showed a tenfold reduction in the appearance 
of frank stroke in the territory of ·the operated 
artery in the neck. There can be no doubt, therefore, 
that the source of the patient's difficulty was most 
often in the prominent lesion at the carotid bifurca-
tion. Surgery, however, has its drawbacks and ran-
dom studies of surgery have failed to precisely define 
the role of arterial surgery. 
Our own NYU random study reveals one rea-
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son for the confusion. In patients who were not 
randomized, the nonsurgical patients showed a con-
siderably smaller initial long-term survival than the 
surgical patients, suggesting a significant measure 
of surgical selection. Where the patients were ran-
domized, long~term survival was equal in · both 
groups; initial surgical mortality, however, was sig-
nificantly greater. 
Our figures show that in patients with full 
recovery from transient cerebral ischemic attacks, 
surgical mortality is down to 3% and long-term· 
survival is greater than in the nonsurgical group 
(numbers too small for statistical significance) . 
Transient ischemic attacks in patients with incom-
plete recovery are characterized by a greater degree 
of surgical mortality; but in the proportion sur-
viving, a larger percentage survived five years. The 
other major point of the surgical study was that 
in patients with completed stroke, surgical mortality 
is prohibitive, particularly in patients who are ob-
tunded, and long-term survival is significantly better 
in the nonsurgical group. Mortality over the long 
term, however, is not simply a function of cerebral 
vascular disease. Associated atherosclerotic disease 
is characteristic of this group of patients. While the 
major cause of death in the postoperative period 
after surgery is stroke, over the long tetm, cardiac 
causes account for as many deaths as stroke, and 
the number of deaths in the surgical and the non-
surgical series approach one another. 
Since stroke surgery is prophylactic, the major 
question remains-will stroke surgery in selected 
patients significantly diminish the proportion of 
stroke and significantly improve survival? No data 
from randomized studies have yet settled this issue 
completely satisfactorily. Thus, the search has gone 
on for safe medications which will depress the ten-
dency for fibrinoplatelet emboli to form on ulcerated 
or irregular plaques. Obviously nothing can be done 
for the initial process of disehgorgement of gum-
matous and cholesterol material from the broken 
down plaque. Anticoagulants have proven to be 
successful in depressing the number of transient 
ischemic episodes; however, anticoagulants can be 
given only to a reliable, stable patient population, 
and such therapy would be much more successful 
in Rochester, Minnesota for Dr. Millikan's and Dr. 
Whisnaqt's patients than for our patients at Bellevue 
Hospital. 
In the 1960's, Frasier Mustard's group in 
Canada (1 , 2) noted inhibition of the platelet 
aggregation release reaction by sulfinpyrazone. Sub-
sequent studies have shown that anti-inflammatory 
drugs, such as butazoladine derivatives and aspirin, 
the pyridopyramidine compounds such as Persan-
tine® and the tricyclic antidepressant drugs, have 
an effect on platelets. The most profound inhibition 
of ADP or collagen-induced platelet (\ggregation 
is shown by aspirin. In the in vitro studies, 37% of 
serotonin is released with no aspirin, as compared 
to no release with aspirin. A tenfold increase in 
ADP reveals that aspirin can no longer be effective 
against aggregation, but that there is continuing 
inhibition of serotonin release. Similarly, aspirin 
inhibits connective tissue induced aggregation as 
well as serotonin release from platelets. This effect 
of aspirin is not confined only to the test tube, but 
it has been shown in dogs that arterial thrombus 
is retarded when the intimal surf(\ce of an artery 
is mechanically or chemically damaged and similar 
results have been shown after endarterectomy in 
patients receiving aspirin ( 3). While it is known 
that as little as 5 gr of aspirin may depress the 
aggregation release reaction for as long as five days 
in man, as judged by the epinephrine challenge to 
platelet rich plasma as well as with most in vitro 
tests, this association of inhibition of aggregation 
is not clearly related to observed inhibition of tran-
sient ischemic episodes. It has been noted, however, 
that aspirin will stop transient retinal ischemic at-
tacks, amaurosis fugax. We have been able to follow 
a most instructive patient at NYU who had as many 
as nine attacks daily of amaurosis fugax , with re-
sponse to increasing doses of aspirin in terms of 
attacks and effect on platelet aggregation release 
reaction. This unusual patient demonstrated that 
the optimal dose of aspirin for amaurosis fugax 
appears to be 5 gr qid. A retrospective study recently 
published in Stroke by Dy ken ( 3) shows a relative 
diminution of transient cerebral ischemic attacks 
in aspirin-treated patients. It is of interest that in 
some of his cases the attacks responded better to 
four aspirin tablets per day than to two, Prospective 
studies of aspirin, directed toward not only the 
question of aspirin inhibition of transient attacks, 
but also to the more important question of prophy-
laxis against completed stroke, are in process in 
the United States and in Canada and no definitive 
statement will be made on this subject for at least 
another year. 
The judicious mixture of surgical therapy and 
prophylactic therapy with a safe platelet antiag-
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gregant appears at this time to be the best combina-
tion of approaches to the axiom: the best time to 
treat a stroke is before it happeris. 
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Cerebral Blood Flow Studies in Stroke* 
JOHN STIRLING MEYER, M.D. 
Professor and Chairman, Department of Neurology, Baylor College 
of Medicine, Houston, Texas 
I will discuss here some work we are doing 
in our laboratory on the measurement of cerebral 
blood flow (CBF). We are using the gamma camera, 
which is connected to a computer, to measure 
regional CBF. We inject 133Xe into the carotid 
artery and, by using multiple probes, measure the 
clearance from multiple regions of the head. The 
adv.antage of the gamma camera is that it has ex-
cellent resolution and has common probe charac-
teristics. It may be thought of in terms of multiple 
probes, although it has a single crystal, and it 
acbieves the desirability of multiple regional CBF 
recordings confined essentially to one hemisphere be-
quse of the depth characteristics of the collimation. 
The formula for height-over-area analysis in 
the clearance for fast and slow flow (or the first and 
second slopes of the curve, Fl and F2) is handled 
by the computer which gives an automatic write-out. 
ln addition, having injected the xenon, which washes 
out fairly rapidly over an interval of 12 minutes, 
we then inject with a nondiffusable isotope, tech-
netium. By use of a different formula, this gjves 
us the regional cerebral blood volume, so that in 
the same patient, we have both the regional cerebral 
blood flow and the regional cerebral blood volume 
on the computer write-out. Table 1 is a typical 
record that comes out of the automatic print-out; 
it has the advantage of being rapid, taking place 
while the patient is being examined. It comes out 
objectively with a minimum amount of error, the 
program being highly reliable, and gives you both the 
regional cerebral blood flow (ROI) and the inean 
hemispheric flow (RCBF "H/ A" ) , which is in good 
agreement with hydrogen clearance using an entirely 
different methodology, as well as the standard 
* This is an edited transcription of a lecture presented 
by Dr. Meyer, February 7, 1974, at the Medical College 
of Virginia, Richmond. 
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deviation. It gives you the fast or so-called gray 
flow (FQ) , the white flow (FW), the so-called 
weight of gray matter (WG), the weight of white 
matter (WW), a regional flow calculated by an-
other method (RCBF "LOG") , and the regional 
cerebral blood volume (RCBF) , which is of con-
siderable use because, knowing blood flow, blood 
volume, and cerebrospinal fluid pressure, you can 
say a great deal about the amount of blood and 
parenchyma present in the region under study and 
about the various pressure-tissue-flow relationships. 
For our 111etabolic studies, we feel that it is less 
traumatic and highly reliable to pass the catheter 
up into the lateral sinus via the brachia! vein ; thi.s 
is done under visualization of the fluoroscope in 
the cardiac catheterization laboratory. I say it is 
highly reliable, because one can inject a little dye 
at the time of placement of the catheter, from which 
much can be learned. About 20% of patients have 
abnormalities of the venous system, and there is 
no question that, with the blind puncture or modifi-
catio~s of it, the needle often finishes up sampling 
blood that was certainly not coming from the brain, 
whjch accounts for some of the errors in methods. 
To summarize some of the data-it will be 
found that the earlier the patient is studied after 
a stroke, the greater is the reduction of CBF. I 
would like to point out that CBF is reduced not 
only on the diseased side but also on the healthy 
side (Table 2) . We called it diaschisis and supposed 
that it was due to the release, following stroke, 
bilaterally or perhaps from the brain stem, of some 
neurotransmitter, and it was suggested that it might 
pe serotonin or some related substance. Judging 
from pur current studies, it now appears that indeed 
there are neurotransmitter releases in a unilateral 
. . 
stroke and that these neurotransmitters, bilaterally, 
include norepinephrine, serotonin, and C-AMP; 
these reduce cerebral blood flow and decrease me-
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TABLE I 
REGIONAL CEREBRAL BLOOD FLOW MEASUREMENTS USING GAMMA CAMERA 
AND lNTERTECHNIQUE COMPUTER SYSTEM 
Typical Print-Out of RCBF Data 
ROI RCBF"H/A" FG WG FW WW RCBF"LOG" RCBV 
1,4 42.2 41. 57 65 . 1 14.81 34.9 32.2 9.62 
2,3 35.2 48.93 38.2 28.27 61.8 36.2 8.95 
2,4 33.7 43.88 46.3 19.70 53.7 30.9 7.58 
2,5 32.5 37.52 49.1 18.96 50.9 28.I 6.29 
2,6 32.0 33.69 61.0 16.27 39.0 26.9 6.09 
3,3 32.2 46.13 47.8 19.62 52.2 32.3 8.30 
3,4 32.5 41.98 49.5 17.73 50.5 29.7 6.49 
3,5 27.6 38.04 34.3 19.81 65.7 26. I 5 . 59 
3,6 26.8 50.74 35.5 25.35 64.5 34. 3 5.21 
4;3 35.4 53.48 30. 3 30.26 69 . 7 37.3 7.36 
4,4 35.4 52.30 44.3 25.99 55.7 37.6 6. 37 
4,5 37.I 51.31 33.0 19.81 67.0 30.2 4.90 
4,6 23.9 31.24 29.9 25.84 70.1 27.5 4.77 
5,4 26.9 49.68 29.0 23.76 71.0 31. 3 5.59 
5,5 24.6 59.84 10.7 28.68 89.3 32.0 4.50 
6,4 19.4 30.68 25.I 17.24 74.9 20.6 4.05 
6,5 22.1 33.82 43.5 40.35 56.5 23 . 2 4.15 
MEAN 30.0 41.87 39.5 23.08 60.5 30.4 6.22 
$.D. 5.7 13.04 13.0 6.27 13.0 4.6 I. 61 
Radioisotope: 133Xe 
Diagnosis: Acute subarachnoid hemorrhage due to rupture of basilar artery aneurysm, diffuse vasospasm, and acute 
hydrocephalus 
TABLE 2 
HEMISPHERIC BLOOD FLOW AND METABOLIC INDEXES 
IN A SERIES OF PATIENTS WITH ACUTE UNILATERAL CEREBRAL lSCHEMIA 
HBF 
(ml / 100 gm brain/ min) 
HMI0 , 
(ml / 100 gm brain/ !llin) 
HMico, 
(ml / 100 gm brain/min) 
HMiar 
(ml / 100 gm brain/ min) 
HG:O 
(ml / 100 gin brain/ min) 
HRQ 
Values = mean ± standard deviation 
N = number of cases 
P = t test values 
HBF = llemispheric blood flow 
Healthy Side Diseased Side 
34.6 ± 3.4 (N = 30) 32.4 ± 3.3 (N = 32) 
f-- -----u.01 < p < 0 .02---------< 
2.28 ± 0.42 (N = 25) 2.07 ± 0.45 (N = 31) 
1.84 ± 0.52 (N = 24) 1.88 ± 0.48 (N = 31) 
3. 54 ± I. 17 (N = 25) 2. 87 ± I. 02 (N = 30) 
f--------10 .02 < p < 0.05---------< 
I. 58 ± 0. 54 (N = 25) I. 46 ± 0. 63 (N = 30) 
0.80±0.17(N = 24) 0.92±0.23(N = 31) 
1--------10.02 < p < 0.05---------< 
HMI0 , = hemispheric oxygen consumption 
HMico, = hemispheric carbon dioxide production 
HMI01 = hemispheric cpnsumption of glucose 
HG:O = hemispheric glucose:oxygen utilization ratio 
HRQ = hemispheric respiratory quotient 
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tabolism bilaterally, despite the fact that one has 
only a unilateral stroke (Fig. 1). 
One notices that with the passage of time, CBF 
improves and after about three weeks, the flow in 
the nonischemic hemisphere returns to normal. The 
quantitative reduction inflow also correlates with 
the size of the infarct, as assessed clinically, as well 
as with the degree of EEG change, particularly if 
it is a cortical infarct; the correlation is a little more 
difficult if it is a subcortical infarct. There are corre-
lations, to some extent, with other assessments of the 
degree of involvement such as of the brain stem. Bi-
lateral reduction of oxygen and glucose consumption 
and C02 production are noted, as well as blood flow 
reduction, although there is a greater reduction on 
the diseased side than on the healthy side, the respi-
ratory quotient (RQ) is normal. 
It should be noted that a hemisphere having 
a major infarct with hemiplegia still consumes appre-
ciable oxygen-more than one would think, consid-
ering the neurological deficit. Also, abnormal me-
tabolism was occurring on both sides (Table 3). 
There was a release of free fatty acids and inorganic 
phosphate, as well as serotonin and norepinephrine, 
from the infarcted brain; this has now been con-
firmed from cerebrospinal fluid. Inorganic phosphate 
from the infarcted brain appears only in the first 
14 days of stroke and tends, with the recovery 
process, to revert to no essential A-V difference. 
I want to mention a little about studies with 
OIASCHISIS - - - VASCULAR OCCLUSION (ARTfRIAl OR VENOUS) 
CARDIAC ARREST 
ANQXIC ANO XIA 
TRAUMA, TUMOR, etc . 
IMPAIRED 
NEUROTRANSMITTER 
FUNCTION J \ REDUCED CEREBRAL 
125 
v 0 HYPEREMIA INCREASED INCREASED GLUCOSE CONSUMPTION ? RELEASE SEROTONI~ TISSUE pO' 
COMA / - RECOVERY- WITH INCREASED- LACTATE - LOCAL ANAEROBIC GLYCOLYSIS 
p!~~~l;---y ~ COLLATERAL FLOW PRODUCTION (P)ASTEUR EFFECT) 
/"
H;200\ NaCl FURTHER 
K' ANOXIA 
CELLULAR 
'PUMPS' FAIL DEPRESSED GLUCCSE ~ _/CONSUMPTION 
~DECREASED ~ 
ENERGY PRODUCTION 
the use of intravenous glycerol and its effects on 
CBF and metabolism. We are interested in glycerol 
because not only did it bring about a significant 
reduction in intracranial pressure in our stroke 
patients, after intravenous treatment, but the pa-
tients also showed a significant clinical improve-
ment. We were unable to show this with mannitol 
and, for this reason, think that perhaps glycerol 
had some metabolic benefits along with its hyper-
osmolar effect. It is a very nice investigative tool 
for manipulating the cerebral metabolism as well. 
An infusion of glycerol increases cerebral blood 
flow, but (and this was a big surprise to us) it 
decreases the oxygen consumption. We have 30 
more patients now and this has become highly sig-
nificant. The C02 production also goes down, and 
the glucose consumption (in a mixed group of 
pa~ients) has a tendency to increase, which was 
TABLE 3 
/3-Hydroxybutyrate 
(mg/di) 
Glutamate 
(mg/ di) 
Triglyceride 
(mg/ di) 
HEMISPHERIC METABOLISM IN ACUTE UNILATERAL CEREBRAL IscHEMIA 
Arterial 
Concentration 
Arteriocerebral Venous Difference 
Healthy Side Diseased Side 
4 . 36±4.47(N = 13) +I.04±0.73*(N = 6) +0.27±0.32*(N = 13) 
t-- ---0. 001 < p < 0 . ()()5,- ---; 
3.98 ± 2.21 (N = 9) +0.25 ± 0.25* (N = 7) +0.21 ± 0.15 (N = 8) 
87.5 ± 38.5(N = 13) +I.3 ± 10.6(N = 9) +I.5 ± 7.0 (N = 13) 
1.153 ± 1. 765 (N = 8) +0.121 ± 0.237 (N = 5) -0.208 ± 0.217* (N = 8) 
2. 34 ± 0.49 (N = 14) -0.13 ± 0 . 23 (N = 6) -0.15 ± 0.12* (N = 14) 
Concentration 
in CSP 
N.E. 
N.E. 
N.E. 
N.E. 
N.E. 
Free Fatty Acid 
(mM/L) 
Inorganic 
Phosphate 
(mg/ di) 
Serotonin 
(µg / dl) 
12.48 ± 4.35 (N = 18) 1.92 ± 3.19(N = 12) -0.23 ± l.92(N = 18) 6.10 ± 4.86* (N 
i--- ---iO. 02 < P < 0. 05*---- -l 
* = statistically significant difference from normal 
Values = mean ± standard deviation 
N = number of cases 
N.E. = not examined 
18) 
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EF FECT OF IV GLYC ER OL ON rCBF 
STEADY STATE 
PoCOz _38 
AFTER 500ml of Glycerol 
PoC02 36.5 
A CASE OF ACUTE CEREBRAL INFARCTION 
HBF • 33.8 ml/IOOgmlmin 
HBF = 36 .8 ml/IOOgm/ min 
significant in diabetics and insignificant in non-
diabetics. We have postulated that we were im-
proving metabolism other than the usual oxidative 
metabolism; possibly, we were recoupling uncoupled 
oxidative metabolism. We also considered that 
glycerol may provide another source of energy, which 
may tend to improve cerebral energy production as 
well as the membrane integrity and function. The 
EEG improves regularly and the improvement ap-
pears within two hours during continuous recording. 
There is an increase in central venous pressure, as 
might be anticipated, due to the hyperosmolar effect 
of an infusion of 500 cc of a substance that is 
drawing fluid into the circulating blood volume. Since 
the intracranial venous pressure is a mean between 
the central venous pressure and the cerebrospinal 
fluid (CSF) pressure, then essentially, there is an 
increase followed by a decrease in the intracranial 
venous pressure. The mean arterial pressure is in-
creased also by a substance that increases a cir-
culating blood volume. Regional CBF and blood 
volume studies. of the effects of glycerol on the 
ischemic area of the middle cerebral artery occlu-
sion show redistribution of blood with an increase 
in blood flow and blood volume in the infarcted 
zone (Fig. 2) . Often, if there is a marked hyperemia 
on the border zone, there is a redistribution of blood 
in the infarcted zone, with reduction on the bordering 
zone. The mean hemispheric flow goes up regularly. 
Our data show a significant reduction, after the use 
of glycerol, in the release of free fatty acids and/ or 
inorganic phosphates from the infarcted brain. We 
believe that glycerol is combining with free fatty 
MEYER: CEREBRAL BLOOD FLOW STUDIES 
acids to form triglycerides. Inorganic phosphate may 
be taken up by ADP to form ATP. It could also 
be that the phospholipids are being resynthesized. 
Norepinephrine and serotonin in the CSF of 
patients with acute stroke are elevated ; it seemed 
likely that, in cerebral ischemia, the reduced tissue 
P02 might be interfering with the synthesis of 
neurotransmitters, such as norepinephrine and sero-
tonin and that the release of these might interfere 
with neuronal function . We measured C-AMP in 
the cerebrospinal fluid of these patients and found 
that it was significantly increased, actually much 
more significantly than serotonin and norepinephrine. 
If these neurotransmitters were disordered in the 
brain and were causing trouble, we wondered 
whether, with the use of adrenergic blockades such 
as propranolol or phenoxybenzamine, one could 
show an effect similar to that of glycerol, and 
indeed, this is what happened . The introduction of 
propranolol shows the same reduction of oxygen 
consumption, C02 production, and glucose utiliza-
tion. This reaction makes sense because norepineph-
rine is known to stimulate glycolysis and oxidative 
consumption and has been shown to be released 
in infarcted brain and to stimulate the release of 
free fatty acid. This finding supported our view 
that the release of these neurotransmitters is very 
important in cerebral infarction and may enhance 
the symptoms. We found also that the release of 
fatty acids was improved by the infusion of pro-
pranolol, which makes sense because norepinephrine 
stimulates the release of free fatty acids from fat 
stores and lipids. Inorganic phosphate, likewise, 
tended to be reduced and the consumption of tri-
glyceride, increased. Phenoxybenzamine, which is 
another a-adrenergic blocker and blocks serotonin 
as well as norepinephrine without having any effect 
whatsoever on hemispheric blood flow, reduced oxy-
gen consumption and C02 production in the same 
pattern that we found with both propranolol and 
glycerol. The use of phenoxybenzamine tended to 
reduce the release of free fatty acids and enhance 
the uptake of inorganic phosphate and triglycerides 
by the brain. 
After about the 14th day, the serotonin dis-
appears, as does the C-AMP, from the cerebrospinal 
fluid in patients with acute cerebral infarction; the 
serotonin change can be correlated with the cerebral 
blood flow . As the serotonin disappears , CBF in-
creases, which supports the view that serotonin is 
important in diaschisis and the bilateral reduction 
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of CBF. Other vasoconstrictive substances, such as 
epinephrine or norepinephrine, angiotensin, or 
prostaglandins may exist, which we have not mea-
sured yet. 
C-AMP is the second messenger for virtually 
all the neurotransmitters of the central nervous sys-
tem, certainly for serotonin and norepinephrine. 
We found that there was similar elevation of C-
AMP in cerebral venous blood when compared 
to the arterial blood in the steady state before 
glycerol. After giving glycerol, there was a reduc-
tion in the cerebral venous C-AMP, an inhibition of 
the release of C-AMP from the infarcted brain. 
An elevation of C-AMP in the steady state was 
noted in the cerebrospinal fluid of patients with 
cerebral infarction as well. When glycerol is given 
intravenously, there is a reduction of the C-AMP 
in the cerebrospinal fluid . 
This consideration of the relationship of neuro-
transmitters not only to cerebral infarction but also 
to subarachnoid hemorrhage is, to my mind, the 
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most promising area of investigation over the next 
decade. There is also a quantity of evidence that 
neurotransmitters play a large part in spasm fol-
lowing subarachnoid hemorrhage and in the dis-
turbance of neurological function in that situation. 
Following subarachnoid hemorrhage, some remedi-
able medical problems arise. Apart from clipping 
of the aneurysm, which the neurosurgeons are able 
to do, there is the problem of communicating hydro-
cephalus, which is extremely common in about 
40% of patients. It can be discerned by the method 
of determining regional CBF and doing a spinal 
tap. If you note an increase in cerebral blood flow 
with removal of 25 cc of spinal fluid, you know 
you have a problem with communicating hydro-
cephalus. This is because autoregulation is disturbed. 
This increase will not occur when a spinal tap is 
done on a normal person who does not have com-
municating hydrocephalus. Finally, one can give 
glycerol and reduce the brain edema in patients 
with subarachnoid hemorrhage and brain swelling. 
Advances in the Surgical Treatment of Patients with 
Extracranial Cerebral Vascular Disease* ** 
THORALF M. SUNDT, JR., M.D. 
Associate Professor of Neurosurgery, Mayo Medical School, 
University of Minnesota, Rochester 
Introduction. Since the subject of surgery for 
carotid artery occlusive disease is too broad to be 
covered in its entirety, we will dwell primarily on 
some results of cerebral blood flow measurements 
and electroencephalograms performed during this 
procedure, their meaning and relationship to states 
of cerebral ischemia, and some controversial aspects 
of the surgery. An understanding of cerebral hemo-
dynamics and the tolerance of neural tissue to 
ischemia is of major importance to any surgeon 
or physician dealing with this illness. 
Cerebral Blood Flow Measurements during 
Carotid Endarterectomy. Cerebral blood flow (CBF) 
measurements, determined from intra-arterially in-
jected 133Xe have been performed routinely on all 
patients on the author's service undergoing carotid 
endarterectomy over the past four years, and there-
fore, flow data are available from 279 cases of 
carotid stenosis and 13 cases of carotid occlusion. 
These measurements have been. determined prior 
to carotid occlusion, during occlusion, with a shunt 
in place (when used), and following restoration of 
flow. Analyses of results of these measurements have 
indicated an increase in CBF, determined by the 
initial slope technique from 58-73 m]/100 gm/min 
when carotid artery stenosis exceeds 90% ( 1) . When 
carotid artery stenosis is less than 90%, analysis 
of these measurements has indicated no essential 
* Presented by Dr. Sundt at the 27th Annual Stone-
burner Lecture Series, February 7, 1974, at the Medical 
College of Virginia, Richmond. 
* * From the Cerebrovascular Clinical Research Cen-
ter and the Department of Neurologic Surgery, Mayo Clinic 
and Mayo Foundation, Rochester, Minnesota 55901; this 
investigation was supported in part by Research Grant NS 
6663 from the National Institutes of Health, Public Health 
Service. 
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change in CBF. These measurements have been 
recorded with the patient under general halothane 
anesthesia with moderate induced hypertension and 
with a constant Paco, of 42 torr. Therefore, these 
anesthetic CBF measurements are higher than those 
found in normal awake patients, where a normal 
CBF approximates 54 m]/100 gm/ min. I do not 
wish to imply that an increase of CBF in this 
setting, of this magnitude, is necessarily lasting or 
of clinical significance other than an area's suscep-
tibility to symptomatic emboli. 
It is necessary to distinguish between the change 
in absolute regional CBF and alteration in relative 
contribution to that flow from the internal carotid 
artery before and after endarterectomy. Even in 
instances where no true alteration in CBF could 
be determined by these types of measurements, 
Boysen (2) found an increase in internal carotid 
artery flow following endarterectomy, and there-
fore an increase in the relative contribution to CBF 
from the vessel operated upon, when a significant 
stenosis was present. 
Electroencephalographic Measurements during 
Carotid Surgery. In addition to CBF measurements, 
all patients undergoing endarterectomy now have 
a constant electroencephalogram (EEG) recorded 
from the time of induction-of-to-arousal-from anes-
thesia. It has been found that the EEG is a valuable 
monitor for evaluating cerebral function during this 
surgery with a properly maintained level of anes-
thesia (3). It is noninvasive, has no risk, and has 
proven to be highly accurate in correlating cerebral 
metabolic function during surgery with the neuro-
logical function postoperatively. The EEG offers a 
continuous technique for monitoring cerebral func-
tion throughout the entire procedure, something 
that is not possible by any other technique unless 
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the patient is operated upon under local anesthesia. 
The very close correlation between the EEG and 
the CBF measurements below 17-18 ml/ 100 gm/ 
min at a Paco, of 40 torr is most impressive. In 
our series to date, we have not had a single CBF 
measurement during carotid occlusion below this 
level that did not have an associated EEG ab-
normality. The lower the occlusion flow, the more 
rapid the EEG changes. A typical EEG demonstrat-
ing the changes with occlusion and resolution with 
a shunt in place is illustrated in Figure 1. 
CBF-Ischemic Tolerance Ratio. The ischemic 
tolerance of neural tissue is directly proportional 
to the relative decrease in CBF. A decrease in CBF 
to between 20 and 30 ml/ 100 gm/ min can be tol-
erated quite well for limited periods of time. When 
the CBF falls to below 18 ml/ 100 gm/ min, cerebral 
metabolic function changes and a physiological pa-
ralysis follows (1 , 3). This is, however, to be dis-
tinguished from infarction. It is probable that this 
degree of ischemia can be tolerated for a period 
of hours, rather than minutes, without major infarc-
tion, whereas flow reductions below 10 ml/ 100 gm/ 
min produce infarction in a much shorter time. 
This hypothesis cannot be tested in its entirety 
clinically, but it has been extensively investigated 
in the laboratory. In squirrel monkeys, a degree of 
ischemia approximating 20 ml/ 100 gm/ min can 
be tolerated for up to two hours without the uniform 
development of a cerebral infarction ( 4). In these ani-
mals cerebral adenosine triphosphate (ATP) falls 
to 55% of normal and cerebral lactate rises to seven 
times normal following two hours of occlusion ( 5). 
During the period of occlusion, the EEG shows 
changes similar to those seen in patients with severe 
flow reductions during carotid occlusion. Following 
restoration of flow in the laboratory preparation, 
there is a gradual rise in ATP, fall in lactate, and 
normalization of the EEG. Ah infarction is not 
uniformly seen in this animal unless occlusion is 
maintained for fout hours . The degree of ischemia 
and metabolic alteration which follows this single 
major vessel occlusion must be distinguished from 
the situation which follows cardiac arrest when there 
is zero blood flow. In this setting, ATP falls to 25% 
of normal in only four minutes, and there is the 
rapid production of cerebral infarction with the 
probability of the "no-reflow phenomenon" ( 6). 
We had previously doubted the necessity for 
a shunt in any case undergoing carotid endarterec-
tomy, on the basis that flow values seldom if ever 
Before clomping 
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Fig. 1-A typical EEG demonstrating the changes seen 
with occlusion for endarterectomy when cerebral blood 
flow falls to 10 ml/100 gm/ min. Changes include both 
generalized slowing and loss of background activity. In 
this patient with opposite carotid artery occlusion, the 
changes were seen bilaterally. Most commonly, changes 
occur only on the side of occlusion. The EEG improves 
following placement of tl)e shunt and improvement in CBF 
values doubles that seen prior to occlusion. (Reprinted by 
permission from J N eurosurg 41:315, 1974.) 
fell to extremely low levels (7) . it is now apparent 
that this hypothesis was incorrect and that, indeed, 
a great many patients have CBF measurements with 
unilateral carotid artery occlusion that fall to ap-
pallingly low levels, and in sorrie instances, to values 
too low to measure, approximating cardiac arrest. 
Furthermore, unfortunately, we have found that the 
degree of backflow is proportional to the cerebral 
vascular resistance which varies quite a bit from 
one patient to another; that is, it is an unreliable 
indicator of CBF and collateral flow. In contrast 
to our previous position, we now readily agree that 
there are definite indications for a shunt during 
carotid endarterectomy. 
Use of a Shunt during Carotid Endarterectomy. 
A shunt has been employed in approximately one-
third of the patients operated upon in this series. 
EEG changes, along with occlusion values below 
the critical perfusion level, occurred in 56 of these 
patients; shunts were used in the remaining cases 
because of borderline perfusion values that could 
conceivably produce a critical perfusion flow in the 
internal capsule area, which might be missed both 
by a CBF measurement and an EEG change. 
Shunts are not used routinely because there 
are several disadvantages in using them. A shunt 
interferes with a precise endarterectomy, can serve 
as a source of emboli when in place, and requires 
constriction of the proximal carotid artery in a 
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tourniquet fashion, a maneuver that can injure the 
vessel wall. 
The time for placement of a shunt has varied 
a great deal from one patient to another; the speed 
of placement has been proportional to the urgency of 
its need. When possible, it is desirable to complete 
the endarterectomy in the internal carotid artery 
prior to placement of the shunt and, thereafter, to 
complete the endarterectomy and angioplastic pro-
cedure. With the shunt in place, the patient is totally 
heparinized, but in addition to having the patient 
totally heparinized, the shunts we are using are 
impregnated with heparin to avoid or minimize the 
possibility of emboli. Using this new type of heparin 
coating, provided for us by Battelle Laboratories 
of Columbus, Ohio, we have seen no platelet ma-
terial at the mouth of the shunt following Hs removal. 
Prior to this added measure, even with total heparin-
ization of the patient, we routinely fo~nd platelet 
material at the mouth of the shunt. 
To this date, none of our patients has de-
veloped an abnormal EpG with carotid occlusion 
that did not revert with prompt placement of a 
shunt; however, one patient in the group did develop 
EEG alterations with the shunt in place, proven to 
be related to microembolism through the shunt, aµd 
this patieqt sustained a permanent neurological 
deficit. Since that occasion, we have been using only 
heparinized shunts and have had no recurrent prob-
lems of that nature. This patient represented the 
only embolic complication from the group in which 
a shunt was employed. · 
CBF, Ischemic Tolerance, and Paco2 • We have 
not routinely employed hypercapnia during the pe-
riod of carotid occlusion. Under halothane general 
anesthesia, hypercapnia predisposes to cardiac ar-
rhythmias, giving problems riot justified by proven 
beneficial effect. Boysen ( 2) found, during carotid 
epdarterectomy, the expected increase in CBF prior 
to carotid clamping from hypercapnia as a result of 
maximal vasodilatation. With carotid clamping, how-
ever, there was a greater relative reduction in CBF 
in comparison to the group studied at normocapnia, 
and furthermore, a paradoxical reaction was occa-
sionally demonstrated. In this paradoxical reaction, 
hypercapnia did not improve regional CBF but rather 
resulted in an intracerebral "steal." We have demon-
strated this in our patients also and it therefore seems 
safe to conclude that hypercapnia cannot be relied 
upon invariably to increase regional perfusion in the 
areas of severe ischemia. 
The use of hypocapnia, to produce a reverse 
steal and hence increase cerebral perfusion to areas 
of ischemia, has been suggested by Lassen ( 8) ; 
however, a careful analysis of their patient group 
with proven cerebral ischemia, treated with hypo-
capnia, indicated no clinical effect from hypocapnia, 
although they were able to procjuce a reverse steal 
with its use. 
Laboratory studies support the clinical findings of 
Lassen and his group (9) and have indicated that al-
though a reverse steal can be produced with the use 
of hypocapnia, the effect of hypocapnia in areas of 
focal ischemia is definitely detrimental. In a group of 
animals with focal ischemia in which hypocapnia was 
induced, the cerebral ATP was significantly less and 
the cerebral lactate significantly higher than corre-
sponding values in hypercapnic and spontaneously 
breathing animals. One mlist conclude that the Paco, 
should be maintained at as near a normal level as 
possible during carotid endarterectomy and that it 
should not be raised to produce hypercapnia or low-
ered to produce hypocapnia. 
Surgical a11d Nonsurgical Lesions. I should now 
like to refer to some of the clinical and surgical 
aspects of this illness. The majority of patients 
upon whom we operated in this series have had 
a severe stenosis or a deep ulceration at the origin 
of the internal carotid artery from the common 
carotid artery. Minor degrees of ulceration at the 
origin of the internal carotid artery from the cmµ-
mon carotid artery are not considered surgical le-
sions unless the patient is quite young. It has been 
our judgment that such small ulcers frequently heal 
spontaneously, and this is supported by a recent 
study designed to determine the frequency of strokes 
from such lesions. Minor degrees of ulceration or 
stenosis at the origin of the internal carotid artery 
are not uncommon in the elderly population, and 
even when associated with a bruit, are not neces-
sarily an indication for surgery. Loops of the in-
ternal carotid artery are rarely symptomatic-not-
withstanding a recent report to the contrary. 
Correlation of Angiographic Findings with 
Symptom Complexes of Carotid Arterial Disease. 
A correlation, 'retrospectively, of the angiographic 
findings , cerebral blood flow measurements, and 
clinical symptomatology in patients suffering from 
carotid ulcerative stenosis has permitted a judgment 
regarding the etiology of the various forms of symp-
tomatology. In general, the focal symptom com-
plexes are felt to be most commonly the result of 
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cerebral embolization (10), but we have noted that 
focal regions of the brain, and to a lesser extent 
the retina, are particularly vulnerable to emboli 
if that region is under a low perfusion pressure; this 
is an angiographic finding-space does not permit 
us to discuss it in detail. In such instances, regions 
of marginal perfusion are dependent in part on 
collateral circulation, so that any embolus to a 
collateral vessel is likely to be of major significance 
symptomatically. Ooviously, such regions of mar-
ginal perfusion are also particularly vulnerable to 
periods of hypotension. In general, amaurosis fugax, 
transient ischemic attacks (TIA's), and small com-
pleted infarcts represent manifestations of cerebral 
embolization (11). A progressing stroke-that is, a 
neurological deficit which is progressive over a period 
of hours-quite often is the result of multiple em-
bolization into a region of very marginal perfusion. 
The temporal profile of this, type of progressing 
stroke must be distinguished from a massive in-
farction that reaches its zenith two or three days 
later from severe cerebral edema. The progressing 
stroke which begins with a minor neurological deficit 
and progresses through intermittent stages of de-
terioration can be helped by emergency surgery in 
many instances, whereas the massive infarction with 
immediate profound ·hemiplegia is often a contra-
indication to surgery. 
Generalized cerebral ischemia represents an 
uncommon, nonembolic, symptom complex that may 
be the patient's only complaint or may coexist with 
symptomatology of focal cerebral ischemia (12). An 
individual with generalized cerebral ischemia must be 
differentiated from the patient with vertebrobasilar 
insufficiency; these patients are suffering from severe 
bilateral carotid arterial stenosis or a high-grade 
stenosis in association with a contralateral occlusion. 
Upon assuming the erect posture, there is a rather 
dramatic fall in the retinai artery pressures, although 
the peripheral blood pressure does not fall pro-
portionately. At this time, the patient may complaih 
of light-headedness or a sensation that he may faint. 
This is not true vertigo. He may complain of dim-
ness of vision or difficulty in balance. The family 
usually reports changes in behavior or memory. 
CBF measurements have indicated a very significant 
increase in CBF following endarterectemy in these 
patients, and there has been a rather gratifying 
improvement following surgery. Approximately 10% 
of our patients have had symptomatology of this 
type. I would like to reemphasize that these are 
not patients with presenile dementia or vague light-
headedness. In addition to the symptoms, ther~ are 
the hard findings of reduced retinal artery pressures, 
bilateral or unilateral carotid bruits of a very sig-
nificant character, and subsequent angiographic 
confirmation of the pathology-severe disease-not 
kinking or minor irregularities. 
It is uncommon that we operate on patients 
for the presence of a bruit alone; however, the char-
acter of the bruit and other features of the examina-
tion, such as the presence or absence of retinal 
emboli, the patient's age, and the · presence or ab-
sence of vascular disease elsewhere, enter into the 
decision regarding the meth()d of treatment. 
Preoperative Risk Factors in Carotid Endarter-
ectomy. Space doe~ not permit details of our system 
for grading a p;itient's risk for surgery and the 
morbidity and mortality related to these risk factors, 
which include obesity, advanced age; coronary artery 
disease, progressing neurological deficits, frequent 
daily transient ischemic attacks, contralateral arterial 
occlusion, high bifurcations, long plaques, and soft 
thrombi. This system is gracied from I through IV 
for carotid stenosis, acute internal carotid occlusion 
being considered grade V and analyzed separately. 
The combined morbidity and mortality in this series 
has ranged from 1 % in low-risk, or grade I, pa-
tients for surgery to 8 % in high-risk grade IV 
patients for surgery ( 12). 
Vessel Patency. Patency in all vessels on wtiich 
we have operated for ulcerative stenotic disease was 
99.3% at the time of discharge from the hospital 
as determined by retinal artery ·pressure (RAP) 
measurements, angiography, or both; however, foµr 
vessels were reopened prior to discharge with in-
sertion of a vein graft because of occlusion in the 
immediate period following surgery. All of these 
occurred earlier in the group in which grafts were 
not employed; all were symptomatic with TIA's; 
all occurred in relatively small vessels; and all were 
detected or confirmed by finding a reduction in the 
RAP which in each case returned to normal after 
restoration of flow and patency. In the first patient, 
reopening was delayed and a permanent upper 
monoparesis and mild expressive aphasia resulted. 
In the other three patients, the vessels were im-
mediately reopened, and there was no delay in dis., 
charge from the hospital and no morbidity. One 
vessel in a grade IV candidate occluded simul-
taneously with a myocardial infarction; flow was 
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not restored and hemiplegia resulted; this has been 
our only permanently occluded artery. 
To Patch or Not To Patch. Admittedly one can 
perform this surgery without the use of a patch and 
have the vessel remain patent in most instances. 
There is little question in my mind at this time, 
however, that the use of a patch improves the 
prognosis for both acute and chronic patency. The 
use of a patch prolongs the procedure, but with 
careful monitoring, this is of no great importance. 
We frequently reinforce the portion of the graft in 
the common carotid artery with a thin teflon sheath 
to prevent an aneurysmal dilatation and excessive 
stress on the graft in patients who are hypertensive. 
Hemorrhagic Infarction. The final controversial 
subject I would like to discuss is that related to the 
risk of hemorrhagic infarction. This risk has led 
some surgeons to consider the presence of any 
recent neurological deficit and certainly a progress-
ing deficit as a relative contraindication to surgery 
(13). The controversy is not easily resolved. Our 
group of patients who were neurologically unstable 
at the time of surgery, considered as grade IV risks, 
embraces a group of 56 patients in whom we have 
had ;m 8% combined morbidity and mortality; the 
risks of not operating are obviously considerably 
higher. This group includes progressing strokes, fre-
quent daily TIA's, impending occlusion with ischemic 
carotid pain, and recent minor fixed deficits in 
association with severe degrees of ulceration. 
Hemorrhagic cerebral infarction can result from 
cerebral embolization with or without surgery (14). 
A very high ris.\c of surgery in these unstable neuro-
logical patients is related to a soft thrombus that 
is frequently present at the bifurcation of the carotid 
artery and is superimposed upon an ulcerated plaque. 
In these patients, extra care must be ~xercised in 
preventing a recurrence of cerebral embolization. 
It wouid seem likely that hemorrhagic infarction 
has often resulted from embolization rather than 
restoration of perfusion pressure to an ischemic 
region of brain. 
The cbmbination of a reduced retinal artery 
pressure on the side of intended surgery, and a 
major branch occlusion intracranially with a region 
of severe ischemia represents, in our judgme,nt, a 
contraindication to surgery. 
Conclusion. The use of intraoperative CBF 
measurements, continuous EEG's, postoperative 
RAP's, vein patches, ~nd intraoperative shunting 
when indicated, has aided materially in reducing 
morbidity and mortality in this surgery. 
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Clinical Advances in the Diagnosis of Cerebral 
Vascular Disease* 
JOHN STIRLING MEYER, M.D. 
Professor and Chairman, Department of Neurology, Baylor College 
of Medicine, Houston, Texas 
I have chosen some thoughts about recent 
clinical advances in the diagnosis of cerebral vascu-
lar disease, which I feel are appropriate for this 
paper, confining my discussion to the signs, symp-
toms, natural history, and risk factors of cerebral 
vascular disease. 
Atherosclerosis and stenosis of the cerebral 
vessels result in occlusion and embolization of the 
brain parenchymatous vessels, particularly if the -
atherosclerotic lesions of the vessels not only stenose 
but cause ulcerated lesions as well, which will give 
rise to fibrinoplatelet emboli and even large, red 
emboli. This process results in slow blood flow, 
turbulence, erythrocyte and platelet aggregation-
with local anoxia resulting in endothelial damage, 
the loss of plasma fluid-resulting in brain edema, 
and compression of capillaries and venules. This 
vicious cycle is depicted in Figure 1, showing a 
worsening of the ischemic and hemorrhagic infarc-
tion. In the area of circulation around the ischemia, 
hyperproteinemia and hemoconcentration occur, 
which tend to cause deposition of the platelets. 
One can easily see these platelets under direct 
examination of the microcirculation of the brain, 
showing increased viscosity and the tendency toward 
thrombosis and further infarction. 
Hypertension will promote atherosclerosis, and 
certain other systemic factors such as hypotension 
or lowered blood pressure, particularly much below 
80-90 mm Hg (systolic), will worsen the situation 
because of distorted autoregulation. Associated poly-
* This is an edited transcription of a lecture presented 
by Dr. Meyer at the 27th Annual Stoneburner Lecture 
Series, February 7, 1974, at the Medical College of Vir-
ginia, Richmond. 
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cythemia or sickle cell disease will be aggravated 
by the situation. 
Conversely, anticoagulants and platelet in-
hibitors tend to prevent the aggregation of these 
platelets and erythrocytes as well as preventing the 
development of thrombosis. Systemic dehydration 
will have an adverse effect while collateral blood 
flow enhancement will tend to improve the situa-
tion. Hyperlipidemia and hyperlipemia will cause 
aggravation for several reasons-they promote 
atherosclerosis and they enhance the tendency to-
ward platelet aggregation and changes in the proper-
ties of the blood. Hypothermia will tend to protect 
the patient by decreasing brain metabolism; sys-
temic anoxia will make him worse. Neurotrans-
mitters are released, probably as a result of the 
deleterious changes. 
Let me summarize the risk factors with which 
the American Heart Association Committee con-
cerned itself in 1971 (1) , which we now agree are 
reasonably well established (Table 1). A hyper-
tension of 160/ 95 mm Hg is present in at least 
85% of cases-a significant risk factor, the control 
of which is one of the great advances in prevention 
of stroke. EKG abnormalities occur in 60-70% of 
our patients with stroke, consisting of left ventri-
cular hypertrophy (L VH), myocardial infarction 
(MI), or a recent or old dysrhythmia. Clinical 
angina, myocardial infarction, claudication, dimin-
ished pulses, bruits-all are associated with a stroke 
patient and should be sought. Diabetes mellitus 
occurs, depending upon how you evaluate it, in at 
least 30-40% of these patients. Certainly, an ele-
vated fasting blood sugar and an abnormal glucose 
tolerance test or a two-hour postprandial blood 
sugar exceeding 160 mg% should be considered sig-
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nificant. Recently, we have been studying the blood 
lipid profile, another important factor, with Dr. 
Gotto at our institution. Type IV lipidemia, par-
ticularly, is a risk factor that occurs in approxi-
mately 30% of these patients. Other factors-
smoking, polycythemia, erythrocytosis, gout, and 
hyperuricemia should be evaluated. Of our patients 
with cerebral vascular symptoms and extracranial 
occlusive disease, 43% had hyperlipoproteinemia, 
and almost all of these were type IV. Of our pa-
tients with intracranial small and large vessel lesions, 
20% had hyperlipoproteinemia, but of those with 
intracranial small vessel disease, only 3% had hyper-
lipoproteinemia. As might be expected, of those with 
combined extra- and intracranial lesions, there is 
an incidence of 25 % . Those with a normal 
angiogram have, essentially, a normal lipoprotein 
pattern. In summary, one can say that hyperlipo-
proteinemia type IV is a significant aspect of extra-
cranial occlusive disease. 
It is wise in evaluating your patients, particu-
larly the young patients with hypotension and 
extracranial occlusive cerebral vascular disease, to 
look for fibromuscular dysplasia. Acute myocardial 
infarction is seen in 10% of patients with acute 
stroke and in 60% of those with chronic arterio-
sclerotic heart disease. As illustrated in Table 2, a 
stroke-prone individual is one who has not yet had 
a stroke but is likely to because of the risk factors 
present in his profile. Thus, a patient with hypo-
tension, diabetes, hyperlipidemia, and/ or arterio-
sclerotic heart disease, who is obese or a heavy 
smoker, is extremely apt, on a prospective clinical 
trial period, to have a stroke and is at great risk. 
Similarly, patients having transient ischemic 
attacks (TIA's) or reversible ischemic neurological 
deficits (RIND's) will proceed to a stroke 30-50% 
of the time within a five-year period. Transient 
ischemic attack is a neurological deficit existing, 
due to cerebral vascular disease, for 24 hours or 
less; whereas reversible ischemic neurological deficit 
is a little stroke lasting longer than 24 hours but 
with recovery in about three weeks. A patient who 
has had a neurological deficit for longer than 24 
hours, progressing in the acute stage is said to have 
a stroke in evolution. A stabilized neurological 
deficit appears in a patient who has a stroke in 
the past and comes in sometime later in a stable 
condition. Table 3 represents a summary of several 
natural history studies of cerebral vascular disease, 
which indicates that of those undergoing TIA's, 
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one-third progress within five years to irreversible 
cerebral infarction; one-third continue to have TIA's 
and therefore continue to be at risk of cerebral in-
farction; and one-third seem to cease having TIA's 
spontaneously within five years, without further neu-
rological disorder, but they are at great risk of 
suffering other complications of atherosclerosis such 
as myocardial infarction. 
The mechanism of TIA's is still under con-
sideration by many scientists and physicians. Cer-
TABLE 1 
RiSK FACTORS IN STROKE* 
1. Hypertension of 160/ 95 mm Hg (present in 853 of 
cases) 
2. Cardiac Enlargement by X-ray 
3. EKG Abnormalities, LVH, MI, and Dysrhythmia 
4. Clinical Angina, MI, Claudication, Diminished Pulses, 
and Bruits 
5. Diabetes Mellitus (2 hr pp 160 mg% or more; FBS 120 
mg% or more) 
6. Elevated Blood Lipids (cholesterol, fl-lipoproteins, 
triglycerides) 
7. Smoking 
8. Erythrocytosis 
9. Gout-Hyperuricemia 
* Reprinted by permission of the American Heart As-
sociation, Inc. (1) 
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TABLE 2 
CLINICAL CLASSIFICATIONS 
1. "Stroke-prone" individual 
2. TIA's and RIND's 
3. Stroke in evolution and patients with moderate-to-
severe neurological deficits still in acute stage 
4. Stabilized neurological deficits 
tainly, the two major headings are recurrent 
fibrinoplatelet emboli and hemodynamic factors. 
What are the remediable mechanisms in TIA's 
(Table 4)? First of all, there is embolization for 
which doctors have advanced treatment. Cardiac 
dysrhythmias can cause cerebral vascular symptoms 
simply by decreasing cardiac output when the rate 
of the heart exceeds 160 or falls below 60. Transient 
hypotension can cause cerebral vascular symptoms 
as well, particularly if the patient has dysautoregu-
lation or impaired autoregulation of the brain. Hy-
pertension with spasm of cerebral vessels, first de-
scribed many years ago and then abandoned, is now 
well established as a significant factor. Hypogly-
cemia, a relatively rare factor, can cause localized 
neurological deficits but will respond to the admin-
istration of glucose. Likewise, polycythemia, the 
subclavian innominate steal syndrome, severe ane-
mia, kinking of vessels in the neck, and external 
compression may, by such things as osteophytes 
and cervical spondylosis, give rise to TIA's. 
While it was considered dangerous at one point 
to lower elevated blood pressure in patients with 
stroke or cerebral vascular symptoms, it now seems 
clear that controlling the hypertension improves the 
prognosis. In a series of hypertensive stroke patients 
treated with Aldomet® for one-to-two weeks, we 
noted that cerebral blood flow actually increased as 
the mean arterial blood pressure was decreased sig-
nificantly and thereby decreased cerebral vascular 
resistance. 
Figure 2 is a sketch of a very important concept 
TABLE 3 
TRANSIENT lSCHEMIC ATTACKS* 
1 / 3 -> Irreversible cerebral infarctions 
1/ 3 -> Continue to have TIA's 
1 / 3 -> Cease in five years 
* It is impossible to predict into which category an 
individual patient with TIA's will fall. 
TABLE 4 
R EMEDIAL MECHANISMS IN TRANSIENT lSCHEM!C ATTACKS 
1. Embolization 
2. Cardiac dysrhythmia 
3. Transient hypotension 
4. Severe hypertension with spasm of cerebral vessels 
5. Hypoglycemia 
6. Polycythemia 
7. Subclavian, innominate steal 
8. Severe anemia 
9. Kinking of vessels 
10. External compression 
of how an ulcerated plaque in the carotid artery 
can be a source of cerebral embolism. Recurrent 
cerebral embolism with recurrent TIA's may occur 
in the same distribution repeatedly-a very im-
portant warning sign. Thus the ulcerated plaque 
may release the embolus which may then lodge 
in the middle cerebral artery territory, causing tur-
bulent flow. Circulating fibrinolysin, apparently 
present in the body normally but probably decreased 
in these patients, tends to dissolve the fibrinoplate-
let deposition. Platelet aggregate inhibitors, such as 
aspirin, Persantine®, sulfinpyrazone, along with anti-
coagulants, tend to inhibit emboli. Today, there is 
a greater tendency to use platelet inhibitors rather 
than anticoagulants. 
We studied cerebral embolization in 42 cases 
prospectively. In our patients, prosthetic heart valves 
Embolus I 
Circulating t 
fibrinolysini!: Ulcerated 
dissolves "'-. 
~ · 
Turbulent flow ':-prom/' 
Fibrin and platelet deposttion 
prevented tJoj / 
Fig. 2. 
Anticoagulants 
Platelet inhibitors 
!Aspirin, persantine, 
sulfinpyruone, eU:. I 
Middle cerebnl artery 
Anterior cerebral artery 
Internal carotid 
MEYER: DIAGNOSIS OF CEREBRAL VASCULAR DISEASE 137 
were important as a source of fibrinoplatelet emboli 
to the brain. Rheumatic heart disease may also 
cause emboli formation; arteriosclerotic heart disease 
may cause emboli as a result of myocardial infarc-
tion, pacemaker failure, or dysrhythmias. Carotid 
plaques emerge along with cardiac disorders as the 
most common causes, accounting for almost all 
emboli. There are rare causes such as aortic aneu-
rysms with mural thrombi, carotid stenosis without 
ulcerated plaque, carotid kinking, and vertebral 
thrombosis. Two types of embolism can result from 
the justifiable insertion of prosthetic valves, although 
it must be emphasized that 90% or more of patients 
receiving them show no complications from their 
use, and they should be considered a great advance 
in surgical treatment. The fibrinoplatelet emboli that 
arise from the valve, particularly if it is a ball valve 
with a rough surface, can be seen and can be treated 
with Persantine®. The larger types of emboli respond 
to anticoagulants. 
Although we never used to think that seizures 
occurred with cerebral vascular disease, it is now 
quite apparent that they commonly occur in cere-
bral embolization. Neurological findings show that 
abnormal tendon jerks· and mo;or deficits are com-
mon and cranial nerve involvement is a frequent 
physical finding; herrlianopsia is relatively frequent 
as well. Regarding the work-up, the arteriogram is 
by far the most valuable test and will usually show 
the occluded vessel early in the course of disease. 
We were able to show the occl~ded vessel in 93% 
of our cases. In 90% of cerebrc1I embolisms, the 
EEG is abnormal. The brain scan is abnormal in 
91 % of the cases and the cerebrospinal fluid (CSF) 
pressure is increased in about 50% of the cases 
(Table 5). The left hemisphere is involved more 
often than the right in cerebral embolisms; the 
incidence was about twice as high in our study. 
Sixty-five percent of emboli of cardiac origin and 
64% of carotid plaque origin lodge in the left hemi-
sphere. This tendency can probably be explained 
by the anatomical distribution of the aorta and the 
great vessels in the neck. The innominate artery 
tends to go against the vector of force or the thrust 
of the cardiac output; it is somewhat protected and 
emboli would tend to go to the right arm rather 
than into the carotid or vertebral artery. The left 
common carotid artery, however, is particularly 
prone to receive the emboli, since it lies directly 
in the direction of the thrust of the cardiac output. 
Also, I believe the incidence of plaques is greater 
Test Performed 
Arteriogram 
Electroencephalogram 
Brain scan 
CSF pressure exceed-
ing 180 mm H,O 
TABLE 5 
No. Cases 
Studied % Normal % Abnormal 
28 
30 
11 
20 
7 
10 
9 
50 
93 
90 
91 
50 
on the left. It could perhaps be argued also that 
a patient who is dysphasic and has a left hemisphere 
lesion is more likely to be diagnosed, but we rejected 
that argument in our own prospective study since 
we think we examined all patients very carefully. 
In our institution, patients with vertebral basilar 
insufficiency have a different type of transient 
ischemic attack from patients with carotid emboli; 
they tend to have more postural vertigo, dizziness, 
photopsia, or homonymous or altitudinal hemianop-
sia. We feel that is because the process of ischemia 
. of the brain stem itself involves those centers that 
are concerned with autoregulation. There is evidence 
now from many laboratbries showing that auto-
regulation, the property of the brain enabling it 
to maintain a constant blood flow despite changes 
in the perfusion pressure, is due, in part, to the 
neurogenic innervation; this property has a brain 
stem or diencephalic-brain stem origin. Ischemia in 
this area will damage the autoregulation process. 
A fall in cerebral perfusion pressure will cause a 
decrease in cerebral blood flow ( CBF), and the 
patient will become dizzy and symptomatic. Data 
from analysis of the sites of lesions in acute and 
in chronic strokes correlated with the delta CBF 
over the delta cerebral perfusion pressure (which 
happens to be called · the autoreguiation index) 
indicate that the effects are more severe in the 
acute stages, especially in those patients with brain 
stem and subcortical infarction as compared to pa-
tients with cortical infarction. Increased intracranial 
pressure is relevant in cerebral infarction. 
Cerebral edema can be lethal. We have tried 
to combat this with hyperosmolar agents; glycerol 
seems to be the best agent that we have evaluated 
in cerebral vascular disease. We find that it is better 
to treat the patient with 10% glycerol intravenously 
for six days rather than four. Glycerol (one should 
not use more than 10%) seems to benefit metabo-
lism as well as lower intracranial pressure; it is 
another source of energy for the brain. 
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Finally, I would like to make a few remarks 
about transient global amnesia and dementia as a 
result of vertebral basilar insufficiency. Transient 
global amnesia and dementia effect persons of middle 
age; they have attacks of loss of memory for a period 
of 24 hours and then make a more or less complete 
recovery. During the attacks, they do not lose per-
sonal identity and knowledge of self, but they have 
loss of memory for just about everything of recent 
occurrence. Tbey are able to carry out routine 
behavior; they can respond when spoken to; they 
may be rather pale and sweaty. The origin of this 
interesting syndrome being uqknown, epilepsy, mi-
graine and various equivalents, and also cerebral 
vascular disease were considered as p01~sibilities . 
We have studied a fairly large series of these patients, 
having followed them now for an interval of two-
to-three years. Tbey actually have vertebral basilar 
insufficiency wmptoms in addition to tpe attacks 
of transient global amnesia. They have drop at-
tacks, ataxia, vertigo and n;msea, vomiting, nystag-
mus, dizziness, light-headedness, syncope, diplopia, 
oscillopsia, paresthesias alternating from side to side, 
circumoral paresthesias, tremor, cortical blind-
ness, episodic bilateral blurred vision, occipital 
headaches-all of which are symptoms of vertebral 
basilar insufficiency. When we analyzed them in 
terms of their age, the youngest was 48 years of age 
and the oldest was 95 wjth a mean of abo~t 70; 
so it is a disease of late-middle-to-·early-elderly aged 
individuals. We noted that the cerebral blood flow 
measµred in these patients was reduced; the major 
reduction W (!S in the occipital area, in the distribu-
tion of the posterior cerebral arteries. We then 
analyzeq the patients for the risk factors for cerebral 
vascular disease mentioned previously; it is ap-
parent that these patients do have a high incidence 
of hypertension, hyperlipidemia, coronary artery 
disease of one sort or another, and diabetes mellitus. 
A study of their natural histories, prospectively, 
indicates that they frequently have had recurrent 
attacks of transient global amnesia, often resulting 
in dementia; this leads to amnesic stroke with per-
manent loss of memory and gross dementia in a 
vast number of cases. These patients usually have 
abnormal EEG's. Bjtemporal EEG's showing oc-
cipital slow waves are found most often; occasion-
ally, bifrontal slow waves are seen as well. Angio-
grams of 12 patients revealed vertebral basilar 
arterial disease in the majority of them. Occlusion 
or steqosis of the posterior cerebral artery was 
extremely common. Thus, clearly, this disease is 
due to vertebral basilar insufficiency, and it is prob-
able that the posterior cerebral artery is responsible 
for loss of memory. 
I have tried to summarize what I consider to 
be recent and, I think, relevant and important clini-
cal findings contributed by neurologists, neurosur-
geons, and · internists in the past few years on the 
subject of cerebral vascular disea~e . 
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Reconstructive lntracranial Voscular Surgery* 
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It is scarcely less than two decades since the 
initial cautious explorations of reconstructive sur-
gery for the prevention of cerebral infarction caused 
by extracranial vascular disease began. The next 
years recorded an accumulative experience in the 
field of vascular surgery. Early clinical investigations 
led to the discovery that extracranial vascular disease 
is a major cause of cerebral infarction or stroke. 
Estimates indicate, however, that only 30-40% of 
the patients with cerebrovascular insufficiency have 
significant extracrania:l occlusive disease. For this 
larger group of patiertts, previous surgical methods 
offer no hope. It is the purpose of this report to 
review the current status of our clinical explorations 
in the area of reconstructive intracran1al vascular 
surgery. 
This is not a new venture for as early as 1944, 
Henschen ( 1) transplanted a pedicle of temporalis 
muscle and artery over the surface of the brain 
in a: type of encephalomyosynangiosis. This pro-
cedure, performed in a patient with biiateral carotid 
stenosis, was similar in concept to the Vineberg-
J ewett operation for revascula:rization of the myo-
cardium, first published in 1947 (2). The patient 
is reported to have improved, but angiographic 
confirmation of graft function was not accomplished. 
The procedure apparently was not explored further 
until the work of Donaghy and Yasargil ( 3) in 
1966. 
Direct reconstruction of the middle cerebral 
artery was successfully performed by Welch ( 4) 
in 1956, an amazing feat achieved without the 
aid of a surgical microscope and many other re-
fined techniques which today are regarded as es-
sential; subsequent reports by Shililto ( 5), Scheibert 
* Presented by Dr. Tew at the 27th Annual Stone-
burner Lecture Series, February 7, 1974, at the Medical 
College of Virginia, Richmond. 
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(6), Drieseh (7), and Chou (8) followed. Jacob-
son, Donaghy, and colleagues (9) first reported that 
the microsurgical technique was of considerable 
value in performing this procedure. Subsequently 
several centers ( 10, 11) have reported their results 
with surgical treatment of occlusions of the middle 
cerebral artery. Yasargil (12) tabulated eleven cases 
in 1969, of which ,he operated on nine, more than one 
week following the onset of symptoms. One case, 
on which he operated withirt two hours of occlusion, 
failed to improve although t.he artery remained 
patent. A second case, on which he operated twelve 
hours following occlusion, developed a hemorrhagic 
infarction. All cases studied by postoperative an-
giography were patent. 
, In our personal experience, we operated on 
only five cases two days-to-two weeks following 
occlusion. Patency was reestablished in each case 
although, in one case, the embolus had already 
passed on to a more distant site. One patient wors-
ened as a result of the procedure probably due to 
hemorrhagic infarction and the other four improved, 
but their improvement was similar to that expected 
in the natural history of this disorder. 
Recorde.d ~xperience certainly indicates that 
reconstruction of flow through the embolically oc-
cluded middle cerebral artery is technically feasible; 
yet, experimental evidence indicates that if restora-
tion of flow is to be of value, it must be accom-
plished in less than four-to-eigbt hours in order 
to reverse hypoxia. It must also be remembered 
that it is in this period that one incurs the greatest 
risk of hemorrhagic infarction if the flow is restored. 
Finally, it is rare, indeed, that the patient reaches 
the surgeon in the allotted time. In conclusion1 it 
seems that this procedure, although technically suc-
cessful, has few indications in practice. · Hopefully 
with the advent of less thrombogenic cardiac valves, 
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Fig. I-Preoperative angiogram demonstrates occlusion of 
internal carotid artery, collateral circulation through oph-
thalmic artery, and the course of the superficial temporal 
artery (arrows). 
the temptation to consider the procedure will dis-
appear. 
Having removed the acutely occluded middle 
cerebral artery from consideration for reconstruction, 
what other lesions and indications for intracranial 
vascular reconstruction exist? A recent study from 
UCLA (13) indicates that 19% of a series of pa-
tients with symptoms of transient cerebral ischemia 
had a completely occluded internal carotid artery 
as a principle hemodynamic factor in their angio-
graphic study. Other studies (14, 15) indicate that 
30-35% of the patients presenting with transient 
cerebral ischeinia or mild infarction have obstruc-
tive lesions inoperable by general vascular tech-
niques. Accordingly, any effective surgical pro-
cedure must either extract the obstructing lesion or 
bypass the area of obstruction. Since a major cause 
of cerebral insufficiency is unsuspected carotid oc-
clusion, extending from the cervical to the cavernous 
portion, extraction of the thrombosis rarely is prac-
tical. Bypass procedures then become important in 
the creation of compensatory vascular channels. 
What then are the indications for these vascular 
augmentation procedures? In a collaborative attempt 
to answer this question, investigators from four 
centers have pooled a hundred cases for retrospective 
analysis ( 16). As a result of this study, the follow-
ing general indications are suggested: 
Generalized Low Perfusion Syndromes 
Symptoms: 
1. impaireq mentation 
2. syncopal episodes 
3. transient motor, speech or sensory deficit 
4. transient or progressive visual loss 
5. ataxia and postural vertigo 
Etiology: 
1. multiple vessel occlusion 
2. multiple stenosis of intracranial vessels 
3. unilateral vessel occlusion with inade-
quate collateral circulation or congenital 
anomalies which interfere with collateral 
circulation 
Lateralized Low Perfusion Syndromes 
Symptoms: 
1. transient or progressive motor, sensory, 
or speech deficit 
Fig. 2-Illustration for technique of anastomosis of super-
ficial temporal artery to a cortical branch of the middle 
cerebral artery (MCA) . 
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Etiology: 
1. middle cerebral stenosis or occlusion 
with inadequate collateral circulation 
2. cervical carotid occlusion or intracranial 
carotid occlusion with inadequate circle 
of Willis 
3. inoperable carotid aneurysms or tumors 
such as meningiomas which produce 
carotid occlusion 
Having agreed on these general indications, a 
prospective study is now underway to determine the 
merits of this approach to cerebral vascular disease 
( 17). This report will be conducted during the next 
three years. Presently, I will review with you the tech-
niques currently employed for cerebral vascular re-
construction and the findings in eighteen cases which 
have been under my personal care. 
Donaghy and Yasargil ( 3) jointly devised the 
concept of performing an arterial graft; perhaps they 
remembered the initial explorations of Henschen. A 
satisfactory superficial temporal artery is required 
for this procedure; in this angiogram, a complete oc-
clusion of the internal carotid artery is demonstrated 
(Fig. 1, see arrows). Delayed filling is noted through 
the ophthalmic and dural communicating arteries. 
The illustration (Fig. 2) demonstrates the tech-
nique: the superficial artery is dissected free from the 
scalp and a small skull flap is turned to expose the 
sylvian fissure and a portion of the temporal and 
frontal lobes. An oblique end-to-side anastomosis is 
created between the temporal artery and a carefully 
selected branch of the middle cerebral artery. A seg-
ment of the superficial temporal artery is first freed 
Fig. 3A-Common carotid angiogram with total occlusion 
of internal carotid artery; superficial temporal artery (STA) 
has been anastomosed to MCA branch at arrow. 
Fig. 3B-Later sequence in angiogram (Fig. 3A). 1 = site 
of STA entrance into cranial cavity and 2 = site of anas-
tomosis. Note retrograde reflex toward proximal MCA 
trunk. 
from its muscular branches for 7-8 cm. The artery 
remains in situ while the craniotomy flap is turned 
and the sylvian fissure is explored. A cortical artery 
of 1.5 mm in diameter or greater is selected as it 
Fig. 3C-Anterior view of later sequence (Fig. 3A) show-
ing site of anastomosis (arrow) and reflex to proximal 
MCA and subsequent filling of distal cortical MCA branches 
indicating that the graft is a major source of perfusion 
for this isolated hemisphere. Note absence of cross-fill 
phenomenon. 
142 TEW: RECONSTRUCTIVE INTRACRANIAL VASCULAR SURGERY 
Fig. 4A- Vein bypass graft. Reversed vein graft is passed 
beneath the zygoma and joined to the proximal internal 
carotid artery. 
leaves the sylvian fissure. Using 20-30 magnification, 
the cortical artery is prepared to receive the trans-
plant. Minute penetrating branches are coagulated 
and incised. The cortical artery is lifted from the sur-
face of the brain and a slip of latex is placed under-
neath it. The temporal artery is incised obliquely and 
brought into the field. The adventitia and other tis-
sues are stripped from the terminal centimeter of the 
temporal vessel. The artery is dilated with pressure 
injection of heparinized saline and bathed in a dilute 
papaverine solution to reduce spasm. A longitudinal 
arteriotomy is made in the thin wall of the middle 
cerebral artery branch by a fragment of sharp razor 
blade. An incision is made the precise length to ac-
commodate the oblique cut of the temporal artery. 
A polyethylene stint, 1.2 mm in diameter, is placed in 
the cortical artery after it is irrigated with heparinized 
saline. Interrupted sutures of 10.0 monofilament 
nylon are placed at either end of the suture line. The 
remaining portion is closed with similar interrupted 
sutures leaving the final three to be placed. The stint 
is then removed and the final sutures are secured. 
The artery is flushed to remove all air and particles 
of thrombus. 
This technique has been employed in 14 cases, 
there being twelve males and two females with an 
average age of 50. Twelve have had symptoms of 
transient ischemia, indicating a lateralized low per-
fusion syndrome. Eight cases have had previous sig-
nificant cerebral infarctions; two have had symptoms 
of progressive dementia indicating generalized low 
perfusion syndromes. Angiography demonstrated 
that twelve patients had occlusion of the ipsilateral 
1. 
3. 
Fig. 48-Technique for intracranial anastomosis of vein 
graft to internal carotid. 1 = anterior clinoid excised; note 
that clamps exclude ophthalmic and posterior communi-
cating artery collateral supply; 2 = end-to-side anastomosis; 
3 = completed graft. 
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internal carotid artery; three had bilateral carotid 
artery occlusion; five had marked stenosis of the 
contralateral internal carotid artery; and three had 
unilateral vertebral artery occlusion. 
Results. Angiography was performed in all cases, 
postoperatively, usually one or two weeks following 
the procedure (Fig. 3). Nine grafts were patent; one, 
not patent on an earlier angiogram, was opened 
when the study was repeated two months later. We 
have recognized that spasm may interfere with early 
visualization of the graft. Four patients had symp-
toms of recurrent cerebral ischemia, one of whom 
had a patent graft. Two patients who had occluded 
grafts have not had recurrent attacks of ischemia. 
Both patients with dementia seem improved. Two 
patients have had recurrent cerebral infarction; both 
had had occluded grafts. One patient suffered a post-
operative intracerebral hemorrhage presumably due 
to hemorrhagic infarction. One patient died of myo-
cardial infarction. Complications consisted (one case 
each) of scalp necrosis, intracranial hemorrhage, sub-
galeal infection, and myocardial infarction; graft oc-
clusion occurred in five cases. 
The results of analyzing my personal cases and 
those of my colleagues ( 16) previously mentioned, 
suggest that the following contraindications to bypass 
graft procedures be considered: 1) major long-
standing neurologic deficit; 2) severe recent cerebral 
infarction less than six weeks; 3) marked cardiovascu-
lar disease; 4) advanced diabetes mellitus; 5) inade-
quate donor artery-that is, a superficial temporal 
artery less than one millimeter in diameter. As noted 
in number five, inadequate donor artery has posed a 
serious problem in this technique; this inadequacy 
was the reason that Lougheed (18), in 1970, sug-
gested the vein bypass procedure. As initially pro-
posed by Lougheed, a saphenous vein graft was taken 
from the leg, the valves were stripped, and the small 
end was anastomosed to the supraclinoid portion of 
the internal carotid artery. The graft was brought out 
over the zygomatic arch. We have subsequently re-
vised this procedure somewhat, simply reversing the 
Fig. SA, B-Postoperative angiograms of a patient who had generalized low perfusion due to occlusion of all major cere-
bral vessels. Lateral angiogram demonstrates course of draft (A). Anterior view illustrates bilateral filling of distal circu-
lation (B). 
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graft and suturing the larger end to the internal caro-
tid artery (Fig. 4). Flow is restored through this seg-
ment as soon as possible, since the hemisphere may 
be depesdent on the collateral supply reaching it 
through the ophthalmic and posterior communicating 
arteries, which must, by necessity, be occluded dur-
ing the cranial anastomosis. We have not yet devel-
oped a satisfactory shunt system to perfuse the hemi-
sphere during the 10-15 minutes required for this 
portion of the procedure. Technically, this is a rela-
tively simple procedure; yet the lack of a satisfactory 
internal bypass prohibits its performance in some of 
the most worthy candidates. The next major obstacle 
to bypassing the internal carotid artery is severe 
plaque formation in the carotid siphon above the an-
terior clinoid. Frequently, endarterectomy is required 
in opening a segment to receive the vein graft. Im-
paired runoff may be a problem in spite_ of careful 
attention to this maneuver. 
The artery is led from the cranium beneath the 
zygoma into the neck. Prior to completion of the 
proximal anastomosis to the common carotid artery, 
a large rubber catheter is passed through the graft to 
open the valves and fill the vein with heparinized 
blood. Our experience with this technique includes 
four cases. Three grafts functioned well; however, 
one patient, our first, died of a massive hemorrhagic 
infarction, although it was six weeks following his 
most recent cerebral infarction. Our second patient 
suffered delayed thrombosis of the graft, a failure we 
believe to be related to compression at the zygomatic 
process. A third graft has functioned well for 14 
months and the patient remains free of ischemic com-
plications. Figure 5 shows the postoperative angio-
grams. A fourth graft was unsuccessful due to severe 
narrowing of the internal carotid artery. Despite 
endarterectomy, satisfactory runoff could not be ob-
tained. 
Conclusion. Although our initial experience 
with these procedures has certainly been less than 
spectacular, it does seem to indicate that further 
pursuit of the project of cerebral revascularization is 
worthwhile. Careful selection of patients, improve-
ment of surgical technique (including the develop-
ment of an internal shunt for bypass), and precise 
tabulation of results remain essential to the continua-
tion of this study. 
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Advances in the Management and Surgical 
Treatment of lntracranial Aneurysms*** 
THORALF M. SUNDT, JR., M.D. 
Associate Professor of Neurosurgery, Mayo Medical School, 
University of Minnesota, Rochester 
Introduction. Patients who have sustained a 
spontaneous subarachnoid hemorrhage are victims 
of a very serious illness. Not only are they subject at 
all tiines to the potentially catastrophic results of a 
recurrent bleed, but they are faced with the manifes-
tations of the irritative effects of blood in the sub-
arachnoid space where the blood may function as a 
poison to the vessel wall. These acutely ill individuals 
may suffer a composite of secondary effects from a 
bleed which may include a communicating hydro-
cephalus, cerebral edema (ischemic or chemically In-
duced), sterile meningitis, inappropriate ADH syn-
drome (osmotic effects of blood in the cerebrospinal 
fluid), spasm, and the likelihood of a reeurrent bleed. 
Physiology and Pathogenesis. Both the physi-
ology and the anatomy of the cerebral blood vessels 
differ from those of comparable size elsewhere in the 
body ( 1). Unlike most organs and muscles, the brain 
maintains a relatively constant blood flow throughout 
a wide range of cardiac output and activity. The flow 
is approximately 700-900 milliliters per millute, 
whether the cardiac output is five liters per minute, 
as during rest, or four or five times that volume, as in 
strenuous exercise (2). Cerebral blood flow appar-
ently is not directly sensitive to circulating epineph-
rine or norepinephrine, as these catecholamines do 
rtot cross the intact blood-brain barrier (3). Further-
mo~e, it is common knowledge that these catechol-
* Presented by Dr. Sundt at the 27th Annual Stone-
burner Lecture Series, February 8, 1974, at the Medical 
Coilege of Virginia, Richmond. 
* * From the Cerebrovascular Clinical Research Cen-
ter and the Department of Neurologic Surgery, Mayo 
Clinic and Mayo Foundation, Rochester, Minnesota 55901; 
this study was supported in part by Research Grant NS 
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amines in physiological doses do not produce marked 
vasoconstriction, even when applied topically to rela-
tively normal cortical vessels. The cerebral circulation 
seems to be governed by its own autoregulation, a 
mechanism at present poorly understood ( 4). In 
health, this mechanism is not directly sensitive to the 
peripheral blood pressure within reasonable extremes. 
In cases of acute head injury, subarachnoid hemor-
rhage or cerebral ischemia, however, the autoregula-
tory mechanism is no longer functional and cerebral 
circulation becomes pressure and volume de-
pendent ( 5). 
The presence of a great abundance of auto-
nomic nerves in the conducting vessels in the sub-
arachnoid space has been the subject of recent in-
tensive investigation directed toward identifying a 
physiological role for this system. Because conflicting 
data are reported from a variety of highly respected 
groups, one might maintain almost any role for this 
system today artd find laboratory data to substantiate 
his position. It is our judgment that the autonomic 
nervous system provides a modulating and buffer 
action for the conducting vessels in the subarachnoid 
space, and we will direct our attention to this aspect 
of the problem a little later in this discussion. 
Intracranial vessels have a characteristic and 
unique design ( 1). Perhaps this is because vessels 
inside the head are protected by a rigid skull and are 
not subject to the moving stresses and angulations of 
vessels in the body. They have a thin intima and ad-
ventitia. The media is also quite thin and riot heavily 
endowed with elastic tissue. There is, however, a 
thick internal elastic membrane of considerable im-
portance in providing the wall with strength. Defects 
in the media occur so frequently that they can hardly 
be termed pathological. 
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Quite different, however, is the occurrence of 
defects in the internal elastic membrane. When this 
membrane fragments and bulges through a defect in 
the media, an aneurysm forms. Controversy con-
tinues over the cause of this fragmentation-whether 
it is congenital or degenerative-and also over the 
importance of a preexisting medial defect. The point 
of ·importance concerning the necessity and tech-
nique for repair is that the elastic lamella ceases to 
exist in the aneurysm itself. Furthermore, as tpe 
aneurysm grows in size, although there is no increase 
in the pressure per unit of area, the total force on 
the aneurysm increases. This subjects the base of the 
aneurysm to increased tension anq tends to cause 
progressive growth of the lesion. 
The weakest points in an aneurysm are usually 
in the dome itself or at its base where it arises ·from 
the vessel. The wall consists of collagenous tissue, 
which is continuous with the adventitia and intima 
of the parent vessel. There is a marked difference in 
the thickness from one aneurysm to another. Fre-
quently through the operating microscope one can 
actually see the blood swirling in eddying currents 
through the walls of a thin aneurysm. In other in-
stances, the aneurysmal wall does not seem different 
in consistency or thickness from the parent vessel; in 
the special case of giant aneurysms, the wall is quite 
thick. There is, of course, no way to predict from 
arteriography alone what the case is in each patient. 
In those patients who survive a subarachnoid hemor-
rhage from an aneurysm, a blood clot forms around 
the aneurysmal membrane, and along with the sur-
rounding arachnoid, seals the vessel ternporarily. 
Surgery of Aneurysms. Most surgery for aneu-
rysms today is performed through the operating rni-
croscope. A description of the procedure for repair 
of an aneurysm might be of interest to those of you 
who are not surgeons. 
We will discuss four aneurysms, two internal 
carotid artery aneurysms and two anterior com-
municating artery aneurysms, the location of most 
aneurysms l!pon which we operate. Space does not 
permit us to cover middle cerebral and basilar aneu-
rysms; their appearance is not greatly different. 
The first case is of a left internal carotid artery 
aneurysm. Looking through the microscope, you ex-
pose the operative field, revealing the white structure 
of the optic nerve. Initially, with the point of an 
eleven blade knife, the arachnoid overlying the optic 
nerve is severed and the dissection is carried laterally 
to identify the internal carotid artery, the aneurysm 
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arising and projecting later(!lly from that structure. 
(We prefer the tip of an eleven blade knife to a pre-
designed surgical instrument for this purpqse; we 
have used the latter and found that they dull all too 
rapidly; the # 11 blade can easily be replaced with a 
new, sharp blade.) There is a noticeable difference 
in the texture of the wall of the aneurysm and the 
carotid artery. The carotid artery is whitish by com-
parison to the aneurysm. A cari:;ful look at the 
aneurysm should permit you to see that the blood is 
swirling in eddying currents through the very thin-
walled lesion. The clip we would use to repair this 
aneurysm is known (!S a clip-graft; in this case it 
would be applied with a right angle applier and the 
clip would circumferentially surround . the intFrnal 
carotid artery and seal the aneurysm at its base. We 
prefer this type of clip for repair of carotid artery 
aneurysms, because these aneurysms arise from a 
relatively wide portion in a relatively large vessel and 
repair with a straight clip does not reinforce the base 
or prevent the redevelopment of an aneurysm in the 
future, and furthermore, should the base tear with 
application, the clip seals the vessel. This is in direct 
contrast to middle cerebral aneurysms, for instance, 
in which ordinarily speaking one is able to find a 
relatively thick base in the aneurysm to accept a 
straight clip. 
The s·econd case is also an internal carotid 
artery aneurysm, but this aneurysm arises not only 
from the internal carotid artery but from the pos-
terior communicatin'g artery as well, which in the 
individual served as the sole source of blood supply 
to the posterior cerebral artery on the side of sur-
gery. We could not use a clip-graft for fear of occlu-
sion of the posterior communicating artery; the aneu-
rysm inust, therefore, be repaired with a Scoville clip, 
a type of straight spring clip. Following clipping of 
this aneurysm, a search made anteriorly to be certain 
of the patency of the pos.terior communicating artery 
showed it to be patent in this patient; and he made an 
uncomplicated postoperative recovery. 
The third case is that of an anterior communi-
cating artery aneurysm. Viewed through the operat-
ing microscope in an approach along the floor of the 
frontal fossa, the optic nerve would initially be iden-
tified and the dissection would be carried medially to 
the location of the anterior communicating artery 
and the aneurysm. Examination of the angiograms 
prior to surgery revealed that this aneurysm pro-
jected anteriorly, and comforted by this knowledge, 
the arachnoid overlying this lesion co~ld be dissected 
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from between the two frontal Jobes at their base, just 
anterior to the anatomical site of the vessel. Initially, 
the aneurysm would be difficult to see, being sur-
rounded by some thick fibrinous material, which in 
turn was overlayed by arachnoid; these structures 
served to seal the aneurysm when it bled. The aneu-
rysm having been dissected anteriorly away from 
the knee of the A-1 segment of the right anterior 
cerebral artery and the anterior communicating ar-
tery, a clip would be placed tangentially at this point, 
and following clipping, a search would be made pos-
teriorly to be certain of patency of the major vessels. 
The final case relates to an anterior communi-
cating artery aneurysm repaired with a clip-graft. 
Both anterior cerebral arteries filled from the right 
A-1 segment-a not uncommon configuration irt 
this type of aneurysm; that is, all too frequently 
both anterior cerebral arteries derive their blood sup-
ply from one side or the other through an enlarged 
A-1 segment. Therefore in this instance it would be 
particularly important to be certain that the anterior 
communicating artery remained patent, and there-
fore, the clip-graft would be placed with the right 
angle clip holder circumferentially around the an-
terior communicating artery sealing the small aneu-
rysm projecting posteriorly at its base. The small 
aneurysms are often much more treacherous than 
the large aneurysms, because they do not offer a 
large enough sac to accept dissection and occlusion 
by a straight clip should they bleed. 
Clinical Features and Diagnosis of Ruptured 
Aneurysms. The sudden onset of an excruciating 
headache, with or without the loss of consciousness, 
indicates a subarachnoid hemorrhage until proven 
otherwise. The patient describes an "explosion" in 
the head ot a feeling of being struck behind the head 
with a hammer. Some patients complain of pain on 
one side, but more commonly the headache is pri-
marily suboccipital in nature. 
Often, the patient will have a seizure with his 
first hemorrhage, but repeated seizures thereafter are 
infreqi.1ent and anticonvulsants are usually not neces-
sary. Patients may vary in their level of conscious-
ness from alert to comatose following recovery of 
the bleed. 
Most patients appear acutely ill and in pain. 
They complain chiefly of headache and commonly 
of nuchal rigidity, which incidentally increases after 
24- 48 hours. Blood pressure is commonly elevated. 
The patients who have suffered more severe hemor-
rhages are confused, stuporous, semicomatosed, or 
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even comatosed. In this group, lateralizing signs such 
as hemiplegia, hemiparesis, or aphasia may be pres-
ent. On the basis of the neurological symptomatology, 
Botterell ( 6) described a system of classification 
from grades I through V based upon the presence or 
absence of findings indicated above. A grade I pa-
tient is one with only minimal symptomatology, pri-
marily headache; a grade V patient is preterminal 
and seldom considered a surgical candidate. Be-
tween grades I and V the classification is based 
upon a level of consciousness and the presence or 
absence of focal findings. This grading classification 
has proved to be of immense help in considering re-
sults of both operative and conservative management. 
Natural History of Subarachnoid Hemorrhage. 
Various studies in the epidemiology of subarachnoid 
hemorrhage from a ruptured intracranial aneurysm 
have indicated the catastrophic nature of this ill-
ness. If a patient remains moribund for more than 
24 hours after his initial bleed, his likelihood of 
a one-year survival is 8% with rather a severe 
morbidity; if he recovers from the bleed with only 
minor symptoms present or a clouding of con-
sciousness, his chances for a one-year survival are 
approximately 50% (7, 8) . Furthermore, approxi-
mately 70% of the patients with an aneurysm 
demonstrated on angiography will have a second 
hemorrhage, the peak incidence of which is in the 
second or third week following the initial bleed (9) . 
The second occurrence is usually more severe than 
the first, frequently leaving the patient in a state of 
unconsciousness or coma. 
Timing of Surgery. Although it would seem 
optimal to operate on the patient within the first 
few days after the bleed in order to prevent a re-
current hemorrhage, experience in early surgery 
from a variety of outstanding institutions has indi-
cated the high morbidity of such a course of action. 
Accordingly, almost all patients initially are managed 
conservatively. 
Initial Management by Clinician. The most im-
portant step in the care of a subarachnoid hemor-
rhage is the early diagnosis of a warning bleed by 
the family physician. All too frequently the warning 
bleed is unrecognized and only after a subsequent 
and more severe bleed is the patient referred for 
definitive management. A sudden, excruciating 
headache with or without the Joss of consCiousness 
is a subarachnoid hemorrhage until · proven other-
wise. A careful atraumatic spinal puncture is neces-
sary in the diagnosis of this illness. 
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As soon as the patient recovers from the insult 
of his first hemorrhage, he should be transported 
by ambulance or air ambulance to a center where 
such problems are handled in volume. These pa-
tients rarely represent acute surgical emergencies, 
and except in instances of an associated large intra-
cerebral or subdural hematoma, benefit from con-
servative management for the first several days 
following hemorrhage. This period of bedrest is 
perhaps even better for the patient in the setting 
of the local facility than at the referral center. It is 
disquieting for the clinician to have a patient with 
a subarachnoid hemorrhage die prior to referral 
or prior to obtaining a neurological consultation , 
but he can be comforted to know that bedrest with 
light sedation and analgesic medication would have 
been recommended for the first four or five days 
or perhaps even longer at most major centers and 
little could have been done by others that was not 
done by himself. 
One is tempted to lower the blood pressure 
moderately in such patients with the hope of pre-
venting a recurrence of bleeding while awaiting 
surgery or diagnostic studies. There are currently 
conflicting reports, however, regarding the useful-
ness of this measure and certainly it is not without 
risk. As mentioned above, patients with a sub-
arachnoid hemorrhage become pressure dependent 
for cerebral perfusion; if a significant degree of 
intracranial vasospasm is present, lowering the blood 
pressure can result in cerebral ischemia and even 
infarction. This is not to say that hypotensive treat-
ment is not indicated in selected instances, but the 
criteria are so complex for hypotensive management 
that definite rules cannot be developed at present. 
The use of dexamethasone or some other 
steroid has been advocated by many experienced 
workers in this field; others feel that the risk of 
a stress ulcer is aggravated by an unproven beneficial 
effect from this drug and have cautioned against its 
use as a routine procedure. My personal experience 
with the use of dexamethasone in this setting, in 
marked contrast to its dramatic effect on the edema 
of gliomas, has not been very encouraging. 
Final data regarding the ability of £-amino-
caproic acid to prevent a rebleed is not available. 
My experience with this drug has not been good, 
but admittedly we have not used it in the large dos-
ages currently recommended. 
Patients who have had a subarachnoid hemor-
rhage are particularly vulnerable to develop a type 
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of inappropriate antidiuretic hormone (ADH) syn-
drome; therefore, moderate restriction of fluids is 
recommended, so that the patient's total fluid intake 
is between 1500 and 2000 ml daily. Serum sodium 
should be drawn every 48 hours and if the patient 
has a fall in the serum sodium, indicating extra-
cellular volume expansion, fluids should be restricted 
to 1000-1200 ml daily. 
Spasm. Early surgery in this illness is risky 
primarily because it accentuates and aggravates a 
state of arterial spasm, a reaction to the vasocon-
strictive effects of blood and its breakdown products 
in the subarachnoid space ( 10). It is a diagnosis 
based upon the caliber of intracranial vessels seen 
on angiography; it may bei focal or generalized, 
minimal or severe, unilateral or bilateral. Sympto-
matically it may produce evidence of both general-
ized and focal cerebral ischemia, the former mani-
fested by an alteration in the level of consciousness 
and confusion, the latter by a focal neurological 
deficit. Although blood related, its etiology and 
pathogenesis are far from being elucidated. 
In general terms, the more severe and wide-
spread the spasm, the worse the patient's clinical 
condition . Extrapolating from our cerebral blood 
flow data, it seems likely that spasm can be tol-
erated until a critical reduction in cerebral blood 
flow occurs-probably somewhere in the level of 
20-30 mljlOO gm/ min. Often, prior to this reduc-
tion in cerebral blood flow, an angiographic appear-
ance of spasm will not be matched by the clinica'I 
appearance of the patient; some individuals look 
amazingly well considering the angiographic picture. 
The reverse is not true; patients who show the 
severe symptomatology of ischemia in this illness 
usually have angiographic correlation not only with 
evidence of focal vessel constriction but also of slow-
ing of flow. 
Recently, we have employed a combination of 
isoproterenol (Isuprel®) and Jidocaine hydrochloride 
(Xylocaine®) in the treatment of cerebral vaso-
spasm ( 11) . Isuprel® is given for its beta-adrenergic 
function and the Xylocaine® is used to counteract 
cardiac arrhythmias that might result from the intra-
venous administration of Isuprel®. All patients have 
had continuous EKG monitoring and special nursing 
care. Both drugs are administered intravenously on 
a continuous basis and should cardiac arrhythmias 
result, the Isuprel® is decreased in its strength and 
rate of administration or the Xylocaine® is increased 
in its strength and rate of administration. 
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There is a wealth of experimental evidence 
to indicate that the conducting vessels in the sub-
arachnoid space have a rich adrenergic nerve supply 
which, after sympathectomy or subarachnoid hemor-
rhage, loses its fluorescence, indicating inactivation 
of the granulated vesicles at the nerve endings. 
These granulated vesicles are important not only 
for metabolism, production, storage, and release of 
norepinephrine but also for the control of function. 
In contrast with cholinergic endings in which an 
enzyme functions to destroy the freed acetylcholine, 
the limited duration of action of the adrenergic 
endings is thought to be related to the prompt 
reuptake of norepinephrine by the granulated 
vesicles. It is possible that some of the adverse 
effect of blood on a vessel is the result of this type 
of end-organ sympathectomy obliterating the func-
tion of the granulated vesicles and their buffer 
action. Alpha and beta sites are pharmacological 
concepts, not anatomical structures, and there is 
evidence that between various vasoconstrictive 
amines there is a competition for a type of membrane 
response. Isoproterenol is given not so much as a 
vasodilator but in an attempt to introduce a non-
vasoconstrictive drug to compete at the end-organ 
for the membrane response and hopefully thereby to 
ameliorate the effects of vasoconstrictor substances 
such as serotonin . Our laboratory studies indicate 
that Isuprel® definitely does shorten the period of 
basilar artery constriction from the topical appli-
cation of blood . 
Table 1 illustrates the author's experience with 
the use of these drugs in operating on 159 patients 
over the past four years. This table is primarily 
intended to demonstrate the distribution of patients 
TABLE 1 
DISTRIBUTION OF TREATED* CASES AMONG ALL PATIENTS 
OPERATED ON ACCORDING TO GRADE AND FINAL 
CLINICAL RESULT 
Final Clinical Result 
Grade Excellent Good Poor Death 
I 63 (7) 3 1 
II 32 (6) 1 (1) 2 2 (1) 
III 14 (5) 13 (3) 8 (2) 4 
IV 2 1 8 (4) 5 (1) 
Total 111 18 18 12 
* No. of treated patients is in parentheses. 
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with this problem as a major complication and 
treated patients are identified in parentheses. The 
result columns indicate the final clinical state of the 
patient and not necessarily the response of the pa-
tient to the administration of these drugs. Most 
patients treated in the grade I and grade II cate-
gories were treated following surgery for the onset 
of a progressive neurological deficit. Most patients 
treated in the grade III and IV categories were 
treated prior to surgery in an attempt to arrest a 
progressive neurological deficit or improve their 
condition to a point where surgery could be tolerated. 
Patients who did not undergo surgery are not il-
lustrated and not included. 
A retrospective analysis of the results of the 
use of these drugs indicates that no improvement 
has been noted, if the drugs have been used after 
a period of two hours from the time of the onset 
of the neurological deficit. Obviously, the more se-
vere the deficit, the more important it is that 
therapy be instituted early. Although an occasional 
dramatic response has been noted, most commonly 
a progressive deficit is halted with a rather major 
recovery in the first 48 hours, and recovery there-
after related only to the predicted improvement 
and recovery pattern seen in patients with regions 
of focal ischemia. The drugs are, however, with 
careful monitoring, safe, and we have had no 
mortality from their use . It now remains for others 
to judge the merits and demerits of this program . 
Thirty patients treated in this group are shown ; 
treatment was discontinued in another five because 
of arrhythmias. 
In considering and analyzing the results of any 
medications, it is necessary that they be evaluated 
in properly selected patients. Spasm, as a major 
complication, was not uniformly seen in the patient 
group and although most morbidity and mortality 
is noted in the high-risk patients, grades III and IV, 
death and morbidity in these patients was not always 
a result of their preoperative state. Poor results and 
death in this group include one patient who bled 
in the hall prior to entering the operating room, 
one who bled during the induction of anesthesia, 
two who sustained a recurrent hemorrhage-the 
result of poor aneurysmal repair, and two who had 
occlusion of a major parent vessel from which a 
giant aneurysm arose. A permanent Korsakoff's 
syndrome accounted for a poor result in two patients 
(one of whom had a giant aneurysm and predated 
surgery). This syndrome, although occasionally the 
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result of spasm, is more commonly a complication 
of surgical trauma in the septa! or preseptal area. 
Conclusion. Improved neuroanesthesia and sur-
gical techniques, especially including magnification 
of vision and an intense light source, have drastically 
lowered the operative mortality and morbidity in 
aneurysm surgery; however, because of a delay in 
surgery to avoid major vasospasm, many patients 
are lost from rebleeding. Until a solution to the 
complication of vasospasm is obtained, most major 
institutions still prefer to delay surgery. Isoproterenol 
and lidocaine seemingly ameliorate this dreaded 
complication but are certainly no panacea and we 
are still looking forward to a final miracle drug 
from one of our sister institutions (12). 
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Clinical Advances in the Evaluation of Deep Coma*** 
CARY SUTER, M.D. 
Chairman, Department of Neurology, Medical College of Virginia, 
Health Sciences Division of Virginia Commonwealth University, 
Richmond 
Today, 1974, in large medical centers, evalua-
tion of the patient in coma is almost a d_aily neces-
sity, and the need to evaluate the patient in deep 
coma arises once or twice every week. Even in 
smaller hospitals the problem is not uncommon. 
This has come about because many laymen and 
most medical personnel are now well trained in 
methods of cardiorespiratory resuscitation (1, 2). 
Persons are not allowed to die easily and once 
resuscitated, are moved to intensive care units where 
life is maintained. Fortunately, if they do not die 
of their underlying disease, such as trauma or 
myocardial infarction, many patients thus rescued 
recover completely; that more do not is due to the 
fact that the brain is such a tender organ-only 
a few minutes without oxygen and neurons die or 
are damaged-only a short while without blood 
flow and, apparently, the cerebral blood does not 
flow again. On the other hand, neurons, silenced 
completely by drugs for hours or even days, may 
recover and soon be alive and well. 
A proper decision as to the cause and degree 
of brain damage may lead to useful treatment and 
recovery or, if the brain is dead, may allow other 
organs to be used for transplantation and relieve 
the family, as well, of hours of anguish and added 
expense. In 1966, Plum and Posner ( 3) outlined 
in an orderly fashion the various clinical observa-
tions necessary for the evaluation of the ordinary 
comatose patient. They did not, however, give special 
attention to the patient in deep coma or the prob-
lem of possible brain death. The problem of diag-
nosing deep coma and determining brain or cerebral 
* Presented by Dr. Suter at the 27th Annual Stone-
burner Lecture Series, February 7, 1974 at the Medical 
College of Virginia, Richmond. 
* * This work was supported in part by NIH Contract 
71-2315. 
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death became more urgent with the advent of wide-
spread organ transplantation. Although at first, the 
problem of evaluation of deep coma was approached 
by each specialist from his own area of expertise, 
a combination of clinical examination and labora-
tory tests has now been developed which promises 
to allow routine and relatively rapid diagnosis and 
prognosis. Impetus for such an approach in the 
United States first came in 1968 from the report 
of the ad hoc committee of the Harvard Medical 
School ( 4) to examine the definition of brain death. 
These so-called "Harvard Criteria" were primarily 
a combination of clinical examination and electro-
encephalogram recording. Standards for acceptable 
electroencephalographic recording were further 
studied and summarized by an ad hoc committee 
on '"EEG Criteria for a Demonstration of Cerebral 
Death" ( 5) of the American Electroencephalo-
graphic Society published in 1970. While these and 
other studies ( 6, 7) emphasized the usefulness of 
the EEG in the evaluation of deep coma, investi-
gators in Europe demonstrated the usefulness of 
cerebral arteriography and the assessment of cere-
bral blood flow as prime criteria for the determina-
tion of brain death ( 8-10). Further refinements of 
the clinical and EEG evaluation of deep coma will 
soon be available in the report of the Na ti on al 
Institutes of Health Collaborative Study on Cere-
bral Survival ( 11) . This study of over 500 patients 
also emphasizes the clinical examination and the 
electroencephalographic study; however, it will in-
clude the report of an ancillary study on a rapid 
bedside method of assessing cerebral blood flow 
by the injection of radio isotopes-the Bolus tech-
nique (12). 
At the Medical College of Virginia, we became 
interested in the problem of acute bedside recording 
in the mid-1960's, particularly in relationship to 
patients with seizures and strokes. We were espe-
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cially interested in changes in patients with cerebral 
emboli who often presented with continuous focal 
seizures (13). This interest was expanded to in-
clude patients in deep coma, primarily for the 
purpose of making decisions related to organ trans-
plant. For over five years, we have maintained 
regular 24-hour EEG coverage in the Medical Col-
lege of Virginia Hospitals. Beginning in 1971, we 
took part in the National Institutes of Health Col-
laborative Study on Cerebral Survival ( 11). From 
this experience, and a survey of recent literature, 
comes the following assessment of our presen~ ap-
proach to the diagnosis of the patient in deep coma. 
The main items of importance in the process are 
presented below. 
Clinical Ex~mination. Responsiveness to stimuli 
is basic to the definition of coma. Persons in deep 
coma do not respond to the spoken word at all; 
they do not respond in any purposeful manner 
but only by reflex movement to other stimulation. 
With deep pain, they may respond not at all or 
respond by reflex movement such as decorticate or 
decerebrate posturing. In some cases, eye blinks, 
either spontaneous or to stimulation, may occur 
and occasionally chewing movements. Ariy easily 
elicited response, particularly of a purposeful nature 
to any stimuli, suggests that the patient is not in 
deep coma. 
The presence or absence of spontaneous res-
piration is, of course, a critical point in the evalua-
tion of deep coma. With brain death, including 
the cerebral cortex as well as the brain stem, there 
will be no spontaneous respiration. With cerebral 
cortex damage alone, but with brain stem function 
intact, respiration may be nearly normal. This ac-
counts for the rare situation of a patient showing 
electrocerebral silence on EEG with some loss of 
other cranial reflexes who surprisingly breathes 
spontaneously after the mechanical respirator is 
disconnected. These are the patients who may sur-
vive for months or years with an EEG showing 
electrocerebral silence. This also indicates the neces-
sity of carefully testing all cranial reflexes before 
cerebral death is pronounced. In general, the ab-
sence of spontaneous respiration is a bad prognostic 
sign in patients with structural lesions, such as 
cerebral hemorrhage or trauma, and to a consider-
able degree in patients with cerebral anoxia. Patients 
in coma from overdose, however, may not have 
spontaneous respiration for a considerable period 
of time and still completely recover. 
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The Harvard criteria emphasize the absence 
of all reflexes, both cranial and spinal, and the lack 
of spontaneous respiration as the prime elements 
in the clinical examination. Experience in the Col-
laborative Study on Cerebral Survival ( 11) has 
confirmed the i!llportance of cerebral reflexes. In 
this regard, the pupillary reflexes are the most im-
portant since fixed dilated pupils (not necessarily 
maximally dilated) and absence of respiration are 
the most common clinical accompaniment of brain 
death. The presence of oculocephalic reflexes indi-
cates that brain stem structures are still alive. The 
presence of oculovestibular reflexes also suggests 
the presence of functioning brain stem structures, 
but this reflex seems to persist longer than the 
oculoceph<ilic reflex. The response of eye blinks, 
either as ;i reflex or spontaneously, also indicates 
some brain stem function and since this is routinely 
recorded in the electroencephalogram, it serves as a 
reminder to the electroencephalographer that brain 
stem function persists, even though the recording 
may show electrocerebral silence otherwise (Fig. 1). 
It :may be noted that the examination of the 
optic fundi is not included as an important factor 
in determination of cerebral death. Although ex-
amination of the optic fundi may help in the etio-
logical diagnosis of coma, it is of little direct help 
in prediction of the level of coma or its outcome. 
Information of the presence or absence of blood 
flow in the retinal vessels is not sufficiently accurate 
to serve as a criterion of brain death. 
EKG 
c,-A, 
eye ·blinks 
o,-A, 
Arm 
Fig. 1-This record shows eye blink, muscle, and EKG 
artifacts. After succinylcholine injection the muscle and 
eye blink artifacts were abolished and no evidence of cere-
bral activity remained. Despite this fact, the patient is still 
alive, nine months after cardiorespiratory arrest. The pa-
tient still remains in coma but breathes spontaneously. 
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One result of our e~perience in the cerebral 
survival stµdy is the und~rstanding that spinal re-
flexes are completely unreliable in the prediction 
of brain death or of the ou.teome of coma. Although 
the paper outlining the Harvard criteria js not 
exactly clear ori this point, it suggests the absence 
of spinal reflexes as part of the criteria; this is 
one part of the Harvard criteria that may definiteiy 
be discarded. Although spinal reflexes are often 
absent, patients in deep coma may show some de-
gree of r~flex movement as well as actual muscle 
stretch reflexes and evc:n Babinski signs. Such re-
flexes, of course, may be suppressed in pa~ients with 
drug overdose, and yet the patient may still recover 
completely. · 
Convulsions or myoclonic jerks are common 
during the 12-24 hours immediately following cere-
bral damage from anoxia due to cardiac arrest. 
During this time, the EEG may indeed show no 
clear activity except the artifacts produced by such 
movements. With the use of succinylcholine or 
Valium®, the cerebral discharges alone can be 
recorded. The oq:urrence of coµvulsions or diffuse 
rhythmic myoclonic jerks can be taken as proof 
of some brain fonctjon. 
Blood pressure, as such, is of little value in 
the evaluation of the patient in deep coma. It is 
true, however, that a sudden fall of blood pressure 
is often a terminal event in a patient with brain 
death maintained on a respirator for a long perioq. 
lt is also apparently true that in patients with cere-
bral trauma or cerebral hemorrhage, the presence 
of excessively high blood pressure is a bad prog-
nostic sign (14) . Thus, excessive alteration, either 
up or down, of the blood pressure is a sign of poor 
prognosis ( 15). 
Temperature is of importance mainly because 
extremely lo'!" temperature may alter cerebral ac-
tivity and be associated with eler;:trocerebral silence 
in the patient who eventually survives. Slight low-
ering of temperature does not seem to have this 
effect. In the ordinary case of deep coma, therefore, 
temperatµre is of no major importance. 
In summary, of all the clinical observations 
of the patients with deep coma, those having to do 
with cranial reflexes, particul;uly the pupils, and 
with respiration, are the most important. 
Tests for P~gs and Metabolic Abnormalities. 
Since recovery from deep c9ma in patients with 
electrocerebral silence on the EEG is seen alrµost 
exclusively in patients whose coma is due to drug 
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overdose or metabolic derangement, the diagnosis 
of toxic and metabolic factors in coma is of great 
importance. Experience in this regard suggests that 
tests for metabolic derangement, at least ordinary 
metabolic derangement, are rapidly and easily ob-
tained. The same is not true of toxicology. Even in 
large tpedical centers, it is often difficult to obtain 
rapid, reliable, quantitative tests for drugs and toxic 
substances. While it is true that drug levels are not 
important in cases of clear trauma or of anoxia 
ser;:ondary to cardiac disease, occasionally the two 
conditions may coincide. For this reason and be-
cause of the legal implications, improvement of our 
services in this area is urgent ( 16) . r;ven though 
rapid toxicology reports may become available in 
large medical centers, it will remaiµ a difficulty for 
some time in smaller hospitals. fortum1tely, evi-
dence at this point suggests that usually the patient 
in deep coma can have an adequate evaluation 
without knowing the actual drug · levels. For in-
stance, in our experience, no patient with dilated 
pupils and electro~erebral silence on the electro-
encephalogram has survived. Since such a case might 
exist, however, due to . drug overdose, this is an 
area if! which the use of a rapid simple test of 
cerebral blood flow would help give a final answer 
concerning cerebral death without reference to drug 
levels ( 10) . 
Another recurring problem of patients in deep 
coma, particularly with anoxic coma, has . to do 
with the fact that many present with convulsive or 
myoclonic seizures. Such patients are often treated 
with rather large doses of anticonvulsant drugs 
which are also sedatives. Obviously, it is not ap-
propriate to accept clinical and EEG evidence of 
brain death in the patient who has just been given 
large doses of such drugs. Quantitative drug levels 
are necessary before final decisions can be made. 
Electroencephalogram. The importance of the 
electroencephalogram in the evaluation of coma 
has escalated in direct proportion to the 24-hour 
availability of such recordings, the excellence of the 
recording technique, and the experience of the elec-
troencephalographer. When these criteria are met, 
the electroencephalogram is indispensable in the 
diagnosis and prognosis of deep coma. 
Meticulous technique is the mark of the ex-
cellent EEG technician and the true electroen-
cephalographer. The model of such meticulous 
technique was established by Hans Berger ( 17) 
in his extensive studies to prove that the oscillations 
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of his recorders were due to cerebral activity and 
not to artifact. Modern electroencephalographers 
have retraced Berger's steps with the opposite intent, 
namely to prove that the oscillations are artifact 
and not cerebral activity. 
Fortunately, with present equipment, excel-
lent artifact-free records may be obtained in even 
the most chaotic intensive care unit. Adequate tech-
nical recording requires that records be made at 
a very high amplification with portions of the record 
being recorded with al) amplification of twd micro-
volts per millimeter. It is then necessary that ail 
deflections of the recording be clearly identified 
either as artifact or as cerebral activity. Common 
artifacts come from the electrocardiogram, from 
rriechanical respirators, from cardiac monitors, and 
from other monitoring equipment. Any slight move-
ment of the bed or patient may present a problem. 
When ~hese artifacts cannot be eliminated, they 
can at least be monitored as a part of the actual 
recording. Figure 2 shows respirator artifact and 
electrocerebral silence when the respirator is briefly 
stopped. Figure 3 shows the monitoring of the 
respirator cycle by an accelerometer actually at-
tached to the respirator instrument. 
The most consistently bothersome artifact is 
that of muscle activity. Even in deeply comatose 
patients and even in patient~ without brain stem 
function, some muscle activity may remain. For-
tunately, since such patients are on respiratory 
support, the use of succinylcholine given intraven-
ously to abolish muscle artifact is an extremely 
useful procedure. This is particularly true since 
in a review of our records on patients in deep 
coma, the type of record which was most con~ 
sistently thought to be technically inadequate was the 
record with muscle artifact. Particularly records 
with low amplitude artifact due to muscle alone 
may_ be thought to show low-fast brain activity. 
Figure 4A shows such a record and the recording 
after succinylcholine (Fig. 4B). 
As regards the Harvard criteria ( 4), our 
studies have shown that all patients with a single 
record of thirty minutes of electrocerebral silence 
with no spontaneous respiration and with dilated 
fixed pupils have died. A recent report of Jorgensen 
(18, 19) from Copenhagen reaches this same con-
clusion, except that he adds to the criteria the loss 
of spontaneous maintenance of systemic blood 
pressure. 
Aside from the useftilness of the electroen-
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Fig. 2-The first record shows regular, recurring respirator 
artifact. The second record shows the disappearance of this 
artifact when the respirator is stopped. Though some very 
slight muscle attifact relnaiiJ.s, the record after the respira-
tor is stopped is essentially that of cerebral silence. 
· cephalograin iri the recording of electrbcerebral 
silence in cases of brain death, experience in a 
great variety of patients with lesser degrees of .coma 
has given a new appreciation of certain distinct 
EEG patterns (13, 20-27). Such distinetive EEG 
EKG','-v-"\-v-"t'~'v-y-v-1-v'iVV~'V'-1/'v-y-v-1' 
Resp-1~-- """' 'Jt ~,,._., • ~ 
Rt 1c:alp . 
__J IOjN 
c::.-o,~ ·~~-~---~--~~-~'-sec_.~~ 
Fig. 3- Monitoring of the respirator cycle by an acceler-
ometer is demonstrated in Channel 3. Although the record-
ing is that of electrocerebrai silence and no marked respira-
tor artifact appears, a slight swaying of the baseline in titne 
with the respiration can l:ie detected in Channels 5 & 6. 
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Arm 
c,-0,-------------------
Fig. 4A-This record shows low amplitude fast activity in 
the sixth channel from electrodes C, and 02. This might be 
considered cerebral activity. 
patterns seen in patients in coma are presented 
below. 
Electrocerebral Silence. As recorded in the 
electroencephalogram, electrocerebral silence con-
sists of no deflections above a millimeter with the 
machine set at an amplification of two microvolts 
per millimeter. Actually, some older machines have 
a background noise level of two-to-three microvolts 
and in tnis situation, some leeway will have to b~ 
given for determination of electrocerebral silence. 
In the newer machine with everything in order, a 
record without deflections beyond a one-millimeter 
range should be obtainable. Nevertheless, it is 
usually impossible, except by special subtraction 
or computer techniques, to remove all of · the EKG 
Arm 
EKG 
F.,-c, 
c,-o, 
F,.-c. 
c,-o, 
T,-C, 
___J IOpV 
c,-T, I sec. 
~i~. 4B-~ter succinylcholine the low amplitude fast ac-
tivity seen m Channel 6 disappeared and therefore was due 
to muscle. artifact. The recording is now that of electro-
cere bra! silence. 
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artifact from the record (28). This usually appears 
as a regular deflection which can be monitored and 
determined to be directly synchronous with the 
EKG (Fig. 5). 
Low Amplitude-Fast Activity (Muscle) Abol-
ished by Succinylcholine. Low and high amplitude 
muscle artifact is seen in many recordings, even in 
patients with severe damage of the brain stem. 
It occurs in patients who already have dilated 
fixed pupils and no spontaneous respiration. If 
these patients are continued on respiratory support, 
eventually all muscle activity ceases. The muscle 
activity may be the only remaining artifact that 
makes it impossible to be sure the record is that 
of electrocerebral silence. Also, the muscle artifact 
may appear actually as beta activity. Since beta 
activity is often seen in patients with overdose who 
will survive, it is extremely important that this 
differential be made. This can be done by a single 
injection of 30-60 mg of succinylcholine intraven-
ously or, better yet, by a slow constant drip of 
succinylcholine ( 29-31). This is done, of course, 
only on patients with respiratory support (Fig. 4B). 
Electrocerebral Silence Except for Myoclonic 
Jerks. We have observed, particularly early in the 
course of deep coma and especially in coma due 
to cerebral anoxia, that the patient may present 
with repeated myoclonic jerks, but the recording, 
except for these jerks, shows no cerebral activity 
(Fig. 6). Succinylcholine given in this situation 
has to be given in very large amounts to block 
the myoclonic jerks. Drugs such as diazepam may 
block the myoclonic jerks but then raise the ques-
tion as to whether the drug might also suppress 
Hand 
EKG 
FP2-c~ 
c,-o, 
FPl-c3 
c,-o, 
T4-C~ 
____J IOJN 
I sec. 
C,-T, 
Fig. 5-At a recording amplitude of 2 µ V / mm, no dis-
cernible cerebral activity appears and this is a typical 
record of electrocerebral silence. Very slight EKG artifact 
is seen. 
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other cerebral activity. In general, this type of 
record is usually, but not always, a very poor 
prognostic sign. The fact that myoclonic jerks exist, 
particularly as they are bilateral and symmetrical, 
indicates that some brain function remains. 
Burst Suppression Pattern. In many records 
of deep coma, particularly due to cerebral anoxia 
and often following a few hours of records which 
show only myoclonic jerks, there may occur a burst 
suppression pattern. In this situation, fairly high 
amplitude complexes, either singly or in paroxysmal 
episodes, occur with intervening periods of electro-
cerebral silence. The intervening period may vary 
from one or two seconds up to a minute or more. 
Such a burst suppression pattern, in general, is a 
bad prognostic sign (Fig. 7). 
PLED's and "Bilateral" PLED's. In a great 
number of patients with cerebral emboli or other 
lesions, particularly associated with some metabolic 
disturbance, bilateral, semirhythmic, periodic dis-
charges are seen but these discharges are definitely 
greater on one side. Often associated with these 
discharges, there are brief but continuous myoclonic 
jerks. In our laboratory at the Medical College of 
Virginia, these were observed in the early 1960's 
and designated "acute spikes" ( 13). They also 
have been described and usually called "PLED's" 
(periodic lateralized epileptiform discharges) in the 
literature (32) . Most patients with this pattern are 
stuporous but may be conscious; depending upon 
the lesion involved, they may proceed with it and 
die or they may recover completely. It is thought 
that the cerebral ischemia, resulting from emboliza-
tion which has produced a temporary anoxia, causes 
the unilateral discharges. In any case, a similar pat-
tern, bilaterally symmetrical, is seen following severe 
cerebral anoxia of a diffused nature such as that due 
to cardiac standstill. In this situation, the bilateral 
PLED's have a much more serious prognosis (Fig. 
8A, B). 
Continuous Spike or Spike Waves. Certain 
patients who are stuporous or in coma present 
with continuous diffuse spike or spike wave dis-
charges. Some of these patients have a chronic form 
of convulsive disorder and are in a type of con-
vulsive state. Such patients are not usually confused 
with deep coma, since reflexes remain and pupils 
react, and the patient breathes spontaneously. Fol-
lowing a reasonably severe anoxic insult, however, 
certain patients also go into a period of one, two, or 
three days of continuous diffuse spike and spike wave 
Arm 
ofter Succinylcholine 
157 
_llOJN 
I sec. 
Fig. 6-ln this record myoclonic seizures such as seen in 
the beginning of the recording occur every 10-30 seconds. 
Succinylcholine suppressed other muscle artifact revealing 
no evidence of cerebral activity between these attacks. 
activity (Fig. 9). This may precede a more severe 
continuous burst suppression record, or it may 
precede a longer period when the patient simply 
has a theta coma. A few of these patients recover, 
usually with some degree of neurological damage. 
Control of such activity with anticonvulsant drugs 
usually does not produce an electrocerebral silence 
record but tends to produce a record with either 
delta or theta activity, so that there is no problem 
concerning decision as to electrocerebral silence. 
Severe Asymmetry. A record with severe asym-
metry, particularly showing essentially electrocere-
BURST SUPPRESSION PATTERN Respiratory arrest 
Coma 
7~!:a~fi 
Cs-Ps ----""'I• 
C4-P4 ---_,_,_.J"~---------v'Y---
__j5Q~V 
lsec. 
Fig. 7- This record shows relatively high amplitude dis-
charges occurring in a rhythmic fashion with only low 
amplitude activity between. Such discharges appearing 
over a period of time in general have a bad prognostic 
significance. 
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Fig. SA-This is a record showing typical periodic lateral-
ized epileptiform discharges (PLED's) secondary to cerebral 
embolus to the right hemisphere in a patient with some 
metabolic derangements. 
bral silence on one side and large delta activity 
on the other, is seen primarily in cerebral trauma 
but occasionally in intracerebral hemorrhage. Such 
a record indicates a poor prognosis for complete 
recovery, though dependent upon the treatment 
carried out and the nature of the illness, the patient 
may survive (Fig. 10). Lesser degrees of asymmetry 
seen in ordinary subdural hematoma, of course, may 
be followed by complete recovery of the patient and 
normality of the EEG. 
Diffuse Delta. Classically, diffuse delta activity 
has been associated with coma or diffuse brain 
damage or disease. Actually, this is not a very 
frequent pattern in the patient in deep coma. The 
presence of diffuse delta may indicate any of a 
great number of relatively acute cerebral disturb-
ances which may be transitory. Thus, many patients 
who show diffuse delta and periods of coma or con-
fusion recover completely. This is particularly true 
following metabolic happenings and following closed 
head trauma (Fig. 11). 
Arm~~L 
EKG ------+-- +-+-----f.,-----f-~+-~---+---+-r~ 
. f,,-T,--------1~~ 
Fig. SB-This is a recording showing periodic generalized 
discharges or so-called bilateral PLED's in a patient with 
diffuse cerebral anoxia secondary to cardiorespiratory arrest. 
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CONTINUOUS SPIKE DISCHARGES 24 hours ofter 
cordio-respirotory arrest 
66 y.n wr; 
9-26-71 
F3-A1 M~~v/i,l\)v-'\)~c,.Ji,~G~l)MA 
C,-A1 "-'\A~\AA,~/i/c.vv11n)0-\J~~\J~)\UJvl. 
o,-A, 'f'~V....\ivv~fl"M.J--Jc1l•'v u.,fA/1A-'J"""-vviilJvUM./lrJ., 
F.-A, M\,A~\M{Wht-"Wt,Al\J<'i""V'~W\V.l).,..J4/w<~"-~\i,i,-1;"... 
c.-A, ~~.).Jcv,l1rviiA-vwy..;,~,,,,..,,,,vMIV\.µVA.11;-\. 
o,-A, ,,}.J-.i.j~~"'''llflrJv"--'AJv .. N>~ 
__JIOOJN 
I sec. 
Fig. 9-This record shows continuous spikes and spike waves 
in a diffuse fashion due to an acute cerebral anoxia. 
Diffuse Theta (Theta Coma). We have observed 
a number of patients with a fairly regular diffuse 
theta activity in the electroencephalogram ( 25). This 
activity is often seen during a recovery stage fol-
lowing cerebral anoxia of a severe degree. At this 
point the patient may deteriorate and revert to burst 
suppression and eventually to electrocerebral silence 
but more often shows a tendency toward recovery. 
This finding of theta coma is of importance directly 
in proportion to how long it occurs. As a transient 
happening, it has a good prognosis in general; if 
theta coma pattern persists for days or weeks, how-
ever, it is usually in association with a patient who 
has received rather severe diffused cerebral damage 
as well as some brain stem damage. Such patients 
usually breathe spontaneously, have some pupillary 
reflexes, but do not respond in purposeful fashion 
T,-q 
T,-1;, 
A-A !'''\~~,/'l..._.,,..A'J.-..,~,._,.~--...._,_,,,..,~, 
I 2 ____J 50jJV 
I sec. 
o,-o, 
Fig. IO-This record shows marked asymmetry with severe 
depression over the left hemisphere secondary to a large 
subdural following trauma in the so-called "battered child." 
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F4-C4 
c.-P. 
Fig. 11- This record shows diffuse delta in a patient 
comatose following a hypoglycemic episode. 
to stimuli. They may stay in this state for long 
periods of time (Fig. 12). 
Diffused "Sleep Spindle" Activity. Reports have 
appeared concerning sleep spindle activity in coma 
associated with brain stem lesions (24), particularly 
in pontine lesions. We have seen one particularly 
impressive case with a cerebellar hemorrhage and 
brain stem compression. This type of record may 
be confused with records in drug overdose which 
may also show sleep spindles. The presence of such 
a record in a deeply comatose patient, however, 
should always raise the possibility of a brain stem 
lesion and compression by a cerebellar lesion, par-
ticularly since this may be a treatable situation 
(Fig. 13). 
F,.,-c, 
c,-o, 
c.-o, 
Fig. 12- This record shows so-called theta coma with 
predominant discharges in the 4- 8 c/sec range in a diffuse 
fashion. This patient had severe diffuse cerebral damage 
following cerebral anoxia but, though comatose, was still 
breathing spontaneously and making nonpurposeful move-
ments to stimuli two months following the injury. 
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EKG--,~'-----,'- -+---+---+---,~~~'-----1~ 
F,-A,~fll~ 
c,-A,~fl~ 
q-A, 
F.-A,~~ 
c.-A,
., __Jsopv 
~-A, ,. I~ Nc'W>r~~ 
Fm. 13-This record shows diffuse spindle activity resem-
bling sleep in a patient with a cerebellar hematoma and com-
pression of the brain stem. Removal of the hematoma re-
sulted in nearly complete recovery of the patient. 
Diffuse Alpha Frequency (Alpha Coma). Re-
ports of normal electroencephalograms in patients 
in coma have appeared (26, 27). What is usually 
meant by this is that the patient has an alpha 
frequency discharge which occurs in a diffuse fash-
ion. Actually, such a diffuse alpha frequency dis-
charge is quite abnormal and is indeed usually 
associated with coma secondary to pontine or brain 
stem lesions or damage. Most such patients have 
died; however, we have recently recorded such 
alpha frequency coma in several patients who sur-
vived (33) . Two of these had coma following 
severe accidental electroshock and one had coma 
following cerebral vascular insufficiency attack. It 
would appear that recovery is not unusual in pa-
tients with alpha frequency coma, particularly when 
the alpha frequency coma is of brief duration 
(Fig. 14). 
Diffuse Beta (Beta Coma). The occurrence of 
diffuse beta activity is usually a sign of drug over-
dose and is seen in patients who are not in really 
deep coma; occasionally, however, it is seen in pa-
tients with brain stem lesions. The literature is 
somewhat confused on this subject, since some of 
the recordings thought to be beta activity probably 
actually represent low amplitude muscle activity 
which could have been abolished by succinylcholine. 
Usually, the recording of a diffuse beta activity 
record is a good prognostic sign, because it is 
usually related to drug overdose (Fig. 15). 
These are some of the characteristic patterns 
with which we have become familiar in the study 
of coma. As time goes on, and larger numbers of 
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F,-A, 
~-A2 -F\J"~~\/"V~~N~Mfl/\Af'Jl/'""'1"'V~NIJ\/IN~'VW"'wW\J\/\jVWWVWVW~µ' 
__J50JJV 
~-A,...,_,_.._,...,.,V-v'"""-NV''-"",.,....,_,___,'W"'~~~'VV""'\/"1,/V"'..._,._,---&1s~-"'\,""--" 
Fig. 14-This record shows so-called alpha frequency coma 
in a patient comatose following cardiorespiratory arrest 
from a severe electric shock. The patient remained comatose 
for nearly three weeks but then slowly regained conscious-
ness and is still living with a large degree of recovery but 
with some slight memory and learning defect. 
cases are collected, more definite prognostic at-
tributes can be given to each type of finding. 
Determination of Cerebral Blood Flow. Al-
though our experience indicates that a careful clinical 
examination and excellent electroencephalographic 
recording give enough information, even within 30-
90 minutes, to make a decision as to the presence 
of brain death (dilated fixed pupils, no spontaneous 
respiration, and electrocerebral silence EEG for 
thirty minutes equal brain death), the addition of 
information about cerebral blood flow might increase 
ones sense of confidence in cases where drugs or 
metabolic abnormalities might be active. For this 
.Fig. 15-This is so-called beta coma seen in a patient 
with a drug overdose who was comatose but who recovered 
rapidly and completely. 
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reason, studies of the possibility for developing 
facilities for the easy evaluation of cerebral blood 
flow should be continued. In this regard, the Bolus 
technique shows prominence ( 10). In this test, 
radioactive material is injected into the veins and 
the resulting radiation is picked up within a few 
seconds from the cranium and from the chest or 
the femoral artery. This is a qualitative not a quan-
titative test, but in patients with brain death, es-
sentially no blood flow is recorded over the cranium 
and the normal flow is recorded in the chest or 
femoral artery probe. This test has not yet been 
firmly authenticated with contrast cerebral arterio-
graphy, but so far its correspondence with other 
studies is excellent. Because it represents a rela-
tively simple bedside test, could be available in a 
large number of hospitals, and offers confirmation 
of brain death from a different parameter, it may 
indeed have widespread application . 
It is assumed that in a case of severe drug 
overdose without cerebral anoxic damage or cerebral 
infarction, the cerebral blood flow would be present 
and, if not normal, at least not severely depressed. 
For this reason this test would become an ideal 
test on a patient with drug overdose who had re-
mained comatose with electrocerebral silence for 
a period of 12-24 hours. In similar cases, where 
ordinary contrast cerebral arteriography has been 
performed, it has shown no cerebral blood flow in 
patients even with overdose after 24 hours. This 
is almost certainly due to the fact that these patients 
have also suffered anoxic damage. Even now, when 
doubt exists, ordinary contrast cerebral angiography 
can give essentially the same type of information 
and should be used more often here in the United 
States as it is now being used in Europe. 
Other Tests. At this point, it does not appear 
that tests and examinations other than those listed 
above will become critical in the examination of 
brain death; nevertheless, a variety of other labora-
tory procdures will, as time goes on, help us to 
understand particular types and particular degrees 
of brain damage. There have been a large number 
of reports concerning values in the cerebral spinal 
fluid of pH, lactic acid , and a variety of enzymes 
related to the stage and degree of brain damage 
(34, 35) . In general, we have not carried out 
lumbar puncture or cerebral spinal fluid examina-
tion routinely in patients with deep coma, since in 
some cases this might be contraindicated because 
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of increased intracranial pressure or other intra-
cranial lesions. 
The more widespread use of monitoring intra-
cranial pressure assures our better understanding 
of what role increased intracranial pressure has in 
the development of deep coma and at what points 
it might be reversed by various forms of treatment 
( 36). From a few observations, it might appear 
that when the intracranial pressure passes a critical 
point in relation to systemic blood pressure, severe 
brain damage follows rather rapidly. So far, the 
monitoring of intracranial pressure has been largely 
in patients with trauma or hemorrhage, but it would 
appear to be a reasonable procedure in most pa-
tients in deep coma. 
What of the Future? As the assessment of the 
patient in deep coma becomes more exact and 
routine, it is reasonable to expect continued progress 
in both diagnosis and treatment, particularly in the 
following areas: 1) The routine collection and cor-
relation of data concerning the clinical examination, 
drug and metabolic levels, electroencephalogram, and 
cerebral blood flow will allow dependable decisions 
concerning cerebral brain death to be made at any 
point in the patient's course in a matter of one or two 
hours. As outlined previously, some combinations 
of these findings will supplant the Harvard criteria 
( 4) as a dependable basis for determining cerebral 
or brain death. 2) Complete assessment of the 
patient in coma will occur earlier and nearer the 
time of the original insult to the brain, thus allowing 
a better understanding of the patterns of evolving 
brain damage or recovery. 3) An understanding 
of the usual course of coma in particular situations, 
such as cerebral trauma, cerebral anoxia from 
cardiac standstill, cerebral hemorrhage, drug over-
dose, and so forth, will allow better management 
and better judgment of prognosis in each particular 
situation. 4) A number of distinctive EEG patterns 
seen in deep coma will be more widely recognized 
and their significance will be validated by large 
series of cases. 5) Criteria concerning evaluation 
of deep coma which, at present, apply mainly to 
adults will be expanded to include an understanding 
of the situation in infants and children. 6) As clini-
cal information and information from laboratory 
work accumulate, useful means of altering the 
course of severe brain damage by the application 
of a variety of medical and surgical treatments will 
be found. 
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Chromosome Abnormalities and Repeated Abortion: 
A Preliminary Report 
SUSAN ENGLISH, B.A., DEBORAH W. HERITAGE, B.A., M.S., 
ANDREW T. L. CHEN, PH.D., REUBEN B. YOUNG, M.D. 
Program In Human Genetics and the Department of Pediatrics, 
Medical College of Virginia, Health Sciences Division, 
Virginia Commonwealth University, Richmond 
The role of chromosome aberrations in the 
etiology of early spontaneous abortions has been 
well established (1). Various investigators have 
found that 25-35% of all such abortions are the 
result of cytogenetic abnormalities (2, 3). The great 
majority of these aberrations are believed to be the 
result of de novo errors in meiosis and only rarely 
can early mitotic mistakes account for these events 
(3). In a minority of cases, one of the parents may 
harbor a transmissible chromosome anomaly. The 
carrier is apparently physically normal and has a 
balanced genetic make-up compatible with life. Dur-
ing gametogenesis, however, unequal gametes may 
be formed, resulting in development of a nonviable 
zygote. This may predispose the carrier to recurrent 
early abortion of his or her offspring. 
Recently, a number of studies have attempted to 
find such a correlation between recurrent pregnancy 
loss and parental chromosome anomalies (3, 4, 5, 
6). An investigation of this type was initiated at 
the Medical College of Virginia in the fall of 1973. 
Letters were sent to obstetricians in eastern Virginia 
requesting referrals of patients with histories of two 
or more spontaneous abortions. Blood was drawn 
from both the husband and wife and karyotype anal-
ysis was performed according to conventional meth-
ods. Five anomalies have been ascertained in the 
25 couples studied so far. A discussion of the sig-
nificance of these findings is considered below. 
A 28-year-old white female was found to have a 
modal chromosome number of 47. The patient was 
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intelligent and physically normal with a history of 
two spontaneous abortions and no live births. Karyo-
type analysis, banding studies, and buccal smears 
showing two sex chromatin bodies in 31 % of 800 
cells analyzed confirmed that the patient was a 
triplo-X female. The incidence of 47,XXX females 
is believed to be about one per 1000 in the normal 
population (7). Due to wide phenotypic variability, 
a clearly defined triplo-X syndrome has not been 
established. Fertility is thought to be unimpaired (8). 
There is, however, a slightly increased risk of sex 
chromosome anomalies in the offspring. 
Chromosome polymorphism was detected in a 
30-year-old white female with a history of two early 
spontaneous abortions. Satellites on chromosome 17 
were seen consistently in all preparations. A poly-
morphism of this type is not believed to contribute 
to repeated fetal wastage ( 4), although the possi-
bility cannot be ruled out until prospective studies 
are done. The patient was in the seventh month of 
an uneventful pregnancy when the study was done. 
Another structural polymorphism was discov-
ered in a husband whose wife had experienced three 
spontaneous abortions and no live births. The hus-
band's karyotype was 46,XY with an enlarged #16 
chromosome. The clinical significance of this finding 
is not known at present, and the patient's chromo-
somes are being studied with banding techniques. 
One of the most interesting findings was tbe as-
certainment of two families with balanced D /D 
(Continued on page 167) 
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after taking a 
potent a11atgesic 3 . 
• ID 
how big a dose will now 
bring relief if it is a narcotic? 
"Tolerance is an ever-present hazard to continued use 
of narcotics .. .. The very first dose diminishes the 
effects of subsequent doses. "1 And, as increasing 
amounts of narcotics are required to control pain, dis-
tressing adverse effects- lethargy, hypotension, con-
stipation, etc.- can needlessly debilitate the patient. 
1. Sadove, M. S.: A look at narcotic and non-narcotic analgesics, 
Postgrad. Med. 49:102, June 1971. 
how big a dose will now 
bring relief if it is Talwin®? 
Chances are, the same 50 mg. Talwin Tablet you pre-
scribe originally will continue to provide good pain 
relief. Talwin can be compared to codeine in analgesic 
efficacy: one 50 mg. tablet appears equivalent in anal-
gesic effect to 60 mg. (1 gr.) of codeine. However, 
patients receiving Talwin Tablets for prolonged periods 
face fewer of the consequences you've come to expect 
with narcotics. There should be fewer "adverse effects" 
on her way of life. 
Tolerance rare: Tolerance to the analgesic effect of Talwin 
Tablets is rare. 
Dependence rare: During three years of wide clinical use, 
there have been a few reports of dependence and of with-
drawal symptoms with orally administered Ta/win. Patients 
with a history of drug dependence should be under close 
supervision while receiving Ta/win orally. 
In prescribing Ta/win for chronic use, the physician should 
take precautions to avoid increases in dose by the patient 
and to prevent the use of the drug in anticipation of pain 
rather than for the relief of pain.* 
Generally well tolerated by most patients*: Infrequently 
causes decrease in blood pressure or tachycardia; rarely 
causes respiratory depression or urinary retention; seldom 
causes diarrhea or constipation. Acute, transient CNS effects, 
described in product information, have occurred in rare 
instances following the use of Talwin Tablets. If dizziness, 
lightheadedness, nausea, or vomiting is encountered, these 
effects may decrease or disappear after the first few doses. 
•see important product information for adverse reactions, patient 
selection, prescribing and precautionary recommendations. 
in chronic pain 
of moderate to severe intensity 
Ta1'1Vift®:::u 
Talwin® Tablets brand of pentazocine (as hydrochloride) 
Analgesic for Oral Use -
Indication: For the relief of moderate to severe pain . 
Contraindication: Talwin should not be administered to patients who are 
hypersensitive to it. 
Warnings: Drug Dependence. There have been instances of psychological 
and physical dependence on parenteral Ta/win in patients with a history of 
drug abuse and, rarely, in patients without such a history. Abrupt discon-
tinuance following the extended use of parenteral Ta/win has resulted in 
withdrawal symptoms. There have been a few reports of dependence and of 
withdrawal symptoms with orally administered Ta/win. Patients with a his-
tory of drug dependence should be under close supervision while receiving 
Ta/win orally. 
In prescribing Ta/win tor chronic use, the physician should take precautions 
to avoid inqeases in dose by the patient and to prevent the use of the drug 
in anticipation of pain rather than for the relief of pain. 
Head ln1ury and Increased Jntracranial Pressure. The respiratory depressant 
effects of Talwin and its potential for elevating cerebrospinal fluid pressure 
may be markedly exaggerated in the presence of head injury, other intra-
cranial lesions, or a preexisting increase in intracranial pressure. Further-
more, Talwin can produce effects which may obscure the clinical course of 
patients with head injuries. In such patients, Talwin must be used with ex-
treme caution and only if its use is deemed essential. 
Usage in Pregnancy. Safe use of Talwin during pregnancy (other than labor} 
has not been established. Animal reproduction studies have not demon-
strated teratogenic or embryotoxic effects. However, Talwin should be 
administered to pregnant patients (other than labor} only when, in the judg-
ment of the physician, the potential benefits outweigh the possible hazards. 
Patients receiving Talwin during labor have experienced no adverse effects 
other than those that occur with commonly used analgesics. Talwin should 
be used with caution in women delivering premature infants. 
Acute CNS Manifestations. Patients rece1vin11 therapeutic doses of Talwin 
have experienced, in rare instances, hallucinations (usually visual}. dis-
orientation, and confusion which have cleared spontaneously within a 
period of hours. The mechanism of this reaction is not known. Such patients 
should be very closely observed and vital signs checked. If the drug is re-
instituted it should be done with caution since the acute CNS manifesta-
tions may recur. 
Usa[te in Children. Because clinical experience in children under 12 years of 
age 1s limited, administration of Talwin in this age group is not recommended . 
Ambulatory Patients. Since sedation, dizziness, and occasional euphoria 
have been noted, ambulatory patients should be warned not to o~erate 
machinery, drive cars, or unnecessarily expose themselves to hazards. 
Precautions: Certain Respiratory Conditions. Although respiratory depres-
sion has rarely been reported after oral administration of Talwin, the drug 
should be administered with caution to patients with respiratory depression 
from any cause, severely limited respiratory reserve, severe bronchial 
asthma and other obstructive respiratory conditions, or cyanosis. 
Impaired Renal or Hepatic Function. Decreased metabolism of the drug by 
the liver in extensive liver disease may predispose to accentuation of side 
effects. Although laboratory tests have not indicated that Talwin causes or 
increases renal or hepatic impairment, the drug should be administered 
with caution to patients with such impairment. 
Myocardial Infarction. As with all drugs, Talwin should be used with caution 
in patients with myocardial infarction who have nausea or vomiting. 
Biliary Surgery. Until further experience is gained with the effects of Talwin 
on the sphincter of Oddi, the drug should be used with caution in patients 
about to undergo surgery of the biliary tract. 
Patients Receiving Narcotics. Talwin is a mild narcotic antagonist. Some 
patients previously given narcotics, including methadone for the daily treat-
ment of narcotic dependence, have experienced withdrawal symptoms after 
receiving Talwin. 
CNS Effect. Caution should be used when Talwin is administered to pa-
tients prone to seizures; seizures have occurred in a few such patients in 
association with the use of Talwin although no cause and effect relationship 
has been established. 
Adverse Reactions: Reactions reported after oral administration of Talwin 
include gastrointestinal: nausea, vomiting; infrequently constipation; and 
rarely abdominal distress, anorexia, diarrhea. CNS effects: dizziness, light-
headedness, sedation, euphoria, headache; infrequently weakness, dis-
turbed dreamsi insomnia, syncope, visual blurring and focusing difficulty, 
hallucinations see Acute CNS Manifestations under WARNINGS}; and rarely 
tremor, irritability, excitement, tinnitus. Autonomic: sweating; infrequently 
flushing; and rarely chills. Allergic: infrequently rash; and rarely urticaria, 
edema of the face. Cardiovascular: infrequently decrease in bjood pressure, 
tachycardia . Hematologic: rarely depression of white blood cells (especially 
granulocytes}. usually reversible and usually associated with diseases or 
other drugs which are known to cause such changes, moderate transient 
eosinophiha. Other: rarely respiratory depression, urinary retention, toxic 
epidermal necrolysis. 
Dosage and Administration: Adults. The usual initial adult dose is 1 tablet (50 mg.} every three or four hours. This may be increased to 2 tablets (100 
mg.} when needed. Total daily dosage should not exceed 600 mg. 
When antiinflammatory or antipyretic effects are desired in addition to 
analgesia, aspirin can be administered concomitantly with Talwin. 
Children Under 12 Years of Age. Since clinical experience in children under 
12 years of age is limited, administration of Talwin in this age group is not 
recommended. 
Duration of Therapy. Patients with chronic pain who have received Talwin 
orally for prolonged periods have not experienced withdrawal symptoms 
even when administration was abruptly discontinued (see WARNINGS}. No 
tolerance to the analgesic effect has been observed. Laboratory tests of 
blood and urine and of liver and kidney function have revealed no signifi-
cant abnormalities after prolonged administration of Talwln. 
Overdosage: Manifestations. Clinical experience with Talwin overdosage has 
been insufficient to define the signs of this condition. 
Treatment. Oxygen, intravenous fluids, vasopressors, and other suppcrtive 
measures should be employed as indicated. Assisted or controlled ventila-
tion should also be considered. Although nalorphine and levallorphan are 
not effective antidotes for respiratory depression due to overdosage or un-
usual sensitivity to Talwin, parenteral naloxone (Narcan®, available through 
Endo Laboratories} is a specific and effective antagonist. 
Talwin is not subject to narcotic controls. 
How Supplied: Tablets, peach color, scored. Each tablet contains Talwin (brand of pentazocine} as hydrochloride equivalent to 50 mg. base. Bottles 
of 100. 
( 16231,) Winthrop Laboratories, New York, N.Y. 10016 rw~.IZ7i.l 
A service to medical education from A. H. Robins: ·1~\ '. ~ Excerpted from Volume 2 offheG.I. 
Sen es 
on physical examination 
of the abdomen: 
Normally palpable organs: 
the edge of the liver descending, 
on inspiration, below the costal 
margin (AJ; the lower pole of the 
right kidney (BJ; the abdominal 
aorta (CJ; the descending colon 
and the sigmoid (DJ; the ascend-
ing colon (E); and occasionally 
the bladder (though rising of 
this organ beyond the pubis 
does not necessarily indicate 
disease). 
Impossible to outline, unless 
diseased, distended or enlarged: 
the gallbladder, pancreas. 
stomach, small intestine, trans-
verse colon and spleen. 
The A . H . Robins G.I. Series consists of six book-
lets. designed to p rovide a Quick. yet comprehen-
sive review o f basic procedures and practices in 
G .I. medicine - with particular emphasis on the 
physical examination as performed in the office or :::.._ 
at bedside. If you have teaching responsibilities. ·-........:. 
limited Quantities are available: Part 1 - Inspection, --...._ _ 
Part 2 - Palpation, Part 3 - Percussion. Part 4 - Auscuffation. Part 5 -
Abdominal Pain and Part 6 - Differenllal D iagnosis of Abdominal 
Disorders. Write to: The Medical Department. A. H . Robins Company. 
1407 Cummings Drive. Richmond . Virginia 23220. 
A service to medical education from A. H. Robins: , ~. l. ::~·~ · Excerpted from Volume 2 offheG.I. 
Sen es 
on physical examination 
of the abdomen : 
Normally palpable organs: 
the edge of the liver descending, 
on inspiration, below the costal 
margin (A); the lower pole of the 
right kidney (BJ; the abdominal 
aorta (CJ; the descending colon 
and the sig moid (DJ; the ascend-
ing colon CEJ; and occasionally 
the bladder (though rising of 
this organ beyond the pubis 
does not necessarily indicate 
disease) . 
Impossible to outline, unless 
diseased, distended or enlarged: 
the gallbladder, pancreas, 
stomach, small intestine, trans-
verse colon and spleen. 
The A . H Robins G I Series consists of six book· 
lets. designed to provide a quick. yet comprehen-
sive review of basic procedures and practices in 
G .I. medicine - with particular emphasis on the 
p hysica l examination as performed in the office or 
at bedside If you have teaching responsibilities . 
limited Quantities are avai lable : Part 1 - lnspection. ~ 
Part 2 - Palpation. Part 3 - Percuss;on. Part 4 - Auscultation. Part 5 -
Abdominal Pam and Part 6 - D1fferent1at Diagnosis of Abdominal 
Disorders. Write to : The Medical Department. A. H . Robins Company. 
1407 Cummings Drive. Richmond . Virginia 23220 
each tablet. 
capsule or 5 cc. 
teaspoonful 
of elixir (23% alcohol) 
hyoscyam1ne sulfate O. 1037 mg. 
atropine sulfate 0.0194 mg. 
hyoscine hydrobrom1de 0.0065 mg 
each 
Donnatal 
No. 2 
0.1037 mg. 
0.0194mg. 
00065mg. Phe~obarb1tal (V.. gr.) 16.2 mg. 
~arning may be habit forming) (Y.! gr.) 32.4 mg. 
each 
Extentab 
0.3111 mg. 
0.0582 mg 
0.0195mg. 
(o/. gr.) 48.6 mg. 
• 
• Brief summary. Adverse Reactions: Blurring of vision. dry mouth. difficult urination, and flushing or dryness of the skin may occur 
on higher dosage levels, rarely on usual dosage. Contraindica-
tions: Glaucoma; renal or hepatic disease; obstructive uropathy 
(for example, bladder neck obstruction due to prostatic hyper-
trophy); or hypersensitivity to any of the ingredients. 
A·H·ROBINS A H Robins Company. Richmond, Virg1n1a 23220 
each tablet. 
capsule or 5 cc. 
teaspoonful 
of elixir (23% alcohol) 
hyoscyam1ne sulfate 0 .1037 mg. 
atropine sulfate 0 .0194 mg. 
•1yosc1ne hydrobromide 0.0065 mg. 
each 
Donnatal 
No. 2 
0 .1037mg. 
0.0194mg. 
00065mg. 
Phenobarbital (JI.I gr.) 16.2 mg. 
,w.irning may be habit forming) 
( YI! gr.) 32.4 mg. 
each 
Extentab 
0.3111 mg. 
0 .0582 mg 
0.0195mg. 
(o/. gr.) 48.6 mg. 
• 
• Brief summary. Adverse Reactions: Blurring of vision , dry mouth. difficult urination. and flushing or dryness of the skin may occur 
on higher dosage levels. rarely on usual dosage. Contraindica-
tions: Glaucoma; renal or hepatic disease; obstructive uropathy 
(for example, bladder neck obstruction due to prostatic hyper-
trophy); or hypersensitivity to any of the ingredients. 
.A·H·ROBI NS A H Robins Company. Ric hmond, V1rg1nia 23220 
Before prescribing, please consult 
complete product information, a sum-
mary of which follows: 
Indications: Tension and anxiety 
states; somatic complaints which are 
concomitants of emotional factors; psy-
choneurotic states manifested by tension, 
anxiety, apprehension, fatigue, depres-
sive symptoms or agitation; symptomatic 
relief of acute agitation, tremor, delirium 
tremens and hallucinosis due to acute 
alcohol withdrawal; adjunctively in skele-
tal muscle spasm due to reflex spasm to 
local pathology, spasticity caused by 
upper motor neuron disorders, athetosis, 
stiff-man syndrome, convulsive disorders 
(not for sole therapy). 
Contraindicated: Known hypersensi-
tivity Q the drug. Children under 6 
months of age. Acute narrow angle glau-
coma; may be used in patients with open 
angle glaucoma who are receiving appro-
priate therapy. 
Warnings: Not of value in psychotic 
patients. Caution against hazardous 
occupations requiring complete mental 
alertness. When used adjunctively in con-
vulsive disorders, possibility of increase 
in frequency and/ or severity of grand mal 
seizures may require increased dosage of 
standard anticonvulsant medication; 
abrupt withdrawal may be associated 
with temporary increase in frequency 
and/ or severity of seizures. Advise 
against simultaneous ingestion of alcohol 
and other CNS depressants. Withdrawal 
symptoms (similar to those with barbitu· 
rates and alcohol) have occurred follow-
ing abrupt discontinuance (convulsions, 
tremor, abdominal and muscle cramps, 
vomiting and sweating). Keep addiction-
prone individuals under careful surveil-
lance because of their predisposition to 
habituation and dependence. In preg-
nancy, lactation or women of childbearing 
age, weigh potential benefit against 
possible hazard. 
Precautions: If combined with other 
psychotropics or anticonvulsants, con-
sider carefully pharmacology of agents 
employed; drugs such as phenothiazines, 
narcotics, barbiturates, MAO inhibitors 
and other antidepressants may potentiate 
its action. Usual precautions indicated in 
patientS severely depressed, or with latent 
depression, or with suicidal tendencies. 
Observe usual precautions in impaired 
renal or hepatic function. Limit dosage to 
smallest effective amount in elderly and 
debilitated to preclude ataxia or over-
sedation. 
Side Effects: Drowsiness, confusion, 
diplopia, hypotension, changes in libido, 
nausea, fatigue, depression, dysarthria, 
jaundice, skin rash, ataxia, constipation, 
headache, incontinence, changes in sali-
vation, slurred speech, tremor, vertigo, 
urinary retention, blurred vision. Para-
doxical reactions such as acute hyper-
excited states, anxiety, hallucinations, 
increased muscle spasticity, insomnia, 
rage, sleep disturbances, stimulation 
have been reported; should these occur, 
discontinue drug. Isolated reports of neu-
tropenia, jaundice; periodic blood counts 
and liver function tests advisable during 
long-term therapy. ® Roche Laboratories Division of Hoffmann- La Roche Inc. 
Nutley, N.J. 07110 
If there's 
good reason to 
prescribe for 
psychic tension ... 
When, for example, 
reassurance and counseling 
on repeated visits 
are not enough 
Effectiveness is 
a good reason to 
consider Valium (diazepam) 
2-mg,5-mg, 
10-mg tablets 
